aidx;assay_category;assay_cell_type;assay_chembl_id;assay_classifications;assay_organism;assay_parameters;assay_strain;assay_subcellular_fraction;assay_tax_id;assay_test_type;assay_tissue;assay_type;assay_type_description;bao_format;bao_label;cell_chembl_id;confidence_description;confidence_score;description;document_chembl_id;relationship_description;relationship_type;src_assay_id;src_id;target_chembl_id;tissue_chembl_id;variant_sequence
CLD0;;A549;CHEMBL620275;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;In vitro inhibitory concentration required against human lung A549 carcinoma cells proliferation;CHEMBL1134048;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL621653;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Synergism with indomethacin in A549 cells;CHEMBL1146678;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL621654;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Synergism with sulindac in A549 cells;CHEMBL1146678;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL619526;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;"Drug interaction towards A549 cell line was determined in terms of combination index in presence of Tometin; Not available";CHEMBL1146678;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;;CHEMBL626815;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.;CHEMBL1130080;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL628546;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;"Statistical significance of IC 50 values; Expressed as R value";CHEMBL1130080;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL635477;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logD7.4);CHEMBL1124835;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL635404;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Micelle/water partition coefficient (Pmic) of the compound was determined;CHEMBL1129683;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL858445;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logP);CHEMBL1121459;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;CCRF-CEM;CHEMBL655021;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Effect on cross resistance of CCRF-CEM cells resistant to vincristine.;CHEMBL1124835;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;Panel CNS (Carcinoma cell lines);CHEMBL658402;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307621;Target assigned is non-molecular;1;Inhibition of proliferation in NCI human CNS tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614459;;
CLD0;;Panel CNS (Carcinoma cell lines);CHEMBL658403;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307621;Target assigned is non-molecular;1;Cytotoxic effect on human CNS tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614459;;
CLD0;;Panel CNS (Carcinoma cell lines);CHEMBL658404;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307621;Target assigned is non-molecular;1;Cytostatic effect on human CNS tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614459;;
CLD0;;;CHEMBL658287;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Inhibitory concentration against human T-cell leukemic cell line (CRFF-CEM) in vitro;CHEMBL1124428;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;CCRF-CEM;CHEMBL658288;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Inhibition against CRFF-CEM-T-Cell leukemic cell line;CHEMBL1124592;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;;CHEMBL662299;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Effect on cross resistance of chinese hamster cells resistant to Actinomycin D.;CHEMBL1124835;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;Panel colon (Carcinoma cell lines);CHEMBL662314;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307624;Target assigned is non-molecular;1;Cytostatic effect on human colon tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614467;;
CLD0;;DLKP cell line;CHEMBL664337;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308451;Target assigned is non-molecular;1;Synergism with sulindac in DLKP cells;CHEMBL1146678;Non-molecular target assigned;N;;1;CHEMBL614482;;
CLD0;;DLKP cell line;CHEMBL664817;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308451;Target assigned is non-molecular;1;Synergism with tolmedin in DLKP cells;CHEMBL1146678;Non-molecular target assigned;N;;1;CHEMBL614482;;
CLD0;;DLKP cell line;CHEMBL664818;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308451;Target assigned is non-molecular;1;"Drug interaction towards DLKP cell line was determined in terms of combination index in presence of Indomethacin; Not available";CHEMBL1146678;Non-molecular target assigned;N;;1;CHEMBL614482;;
CLD0;;DU-145;CHEMBL667652;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;In vitro cytotoxic activity against prostate carcinoma (DU-145) cells assayed by inhibition of [3H]-labeled thymidine incorporation;CHEMBL1134309;Non-molecular target assigned;N;;1;CHEMBL613508;;
CLD0;;HT-29;CHEMBL879379;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Inhibitory activity against growth of HT-29 cell line;CHEMBL1131603;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL687850;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Tested for cytotoxicity against HT-29 (MDR)cells;CHEMBL1145018;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL687851;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Tested for cytotoxicity against HT-29 (wt)cells;CHEMBL1145018;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL695208;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;In vitro cytotoxic activity against colon adenocarcinoma (HT-29) cells assayed by inhibition of [3H]-labeled thymidine incorporation;CHEMBL1134309;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HeLa;CHEMBL696195;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity tested against Hela C1 cells;CHEMBL1131902;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HeLa;CHEMBL697745;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity tested against Hela T5 cells;CHEMBL1131902;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;L1210;CHEMBL700818;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;The compound was tested in vitro for growth of inhibitory activity against lymphoid leukemia L1210 cells;CHEMBL1124678;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705357;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Mitotic index (fraction of cells in mitosis divided by total cells ) for cultured lymphoid leukemia L1210 cells;CHEMBL1124678;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;KB 3-1;CHEMBL703333;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307659;Target assigned is non-molecular;1;"Cytotoxicity was evaluated against KB-C2 cells at 0.1 ug/mL; No cytotoxicity";CHEMBL1132809;Non-molecular target assigned;N;;1;CHEMBL614590;;
CLD0;;KB ;CHEMBL704656;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Compound was evaluated for its cytotoxicity against vincristine-sensitive KB/S human oral epidermoid carcinoma cell lines.;CHEMBL1130866;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL704659;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Compound was evaluated for its cytotoxicity against vincristine-resistant KB/VJ300 human oral epidermoid carcinoma cell lines.;CHEMBL1130866;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL703878;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against drug-resistant tumor cell line KB7D.;CHEMBL1132294;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL703879;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Concentration required to reduce proliferation of KB subclones passaged in the presence of etoposide 7 uM (KB7D) cell line by 50% as determined by the MTT method;CHEMBL1148410;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL703880;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Concentration required to reduce proliferation of KB subclones passaged in the presence of vincristine 0.02 uM (KB7D) cell line by 50% as determined by the MTT method;CHEMBL1148410;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL701387;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against drug-resistant tumor cell line KBCamp.;CHEMBL1132294;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL701390;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against drug-resistant tumor cell line KBMDR.;CHEMBL1132294;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL701391;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Concentration required to reduce proliferation of KB subclones passaged in the presence of doxorubicin 0.09 uM (KBMDR) cell line by 50% as determined by the MTT method;CHEMBL1148410;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL873221;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against drug-resistant tumor cell line KBV20C.;CHEMBL1132294;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL702198;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Concentration required to reduce proliferation of KB human nasopharyngeal carcinoma (KBWT) cell line by 50% as determined by the MTT method;CHEMBL1148410;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB 3-1;CHEMBL699927;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307659;Target assigned is non-molecular;1;"Cytotoxicity was evaluated against KB CV-60 cells at 0.1 ug/mL; No cytotoxicity";CHEMBL1132809;Non-molecular target assigned;N;;1;CHEMBL614590;;
CLD0;;KB ;CHEMBL872416;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against drug-resistant tumor cell line KBwt.;CHEMBL1132294;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;;CHEMBL702225;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Compound concentration required to reduce the cell proliferation of Wild type and Drug- resistant KB subclones passaged in the presence of doxorubicin 0.09 uM by 50%;CHEMBL1135654;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;KB ;CHEMBL700543;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Default value - Target unknown or has yet to be assigned;0;Compound concentration required to reduce the cell proliferation of Wild type and Drug- resistant human nasopharyngeal carcinoma KB cells by 50%;CHEMBL1135654;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL700544;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Compound concentration required to reduce the cell proliferation of Wild type and drug-resistant KB subclones passaged in the presence of etoposide 7 uM by 50%;CHEMBL1135654;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL705970;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Effect on the proliferation Wild -type and Drug- resistant KB subclones passaged in the presence of vincristine 0.02 uM;CHEMBL1135654;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;L1210;CHEMBL703766;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Concentration that causes a mitotic index (number of cells in mitosis divided by total cells) of 0.5 for cultured lymphoid leukemia L1210 cells during an exposure period of 12 h;CHEMBL1125562;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL702770;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Fraction of cell population of cultured lymphoid leukemia L1210 cells in mitosis at a dose of 0.3 uM after 24 hr;CHEMBL1122127;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704902;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Concentration required to inhibit proliferation of cultured lymphoid leukemia L1210 cells to 50% growth over 48 hours;CHEMBL1126221;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703372;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Concentration that inhibits proliferation of cultured lymphoid leukemia L1210 cells to 50% control growth during 48 h;CHEMBL1125562;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704718;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Tested for the inhibition of L1210 cell proliferation.;CHEMBL1125276;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707011;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibitory concentration against proliferation of cultured lymphoid leukemia L1210 cells during 48 hrs.;CHEMBL1122127;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705548;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibitory activity against growth of L1210 cell line;CHEMBL1131603;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;Panel leukemia (Carcinoma cell lines);CHEMBL708160;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307533;Target assigned is non-molecular;1;Inhibition of proliferation in NCI human leukemia tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614083;;
CLD0;;Panel leukemia (Carcinoma cell lines);CHEMBL708163;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307533;Target assigned is non-molecular;1;Cytotoxic effect on human leukemia tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614083;;
CLD0;;Panel leukemia (Carcinoma cell lines);CHEMBL708164;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307533;Target assigned is non-molecular;1;Cytostatic effect on human leukemia tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614083;;
CLD0;;MCF7;CHEMBL705712;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Inhibitory activity against growth of MCF-7 cell line;CHEMBL1131603;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;NCI/ADR-RES;CHEMBL712027;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;Cytotoxicity against MCF-7/Adr cells.;CHEMBL1130080;Non-molecular target assigned;N;;1;CHEMBL613829;;
CLD0;;MES-SA/Dx5;CHEMBL711532;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308373;Target assigned is non-molecular;1;In vitro cytotoxic activity against uterine sarcoma (MES-SA) cells assayed by inhibition of [3H]-labeled thymidine incorporation;CHEMBL1134309;Non-molecular target assigned;N;;1;CHEMBL613827;;
CLD0;;NCI;CHEMBL712288;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308688;Target assigned is non-molecular;1;Inhibition of proliferation in NCI 60 human tumor cell line panel, MG-MID represents mean value;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL712289;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Cytostatic effect on 60 human tumor cell line panel, MG-MID represents mean value;CHEMBL1135474;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL722088;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated in vivo for antileukemic activity by calculating Percent increase in life span at dose of 2 mg/kg;CHEMBL1125562;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL735923;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.7', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.7'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase in life span at the highest nontoxic dose against P-388 tumor cell after 1 day at 2.7 mg/kg;CHEMBL1122127;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737255;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.33', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.33'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase in life span at the highest nontoxic dose against P-388 tumor cell after 1-9 day at 0.33 mg/kg;CHEMBL1122127;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL735158;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent increase in life span at dose 0.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL735806;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent increase in life span at dose 1 mg/kg/day in 10 mice implanted with P388 leukemia cell line;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL735807;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent increase in life span at dose 1.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL739521;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent increase in life span at dose 2 mg/kg/day in 10 mice implanted with P388 leukemia cell line;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL739566;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia cells intraperitoneally at a dose of 0.22 mg/kg per day for 1-9 scheduled days;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739569;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intraperitoneally at a dose of 1 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739571;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intraperitoneally at a dose of 2.7 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739572;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intraperitoneally at a dose of 2 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739576;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 0.5 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739577;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 1.5 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739744;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 1 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739745;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 2.5 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL740427;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 2 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739904;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 3.5 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738758;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 3 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738759;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 4.5 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738762;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 4 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738763;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 5.5 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738768;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 5 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738769;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 6.5 mg/kg per day;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738393;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg as range.;CHEMBL1130845;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738394;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 364, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Central Analgesic Activity', 'l3': 'Chemotherapy Induced Pain for Peripheral Neuropathic Pain', 'source': 'Vogel_2008'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg in the presence of vincristine at 0.1 mg/kg as range.;CHEMBL1130845;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737412;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Acute iv toxicity against mice after a dose of injection;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739814;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 364, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Central Analgesic Activity', 'l3': 'Chemotherapy Induced Pain for Peripheral Neuropathic Pain', 'source': 'Vogel_2008'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg as in the presence of vincristine at 0.1 mg/kg as the ratio of median survival time of treated mice to control mice;CHEMBL1130845;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739815;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg as the ratio of median survival time of treated mice to control mice;CHEMBL1130845;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL742245;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Number of survivors on 60th day at dose 1 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL742246;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Number of survivors on 60th day at dose 1.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL738074;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Number of survivors on 60th day at dose 2 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL741075;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 0.33 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL741076;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 1 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL741226;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 2.7 mg/kg/day; 0/11";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL741227;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 2 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL741231;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 0.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL741232;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 1.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL742030;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 1 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL742031;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 2.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL737974;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 2 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL743071;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 3.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL743073;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 3 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL738998;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 4.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL739001;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 4 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL739002;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 5.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL739006;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL739007;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 6.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL879314;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 0.22 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL739018;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 1 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL737898;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 2.7 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL737900;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 2 mg/kg/day; 0/11";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL738059;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 0.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL742594;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 1.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL741834;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 1 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL741835;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 2.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL744418;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 2 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL744419;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 3.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL878922;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 3 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL744421;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 4.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL744424;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 4 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL746011;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 5.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL746015;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL746016;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 6.5 mg/kg/day; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL746024;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Number of survivors on 30th day at dose 0.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL746025;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Number of survivors on 30th day at dose 1 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL742720;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Number of survivors on 30th day at dose 1.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL742637;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Number of survivors on 30th day at dose 2 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL746663;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Number of survivors on 60th day at dose 0.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL746672;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg as percent ratio of median survival time of treated mice to control mice;CHEMBL1130845;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL746673;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 364, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Central Analgesic Activity', 'l3': 'Chemotherapy Induced Pain for Peripheral Neuropathic Pain', 'source': 'Vogel_2008'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg in the presence of vincristine at 0.1 mg/kg as percent ratio of median survival time of treated mice to control mice;CHEMBL1130845;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;NCI-H460;CHEMBL750707;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;In vitro cytotoxic activity against nonsmall cell lung carcinoma (NCI-H460) cells assayed by inhibition of [3H]-labeled thymidine incorporation;CHEMBL1134309;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;NSCLC;CHEMBL751411;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Inhibition of proliferation in NCI human non-small cell lung tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;NSCLC;CHEMBL751412;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Cytotoxic effect on human non-small cell lung carcinoma cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;NSCLC;CHEMBL751414;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Cytostatic effect on human non-small cell lung carcinoma tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;P388;CHEMBL758683;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;"The compound was evaluated in vitro for the P388 cell spindle disruption.; 0.02-0.04";CHEMBL1126349;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL761079;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity against mice implanted with lymphatic leukemia P388 cells (10e6 tumor cells) after intraperitoneal administration of 2 mg/kg per injection (1-5 days);CHEMBL1126221;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756391;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was tested for % increase in life span of P388 tumor;CHEMBL1126349;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756539;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was tested for % increase in life span of adriamycin resistant P388 tumor;CHEMBL1126349;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756541;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was tested for % increase in life span of vincristine resistant P388 tumor;CHEMBL1126349;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL755408;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Increase in the life span of mice implanted with lymphocytic leukemia P388 at the highest nontoxic dose of 1.5 mg/kg given to the compound intraperitoneally;CHEMBL1124678;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758077;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vitro inhibitory concentration required against murine P388 leukemic cells proliferation;CHEMBL1134048;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL761423;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Long-term survivors (LTS) for 60 days at optimal dose of 3.0 mg/kg for antitumor activity against P388 leukemia cells in 15 mice.;CHEMBL1125276;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL759423;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Compound was tested for T/C range at optimal dose of 3.0 mg/kg for antitumor activity against P388 leukemia cells in mice; value ranges from 165-181";CHEMBL1125276;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;PC-12;CHEMBL758459;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307976;Target assigned is non-molecular;1;Compound was evaluated for in vitro growth inhibition activity against multi drug resistant (MDR) PC-12 cell line.;CHEMBL1130905;Non-molecular target assigned;N;;1;CHEMBL612556;;
CLD0;;PC-6;CHEMBL759723;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307571;Target assigned is non-molecular;1;Compound was evaluated for in vitro growth inhibition activity against sensitive PC-6 cell line.;CHEMBL1130905;Non-molecular target assigned;N;;1;CHEMBL614235;;
CLD0;;Panel prostate (Carcinoma cell lines);CHEMBL765161;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308427;Target assigned is non-molecular;1;Cytotoxic effect on human prostate tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614692;;
CLD0;;;CHEMBL788350;[];Rattus norvegicus;[];;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Acute iv toxicity against rat after a dose of injection;CHEMBL1122917;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL790288;[];Rattus norvegicus;[];;;10116.0;;Brain;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;The capillary permeability of radioligand was measured in Rat brain;CHEMBL1121459;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638188;
CLD0;;;CHEMBL818983;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;In vitro inhibition of tubulin polymerization measured as turbidity formed by centrifugation;CHEMBL1131603;Direct protein target assigned;D;;1;CHEMBL2094134;;
CLD0;;;CHEMBL815200;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Multiple homologous protein targets may be assigned;4;The compound tested for the inhibition of tubulin polymerization.;CHEMBL1125276;Homologous protein target assigned;H;;1;CHEMBL2095182;;
CLD0;;;CHEMBL816889;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;The compound was evaluated in vitro for the mammalian brain tubulin polymerization using standard assay.;CHEMBL1126349;Homologous protein target assigned;H;;1;CHEMBL3658;;
CLD0;;;CHEMBL817771;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;beta-Tubulin GTPase activity at 1 uM concentration.;CHEMBL1134638;Homologous protein target assigned;H;;1;CHEMBL3394;;
CLD0;;;CHEMBL817773;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;beta-Tubulin GTPase activity at 10 uM concentration.;CHEMBL1134638;Homologous protein target assigned;H;;1;CHEMBL3394;;
CLD0;;Panel breast (Carcinoma cell lines);CHEMBL819386;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307607;Target assigned is non-molecular;1;Inhibition of proliferation in NCI human breast tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614362;;
CLD0;;Panel breast (Carcinoma cell lines);CHEMBL819387;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307607;Target assigned is non-molecular;1;Cytotoxic effect on human breast tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614362;;
CLD0;;Panel breast (Carcinoma cell lines);CHEMBL881118;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307607;Target assigned is non-molecular;1;Cytostatic effect on human breast tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614362;;
CLD0;;Panel colon (Carcinoma cell lines);CHEMBL823453;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307624;Target assigned is non-molecular;1;Inhibition of proliferation in NCI human colon tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614467;;
CLD0;;Panel colon (Carcinoma cell lines);CHEMBL823454;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307624;Target assigned is non-molecular;1;Cytotoxic effect on human colon tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614467;;
CLD0;;Panel melanoma (Carcinoma cell lines);CHEMBL822046;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307948;Target assigned is non-molecular;1;Inhibition of proliferation in NCI human melanoma tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL612280;;
CLD0;;Panel melanoma (Carcinoma cell lines);CHEMBL822048;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307948;Target assigned is non-molecular;1;Cytotoxic effect on human melanoma tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL612280;;
CLD0;;Panel melanoma (Carcinoma cell lines);CHEMBL822051;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307948;Target assigned is non-molecular;1;Cytostatic effect on human melanoma tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL612280;;
CLD0;;Panel ovarian (Carcinoma cell lines);CHEMBL823206;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307754;Target assigned is non-molecular;1;Inhibition of proliferation in NCI human ovarian tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL615007;;
CLD0;;Panel ovarian (Carcinoma cell lines);CHEMBL823207;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307754;Target assigned is non-molecular;1;Cytotoxic effect on human ovarian tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL615007;;
CLD0;;Panel ovarian (Carcinoma cell lines);CHEMBL823208;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307754;Target assigned is non-molecular;1;Cytostatic effect on human ovarian tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL615007;;
CLD0;;Panel prostate (Carcinoma cell lines);CHEMBL821746;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308427;Target assigned is non-molecular;1;Inhibition of proliferation in NCI human prostate tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614692;;
CLD0;;Panel prostate (Carcinoma cell lines);CHEMBL821747;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308427;Target assigned is non-molecular;1;Cytostatic effect on human prostate tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL614692;;
CLD0;;P388;CHEMBL872809;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;The compound was evaluated in vitro for the inhibition of P388D1 cell colony formation.;CHEMBL1126349;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL821657;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;The compound was evaluated in vitro for the inhibition of murine leukemia P388D1 cell proliferation.;CHEMBL1126349;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL846831;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Chemosensitizing index is the ratio of IC50 (vincristine) to that of IC50 (vincristine+sinensetin);CHEMBL1146678;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL845556;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Relative resistance is the ratio of IC50 values of drug with JTV-519 to that without the reversing agent;CHEMBL1146678;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;Panel renal (Carcinoma cell lines);CHEMBL848063;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307963;Target assigned is non-molecular;1;Inhibition of proliferation in NCI human renal tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL612516;;
CLD0;;Panel renal (Carcinoma cell lines);CHEMBL848064;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307963;Target assigned is non-molecular;1;Cytotoxic effect on human renal tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL612516;;
CLD0;;Panel renal (Carcinoma cell lines);CHEMBL848065;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307963;Target assigned is non-molecular;1;Cytostatic effect on human renal tumor cell lines;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL612516;;
CLD0;;;CHEMBL845710;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Cytotoxic effect on 60 human tumor cell line panel, MG-MID represents mean value;CHEMBL1135474;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;CNS cell;CHEMBL831456;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307705;Target assigned is non-molecular;1;Total growth inhibition of human CNS cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614782;;
CLD0;;Colon cell;CHEMBL831458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307625;Target assigned is non-molecular;1;Total growth inhibition of human Colon cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614469;;
CLD0;;NSCLC;CHEMBL831460;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Total growth inhibition of human NSCLC cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;Renal cell;CHEMBL831462;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307695;Target assigned is non-molecular;1;Total growth inhibition of human Renal cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614738;;
CLD0;;Panel NCI-60 (60 carcinoma cell lines);CHEMBL831464;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307560;Target assigned is non-molecular;1;Total growth inhibition of human MG-MID cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614194;;
CLD0;;Breast carcinoma cell;CHEMBL831466;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307509;Target assigned is non-molecular;1;Total growth inhibition of human Breast cell line at 10E-3 M concentration ;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614026;;
CLD0;;Leukemia cell;CHEMBL831469;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Total growth inhibition of human Leukemia cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614844;;
CLD0;;Melanoma cell;CHEMBL831549;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Total growth inhibition of human Melanoma cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614126;;
CLD0;;Ovarian carcinoma cell;CHEMBL831551;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307679;Target assigned is non-molecular;1;Total growth inhibition of human Ovarian cell line at 10E-3 M concentration ;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614667;;
CLD0;;Prostate cell;CHEMBL831553;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307720;Target assigned is non-molecular;1;Total growth inhibition of human Prostate cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614850;;
CLD0;;HCT-116;CHEMBL836381;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Compound was tested for growth inhibition of human colon carcinoma HCT116 cell line;CHEMBL1138726;Non-molecular target assigned;N;;1;CHEMBL394;;
CLD0;;A549;CHEMBL824968;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Inhibition of human non-small cell lung cancer A549 cell proliferation;CHEMBL1138726;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;NCI-H460;CHEMBL837301;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Compound was tested for growth inhibition of human non-small cell lung cancer NCI-H460 cell line;CHEMBL1138726;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;CNS cell;CHEMBL825195;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307705;Target assigned is non-molecular;1;Growth inhibitory concentration dissolved in DMSO against human CNS cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614782;;
CLD0;;Colon cell;CHEMBL825197;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307625;Target assigned is non-molecular;1;Growth inhibitory concentration dissolved in DMSO against human Colon cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614469;;
CLD0;;NSCLC;CHEMBL836251;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Growth inhibitory concentration dissolved in DMSO against human NSCLC cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;Renal cell;CHEMBL836253;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307695;Target assigned is non-molecular;1;Growth inhibitory concentration dissolved in DMSO against human Renal cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614738;;
CLD0;;Breast carcinoma cell;CHEMBL836255;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307509;Target assigned is non-molecular;1;Growth inhibitory concentration dissolved in DMSO against human Breast cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614026;;
CLD0;;Panel NCI-60 (60 carcinoma cell lines);CHEMBL836257;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307560;Target assigned is non-molecular;1;Growth inhibitory concentration dissolved in DMSO against human MG-MID cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614194;;
CLD0;;Ovarian carcinoma cell;CHEMBL836259;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307679;Target assigned is non-molecular;1;Growth inhibitory concentration dissolved in DMSO against human Ovarian cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614667;;
CLD0;;Melanoma cell;CHEMBL833731;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Growth inhibitory concentration dissolved in DMSO against human Melanoma cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614126;;
CLD0;;Prostate cell;CHEMBL833733;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307720;Target assigned is non-molecular;1;Growth inhibitory concentration dissolved in DMSO against human Prostate cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614850;;
CLD0;;Leukemia cell;CHEMBL832913;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Growth inhibitory concentration dissolved in DMSO against human leukemia cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614844;;
CLD0;;;CHEMBL833941;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;Compound was tested for inhibition of tubulin polymerisation;CHEMBL1138726;Homologous protein target assigned;H;;1;CHEMBL3186;;
CLD0;;ARO;CHEMBL833212;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307996;Target assigned is non-molecular;1;Cytotoxic activity against human tumor Aro cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;PT45;CHEMBL833220;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxic activity against human tumor PT45 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;A 172;CHEMBL833357;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308491;Target assigned is non-molecular;1;Cytotoxic activity against human tumor A-172 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL614512;;
CLD0;;C8305;CHEMBL833358;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxic activity against human tumor C8305 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HT-29;CHEMBL833359;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxic activity against human tumor HT-29 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;MCF7;CHEMBL833360;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxic activity against human tumor MCF-7 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;SW 13;CHEMBL826399;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxic activity against human tumor SW 13 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL833370;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Cytotoxic activity against human tumor Hep 3B cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HepG2;CHEMBL833371;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxic activity against human tumor Hep G2 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;IGROV-1;CHEMBL833385;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;Cytotoxic activity against human tumor Igrov-1 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL613984;;
CLD0;;OVCAR-3;CHEMBL833386;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Cytotoxic activity against human tumor Ovcar-3 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;NCI-H295;CHEMBL834614;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxic activity against human tumor NCI-H295 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB 3-1;CHEMBL834628;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307659;Target assigned is non-molecular;1;inhibitory concentration against human MDR KB/V cell line;CHEMBL1137855;Non-molecular target assigned;N;;1;CHEMBL614590;;
CLD0;;;CHEMBL834631;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Cytotoxic activity against human tumor PLC/PRF/5 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Paca 2;CHEMBL834653;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxic activity against human tumor Mia Paca 2 cell line;CHEMBL1144427;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;CNS cell;CHEMBL837016;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307705;Target assigned is non-molecular;1;Cytotoxic effect dissolved in DMSO against CNS cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614782;;
CLD0;;Colon cell;CHEMBL837023;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307625;Target assigned is non-molecular;1;Cytotoxic effect dissolved in DMSO against Colon cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614469;;
CLD0;;NSCLC;CHEMBL837025;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Cytotoxic effect dissolved in DMSO against NSCLC cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;Renal cell;CHEMBL876008;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307695;Target assigned is non-molecular;1;Cytotoxic effect dissolved in DMSO against Renal cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614738;;
CLD0;;Breast carcinoma cell;CHEMBL837109;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307509;Target assigned is non-molecular;1;Cytotoxic effect dissolved in DMSO against Breast cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614026;;
CLD0;;Panel NCI-60 (60 carcinoma cell lines);CHEMBL837111;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307560;Target assigned is non-molecular;1;Cytotoxic effect dissolved in DMSO against MG-MID cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614194;;
CLD0;;Ovarian carcinoma cell;CHEMBL837113;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307679;Target assigned is non-molecular;1;Cytotoxic effect dissolved in DMSO against Ovarian cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614667;;
CLD0;;Leukemia cell;CHEMBL837115;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Cytotoxic effect dissolved in DMSO against Leukemia cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614844;;
CLD0;;Melanoma cell;CHEMBL837117;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Cytotoxic effect dissolved in DMSO against Melanoma cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614126;;
CLD0;;Prostate cell;CHEMBL837119;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307720;Target assigned is non-molecular;1;Cytotoxic effect dissolved in DMSO against Prostate cell line at 10E-3 M concentration;CHEMBL1141167;Non-molecular target assigned;N;;1;CHEMBL614850;;
CLD0;;;CHEMBL826249;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;Compound was tested for inhibition of tubulin polymerisation at 1 uM;CHEMBL1138726;Homologous protein target assigned;H;;1;CHEMBL3186;;
CLD0;;HeLa;CHEMBL862161;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HepG2;CHEMBL861034;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;NCI-H295R;CHEMBL861035;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307998;Target assigned is non-molecular;1;Cytotoxicity against human H295R cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL612593;;
CLD0;;OVCAR-3;CHEMBL861036;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Cytotoxicity against human Ovcar3 cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;MCF7;CHEMBL861037;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;ARO;CHEMBL861038;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307996;Target assigned is non-molecular;1;Cytotoxicity against human Aro cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL612590;;
CLD0;;A549;CHEMBL861039;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;HT-29;CHEMBL861040;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT29 cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;PT-45;CHEMBL861041;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307992;Target assigned is non-molecular;1;Cytotoxicity against human PT45 cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL612586;;
CLD0;;4T1;CHEMBL861042;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307995;Target assigned is non-molecular;1;Cytotoxicity against mouse 4T1 cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL612589;;
CLD0;;BNL;CHEMBL861043;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307984;Target assigned is non-molecular;1;Cytotoxicity against mouse BNL cells by MTT assay;CHEMBL1138193;Non-molecular target assigned;N;;1;CHEMBL612576;;
CLD0;;OVCAR-3;CHEMBL867647;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Multiple direct protein targets may be assigned;5;Microtubule disassembly in Ovcar3 cells at 5 uM;CHEMBL1138193;Direct protein target assigned;D;;1;CHEMBL2095182;;
CLD0;;MCF7;CHEMBL866242;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells by MTT assay;CHEMBL1146977;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL866243;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells by clonogenic assay;CHEMBL1146977;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;WRL68;CHEMBL866244;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307993;Target assigned is non-molecular;1;Cytotoxicity against human WRL68 cells by MTT assay;CHEMBL1146977;Non-molecular target assigned;N;;1;CHEMBL612587;;
CLD0;;WRL68;CHEMBL866245;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307993;Target assigned is non-molecular;1;Cytotoxicity against human WRL68 cells by clonogenic assay;CHEMBL1146977;Non-molecular target assigned;N;;1;CHEMBL612587;;
CLD0;;KB ;CHEMBL866246;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells by MTT assay;CHEMBL1146977;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL866247;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells by clonogenic assay;CHEMBL1146977;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;PA-1;CHEMBL866248;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308812;Target assigned is non-molecular;1;Cytotoxicity against human PA1 cells by MTT assay;CHEMBL1146977;Non-molecular target assigned;N;;1;CHEMBL614949;;
CLD0;;PA-1;CHEMBL866249;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308812;Target assigned is non-molecular;1;Cytotoxicity against human PA1 cells by clonogenic assay;CHEMBL1146977;Non-molecular target assigned;N;;1;CHEMBL614949;;
CLD0;;COLO 320DM;CHEMBL866250;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307647;Target assigned is non-molecular;1;Cytotoxicity against human Colo320DM cells by MTT assay;CHEMBL1146977;Non-molecular target assigned;N;;1;CHEMBL614562;;
CLD0;;COLO 320DM;CHEMBL866251;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307647;Target assigned is non-molecular;1;Cytotoxicity against human Colo320DM cells by clonogenic assay;CHEMBL1146977;Non-molecular target assigned;N;;1;CHEMBL614562;;
CLD0;;MDA-MB-435;CHEMBL855605;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against multidrug resistant MDA435/LCC6 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;MDA-MB-435;CHEMBL855609;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against MDA435/LCC6 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;P388/ADR;CHEMBL855610;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;Antiproliferative activity against adriamycin resistant P388 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614218;;
CLD0;;P388;CHEMBL855617;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against P388 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;MDA-MB-435;CHEMBL855045;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;MDA-MB-435;CHEMBL855046;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM verapamil by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;MDA-MB-435;CHEMBL855052;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant MDA435/LCC6 cells;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;P388/ADR;CHEMBL855054;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614218;;
CLD0;;P388/ADR;CHEMBL855055;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM verapamil by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614218;;
CLD0;;P388;CHEMBL855056;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant P388 cells;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;Panel leukemia (Carcinoma cell lines);CHEMBL855036;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307533;Target assigned is non-molecular;1;Anticancer activity against leukemia cancer cell lines of NCI60 panel;CHEMBL1137368;Non-molecular target assigned;N;;1;CHEMBL614083;;
CLD0;;NSCLC;CHEMBL855037;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Anticancer activity against NSCLC cancer cell lines of NCI60 panel;CHEMBL1137368;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;Panel colon (Carcinoma cell lines);CHEMBL855038;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307624;Target assigned is non-molecular;1;Anticancer activity against colon cancer cell lines of NCI60 panel;CHEMBL1137368;Non-molecular target assigned;N;;1;CHEMBL614467;;
CLD0;;Panel CNS (Carcinoma cell lines);CHEMBL855039;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307621;Target assigned is non-molecular;1;Anticancer activity against CNS cancer cell lines of NCI60 panel;CHEMBL1137368;Non-molecular target assigned;N;;1;CHEMBL614459;;
CLD0;;Panel melanoma (Carcinoma cell lines);CHEMBL855040;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307948;Target assigned is non-molecular;1;Anticancer activity against melanoma cancer cell lines of NCI60 panel;CHEMBL1137368;Non-molecular target assigned;N;;1;CHEMBL612280;;
CLD0;;Panel ovarian (Carcinoma cell lines);CHEMBL855041;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307754;Target assigned is non-molecular;1;Anticancer activity against ovarian cancer cell lines of NCI60 panel;CHEMBL1137368;Non-molecular target assigned;N;;1;CHEMBL615007;;
CLD0;;Panel renal (Carcinoma cell lines);CHEMBL855042;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307963;Target assigned is non-molecular;1;Anticancer activity against renal cancer cell lines of NCI60 panel;CHEMBL1137368;Non-molecular target assigned;N;;1;CHEMBL612516;;
CLD0;;Panel prostate (Carcinoma cell lines);CHEMBL855043;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308427;Target assigned is non-molecular;1;Anticancer activity against prostate cancer cell lines of NCI60 panel;CHEMBL1137368;Non-molecular target assigned;N;;1;CHEMBL614692;;
CLD0;;Panel breast (Carcinoma cell lines);CHEMBL855044;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307607;Target assigned is non-molecular;1;Anticancer activity against breast cancer cell lines of NCI60 panel;CHEMBL1137368;Non-molecular target assigned;N;;1;CHEMBL614362;;
CLD0;;KB ;CHEMBL856011;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL913041;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 0.1 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL913042;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 0.3 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL913043;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 1 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL913044;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 3.16 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL913045;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 10 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853888;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 31.6 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853889;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 100 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853890;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 316 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853891;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 0.1 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853892;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 0.3 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853893;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 1 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853894;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 3.16 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853895;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 10 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853896;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 31.6 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853897;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 100 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853898;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 316 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853899;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 0.1 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853900;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 0.3 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853901;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 1 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853902;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 3.16 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853903;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 10 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853904;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 31.6 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853905;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 100 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL853906;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 316 nM;CHEMBL1138222;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;COLO 205;CHEMBL910671;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;Cytotoxicity against COLO205 cells;CHEMBL1139851;Non-molecular target assigned;N;;1;CHEMBL614561;;
CLD0;;KB ;CHEMBL910672;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against KB cells expressing MDR1;CHEMBL1139851;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;;CHEMBL910673;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against KB8.5 cells expressing MDR1;CHEMBL1139851;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB-V1;CHEMBL910674;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295414;Target assigned is non-molecular;1;Antiproliferative activity against KBV1 cells expressing MDR1;CHEMBL1139851;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL910675;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Default value - Target unknown or has yet to be assigned;0;Ratio of IC50 for KB8.5 cells to IC50 for KB cells;CHEMBL1139851;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;KBV1;CHEMBL910676;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Ratio of IC50 for KBV1 cells to IC50 for KB cells;CHEMBL1139851;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;HeLa;CHEMBL912484;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Induction of apoptosis in HeLa cells assessed as effect on sub-G1 population;CHEMBL1139851;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;SMMC-7721;CHEMBL916633;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308059;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human SMMC7721 cells after 48 hrs;CHEMBL1139860;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;HL-60;CHEMBL916634;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 48 hrs;CHEMBL1139860;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;L02;CHEMBL916635;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human L02 cells after 48 hrs;CHEMBL1139860;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;MDA-MB-231;CHEMBL886026;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Antiproliferative activity against human MDA-MB-231 cells after 4 days;CHEMBL1143713;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;MCF7;CHEMBL886027;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells after 5 days;CHEMBL1143713;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MDA-MB-231;CHEMBL886028;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cell cycle arrest in MDA-MB-231 cells by accumulation at G2/M phase after 24 hrs by flow cytometry;CHEMBL1143713;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;U-87MG ATCC;CHEMBL886032;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307575;Default value - Target unknown or has yet to be assigned;0;Effect on cell morphology in human U87 cells assessed as disruption of microtubule network and loss of function at 10 nM after 3 hrs;CHEMBL1143713;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;COLO 205;CHEMBL887766;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;Cytotoxicity against COLO205 cells;CHEMBL1144649;Non-molecular target assigned;N;;1;CHEMBL614561;;
CLD0;;KB ;CHEMBL888943;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against KB cells;CHEMBL1144649;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;;CHEMBL888944;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against KB8.5 cells;CHEMBL1144649;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB-V1;CHEMBL888945;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295414;Target assigned is non-molecular;1;Antiproliferative activity against KBV1cells;CHEMBL1144649;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL888946;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Default value - Target unknown or has yet to be assigned;0;Ratio of IC50 for KB8.5 cells to IC50 for KB cells;CHEMBL1144649;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;KB V1;CHEMBL888947;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Ratio of IC50 for KB8.5 cells to IC50 for KB V1 cells;CHEMBL1144649;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;Leukemia cell;CHEMBL888485;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Antitumor activity against leukemia cells;CHEMBL1145408;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;NSCLC;CHEMBL888486;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Antitumor activity against NSCLC cells;CHEMBL1145408;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;;CHEMBL888487;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antitumor activity against colon tumor cells;CHEMBL1145408;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;CNS tumor;CHEMBL888488;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antitumor activity against CNS tumor cells;CHEMBL1145408;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Melanoma cell;CHEMBL888489;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Antitumor activity against melanoma cells;CHEMBL1145408;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL888490;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antitumor activity against renal tumor cells;CHEMBL1145408;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL888491;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antitumor activity against prostate tumor cells;CHEMBL1145408;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL888492;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antitumor activity against ovarian tumor cells;CHEMBL1145408;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL888493;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antitumor activity against breast tumor cells;CHEMBL1145408;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MCF7;CHEMBL888636;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Growth inhibition of Pgp deficient MCF7 cells expressing MRP1;CHEMBL1145421;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;NCI/ADR;CHEMBL888637;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Growth inhibition of NCI/ADR cells expressing Pgp/MRP1;CHEMBL1145421;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MCF7-VP;CHEMBL888638;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307299;Target assigned is non-molecular;1;Growth inhibition of Pgp deficient MCF7/VP cells expressing MRP1;CHEMBL1145421;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;A549;CHEMBL890270;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells by SRB microtiter plate assay;CHEMBL1145456;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;KB ;CHEMBL890271;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells by SRB microtiter plate assay;CHEMBL1145456;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;DU-145;CHEMBL890272;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;Cytotoxicity against human DU145 cells by SRB microtiter plate assay;CHEMBL1145456;Non-molecular target assigned;N;;1;CHEMBL613508;;
CLD0;;ZR-75-1;CHEMBL890273;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307615;Target assigned is non-molecular;1;Cytotoxicity against human ZR751cells by SRB microtiter plate assay;CHEMBL1145456;Non-molecular target assigned;N;;1;CHEMBL614393;;
CLD0;;;CHEMBL890274;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against multidrug resistant human KB-Vin cells by SRB microtiter plate assay;CHEMBL1145456;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;A549;CHEMBL890773;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against A549 cells after 48 hrs by MTT assay;CHEMBL1146228;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;SMMC-7721;CHEMBL890774;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Cytotoxicity against SMMC7721 cells after 48 hrs by MTT assay;CHEMBL1146228;Non-molecular target assigned;N;;1;CHEMBL613831;;
CLD0;;AGS;CHEMBL890775;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308078;Target assigned is non-molecular;1;Cytotoxicity against AGS cells after 48 hrs by MTT assay;CHEMBL1146228;Non-molecular target assigned;N;;1;CHEMBL613860;;
CLD0;;HT-29;CHEMBL890776;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against HT29 cells after 48 hrs by MTT assay;CHEMBL1146228;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;;CHEMBL897535;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Multiple direct protein targets may be assigned;5;Inhibition of tubulin polymerization at 20 uM;CHEMBL1148871;Direct protein target assigned;D;;1;CHEMBL2095182;;
CLD0;;K562;CHEMBL899158;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by MTT assay;CHEMBL1137538;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;;CHEMBL899159;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human multidrug resistant Lucena1 cells assessed as cell viability after 48 hrs by MTT assay;CHEMBL1137538;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MDA-MB-231;CHEMBL900374;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Antiproliferative activity against human MDA-MB-231 cells after 4 days by microplate assay;CHEMBL1137541;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;MCF7;CHEMBL900375;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells after 5 days by microplate assay;CHEMBL1137541;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MDA-MB-231;CHEMBL900385;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cell cycle arrest in MDA-MB-231 cells by accumulation at G2/M phase at 0.01 uM after 24 hrs by flow cytometry;CHEMBL1137541;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;MDA-MB-231;CHEMBL900386;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cell cycle arrest in MDA-MB-231 cells by accumulation at G2/M phase at 0.1 uM after 24 hrs by flow cytometry;CHEMBL1137541;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;HeLa;CHEMBL900695;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HepG2;CHEMBL900696;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;H295R;CHEMBL900697;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human H295R cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;OVCAR-3;CHEMBL900698;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Cytotoxicity against human Ovcar3 cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;MCF7;CHEMBL900699;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;ARO;CHEMBL900700;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307996;Target assigned is non-molecular;1;Cytotoxicity against human Aro cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL612590;;
CLD0;;A549;CHEMBL900701;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;HT-29;CHEMBL900702;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT29 cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;PT-45;CHEMBL900703;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307992;Target assigned is non-molecular;1;Cytotoxicity against human PT45 cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL612586;;
CLD0;;OE19;CHEMBL900704;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308462;Target assigned is non-molecular;1;Cytotoxicity against human OE19 cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL1075555;;
CLD0;;OE33;CHEMBL900705;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308776;Target assigned is non-molecular;1;Cytotoxicity against human OE33 cells after 72 hrs by MTT assay;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL1075556;;
CLD0;;A549;CHEMBL900710;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cell cycle arrest in human A549 cells assessed as accumulation at G1 phase at 1 uM after 24 hrs;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL900711;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cell cycle arrest in human A549 cells assessed as accumulation at G1 phase at 0.1 uM after 24 hrs;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL900712;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 1 uM after 24 hrs;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL900713;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 0.1 uM after 24 hrs;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL900714;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 1 uM after 24 hrs;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL900715;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cell cycle arrest in human A549 cells assessed as accumulation at sub Go phase at 1 uM after 24 hrs;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL900716;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cell cycle arrest in human A549 cells assessed as accumulation at sub Go phase at 0.1 uM after 24 hrs;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL900717;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 0.1 uM after 24 hrs;CHEMBL1137570;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;KB ;CHEMBL901937;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2/M phase after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901938;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 0.1 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901940;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 0.3 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901941;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 1 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901939;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 3.16 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901942;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 10 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901943;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 31.6 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901944;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 100 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901945;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 316 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901947;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 0.1 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901948;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 0.3 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901949;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 1 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901950;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 3.16 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901951;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 10 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901952;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 31.6 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901953;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 100 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901954;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 316 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901956;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 0.1 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901957;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 0.3 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901958;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 1 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901959;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 3.16 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901960;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 10 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901961;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 31.6 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901962;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 100 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL901963;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 316 nM after 24 hrs by flow cytometric analysis;CHEMBL1138290;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;A2780 ADR;CHEMBL903354;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3988401;Target assigned is non-molecular;1;Cytotoxicity againt multidrug-resistant human 2780AD cells;CHEMBL1139110;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;A2780;CHEMBL903355;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Cytotoxicity againt human A2780 cells;CHEMBL1139110;Non-molecular target assigned;N;;1;CHEMBL614004;;
CLD0;;A2780;CHEMBL887777;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Growth inhibition of human A2780 cells;CHEMBL1139973;Non-molecular target assigned;N;;1;CHEMBL614004;;
CLD0;;A2780 ADR;CHEMBL887781;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3988401;Target assigned is non-molecular;1;Growth inhibition of multidrug-resistant human 2780AD cells;CHEMBL1139973;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL926278;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells;CHEMBL1140639;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB/VJ300;CHEMBL926279;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513114;Target assigned is non-molecular;1;Cytotoxicity against human KB/VJ300 cells;CHEMBL1140639;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL942827;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells;CHEMBL1141328;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB/VJ300;CHEMBL942828;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513114;Target assigned is non-molecular;1;Cytotoxicity against human KB/VJ300 cells;CHEMBL1141328;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;A 172;CHEMBL943165;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308491;Target assigned is non-molecular;1;Cytotoxicity against human A172 cells after 6 days;CHEMBL1141436;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;T47D;CHEMBL944953;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307606;Target assigned is non-molecular;1;Induction of apoptosis in human T47D cells assessed as caspase activation after 24 hrs by HTS assay;CHEMBL1140741;Non-molecular target assigned;N;;1;CHEMBL614361;;
CLD0;;HCT-116;CHEMBL944954;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Induction of apoptosis in human HCT116 cells assessed as caspase activation after 24 hrs by HTS assay;CHEMBL1140741;Non-molecular target assigned;N;;1;CHEMBL394;;
CLD0;;SNU-398;CHEMBL944955;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307619;Target assigned is non-molecular;1;Induction of apoptosis in human SNU398 cells assessed as caspase activation after 24 hrs by HTS assay;CHEMBL1140741;Non-molecular target assigned;N;;1;CHEMBL614454;;
CLD0;;KB ;CHEMBL932492;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells assessed as cell viability after 48 hrs by MTS assay;CHEMBL1142402;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KBV20C;CHEMBL932493;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against multidrug resistant P-gp expressing human KBV20C cells assessed as cell viability after 48 hrs by MTS assay;CHEMBL1142402;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;K562;CHEMBL922492;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cell cycle arrest in human K562 cells assessed as accumulation at G2/M phase at 10 uM after 24 hrs by flow cytometry;CHEMBL1144837;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;HeLa;CHEMBL1020849;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 48 hrs by MTT assay;CHEMBL1159320;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HEp-2;CHEMBL1020850;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307694;Target assigned is non-molecular;1;Cytotoxicity against human Hep2 cells after 48 hrs by MTT assay;CHEMBL1159320;Non-molecular target assigned;N;;1;CHEMBL614735;;
CLD0;;CHO;CHEMBL1020852;[];Cricetulus griseus;[];;;10029.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Cytotoxicity against CHO cells after 48 hrs by MTT assay;CHEMBL1159320;Non-molecular target assigned;N;;1;CHEMBL613853;;
CLD0;;;CHEMBL1020853;[];Bos taurus;[];;;9913.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against bovine Bon-Fib cells after 48 hrs by MTT assay;CHEMBL1159320;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;BGC-823;CHEMBL965889;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307635;Target assigned is non-molecular;1;Cytotoxicity against human BGC823 cells;CHEMBL1148213;Non-molecular target assigned;N;;1;CHEMBL614526;;
CLD0;;KB ;CHEMBL955283;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells;CHEMBL1148992;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;CCRF-CEM;CHEMBL958552;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM cells;CHEMBL1158863;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;ASK;CHEMBL998378;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 100 ug/mL;CHEMBL1147382;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;ASK;CHEMBL1000967;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 20 ug/mL;CHEMBL1147382;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;ASK;CHEMBL1000968;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 4 ug/mL;CHEMBL1147382;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;ASK;CHEMBL1000969;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.8 ug/mL;CHEMBL1147382;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;ASK;CHEMBL1000970;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.16 ug/mL;CHEMBL1147382;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;ASK;CHEMBL1000971;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.032 ug/mL;CHEMBL1147382;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;ASK;CHEMBL1000972;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.0064 ug/mL;CHEMBL1147382;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;ASK;CHEMBL1000973;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.00128 ug/mL;CHEMBL1147382;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL986544;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human Non-small cell lung carcinoma cells;CHEMBL1155808;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL986545;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human colon cancer cells;CHEMBL1155808;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL986546;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human central nervous system cancer cells;CHEMBL1155808;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Melanoma cell;CHEMBL986547;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Cytotoxicity against human melanoma cells;CHEMBL1155808;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL986548;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human ovarian cancer cells;CHEMBL1155808;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL986549;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human renal cancer cells;CHEMBL1155808;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL986550;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human prostate cancer cells;CHEMBL1155808;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL986551;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human breast cancer cells;CHEMBL1155808;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Leukemia cell;CHEMBL986552;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Cytotoxicity against human leukemia cells;CHEMBL1155808;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Leukemia cell;CHEMBL1008914;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Antitumor activity against human Leukemia cells after 48 hrs by SRB assay;CHEMBL1140214;Non-molecular target assigned;N;;1;CHEMBL614844;;
CLD0;;NSCLC;CHEMBL1008915;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Antitumor activity against human NSCLC cells after 48 hrs by SRB assay;CHEMBL1140214;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;Cancer cell lines;CHEMBL1008916;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Antitumor activity against human Colon cancer cells after 48 hrs by SRB assay;CHEMBL1140214;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1008917;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Antitumor activity against human CNS cancer cells after 48 hrs by SRB assay;CHEMBL1140214;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Melanoma cell;CHEMBL1008918;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Antitumor activity against human Melanoma cells after 48 hrs by SRB assay;CHEMBL1140214;Non-molecular target assigned;N;;1;CHEMBL614126;;
CLD0;;Cancer cell lines;CHEMBL1008919;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Antitumor activity against human ovarian cancer cells after 48 hrs by SRB assay;CHEMBL1140214;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1008920;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Antitumor activity against human renal cancer cells after 48 hrs by SRB assay;CHEMBL1140214;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1008921;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Antitumor activity against human prostate cancer cells after 48 hrs by SRB assay;CHEMBL1140214;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1008922;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Antitumor activity against human Breast cancer cells after 48 hrs by SRB assay;CHEMBL1140214;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HT-29;CHEMBL1008925;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cell cycle arrest in human HT-29 cells assessed as accumulation at G2/M phase at 30 nM after 24 hrs by flow cytometry;CHEMBL1140214;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL1008926;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307768;Direct single protein target assigned;9;Inhibition of ornithine decarboxylase in human HT-29 cells assessed as release of radioactive CO2 from [14C-carboxyl] ornithine;CHEMBL1140214;Direct protein target assigned;D;;1;CHEMBL1869;;
CLD0;;KB ;CHEMBL997589;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997590;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 0.1 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997591;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 0.1 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997592;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 0.1 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997593;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 0.3 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997594;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 0.3 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997595;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 0.3 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997596;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 1 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997597;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 1 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997598;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 1 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997599;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 3.16 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997600;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 3.16 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997601;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 3.16 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997602;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 10 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997603;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 10 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997604;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 10 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL997605;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 31.6 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL998459;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 31.6 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL998460;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 31.6 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL998461;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 100 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL998462;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 100 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL998463;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 100 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL998464;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 316 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL998465;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 316 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;KB ;CHEMBL998466;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 316 nM after 24 hrs by FACS analysis;CHEMBL1140930;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;MDA-MB-231;CHEMBL1001107;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cytotoxicity against human MDA-MB-231 cells after 48 hrs by alamar blue assay;CHEMBL1140891;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;MIA PaCa-2 ;CHEMBL1001108;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308500;Target assigned is non-molecular;1;Cytotoxicity against human MIAPaCa2 cells after 48 hrs by alamar blue assay;CHEMBL1140891;Non-molecular target assigned;N;;1;CHEMBL614725;;
CLD0;;SNU-423;CHEMBL1001109;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308367;Target assigned is non-molecular;1;Cytotoxicity against human SNU423 cells after 48 hrs by alamar blue assay;CHEMBL1140891;Non-molecular target assigned;N;;1;CHEMBL1075584;;
CLD0;;UCI101;CHEMBL1001110;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human UCI101 cells after 48 hrs by alamar blue assay;CHEMBL1140891;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;C6;CHEMBL987561;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Cytotoxicity against rat C6 cells after 3 days treated 4 hrs before db-cAMP challenge by MTT assay;CHEMBL1158219;Non-molecular target assigned;N;;1;CHEMBL614657;;
CLD0;;C6;CHEMBL987565;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308345;Default value - Target unknown or has yet to be assigned;0;Inhibition of tubulin polymerization in rat C6 cells after 4 hrs;CHEMBL1158219;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;C6;CHEMBL988383;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Cytotoxicity against rat C6 cells assessed as cell release at 50 ug/mL to 2.5 mg/mL after 5 hrs by MTT assay in absence of db-cAMP;CHEMBL1158219;Non-molecular target assigned;N;;1;CHEMBL614657;;
CLD0;;HT-29;CHEMBL981345;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981347;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981348;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981349;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;P388;CHEMBL981350;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981351;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981352;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981353;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;SMMC-7721;CHEMBL989465;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Cytotoxicity against human SMMC7721 cells by MTT assay;CHEMBL1147261;Non-molecular target assigned;N;;1;CHEMBL613831;;
CLD0;;HO8910;CHEMBL989466;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human HO8910 cells by MTT assay;CHEMBL1147261;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL947536;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as reduction in DNA peak by pre-incubation method;CHEMBL1150198;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL947537;[];Saccharomyces cerevisiae;[];;;4932.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to yeast tRNA assessed as reduction in tRNA peak by pre-incubation method;CHEMBL1150198;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;BHK-21;CHEMBL1004852;[];Mesocricetus auratus;[];;;10036.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Cytotoxicity against human MRP1 expressing hamster BHK21 cells after 72 hrs by MTT assay;CHEMBL1156492;Non-molecular target assigned;N;;1;CHEMBL614527;;
CLD0;;BHK-21;CHEMBL1004853;[];Mesocricetus auratus;[];;;10036.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Cytotoxicity against hamster BHK21 cells after 72 hrs by MTT assay;CHEMBL1156492;Non-molecular target assigned;N;;1;CHEMBL614527;;
CLD0;;KB/S;CHEMBL998841;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against vincristine sensitive human KB/S cells;CHEMBL1156666;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB/VJ300;CHEMBL998842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513114;Target assigned is non-molecular;1;Cytotoxicity against vincristine resistant human KB/VJ300 cells;CHEMBL1156666;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL978157;[];Agrobacterium tumefaciens;[];;;358.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of Agrobacterium tumefaciens-induced tumor growth in potato tuber disk after 21 days;CHEMBL1155941;Non-molecular target assigned;N;;1;CHEMBL612504;;
CLD0;;Bel-7402;CHEMBL991279;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307770;Target assigned is non-molecular;1;Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay;CHEMBL1143300;Non-molecular target assigned;N;;1;CHEMBL614279;;
CLD0;;HepG2;CHEMBL991280;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay;CHEMBL1143300;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;SMMC-7721;CHEMBL991281;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Antiproliferative activity against human SMMC7721 cells after 72 hrs by MTT assay;CHEMBL1143300;Non-molecular target assigned;N;;1;CHEMBL613831;;
CLD0;;CCRF-CEM;CHEMBL991282;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cell cycle arrest in human CEM cells assessed as accumulation at G2/M phase at 3.2 uM after 12 hrs by flow cytometry;CHEMBL1143300;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL991283;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cell cycle arrest in human CEM cells assessed as accumulation at G2/M phase at 0.1 uM after 12 hrs by flow cytometry;CHEMBL1143300;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;OVCAR-3;CHEMBL983438;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Cell cycle arrest in human OVCAR-3 cells assessed as accumulation at subG0 phase at 1 uM by flow cytometry;CHEMBL1149784;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;OVCAR-3;CHEMBL983439;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Cell cycle arrest in human OVCAR-3 cells assessed as accumulation at G0/G1 phase at 1 uM by flow cytometry;CHEMBL1149784;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;OVCAR-3;CHEMBL983440;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Cell cycle arrest in human OVCAR-3 cells assessed as accumulation at S phase at 1 uM by flow cytometry;CHEMBL1149784;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;OVCAR-3;CHEMBL983441;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Cell cycle arrest in human OVCAR-3 cells assessed as accumulation at G2/M phase at 1 uM by flow cytometry;CHEMBL1149784;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;MCF7;CHEMBL1029859;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells;CHEMBL1136853;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;HeLa;CHEMBL1029860;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells;CHEMBL1136853;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;;CHEMBL1018093;[];Human immunodeficiency virus 1;[];;;11676.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of HIV1 RT;CHEMBL1137798;Direct protein target assigned;D;;1;CHEMBL247;;
CLD0;;P388;CHEMBL1024044;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 364, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Central Analgesic Activity', 'l3': 'Chemotherapy Induced Pain for Peripheral Neuropathic Pain', 'source': 'Vogel_2008'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.2'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against vincristine-resistant mouse P388 cells implanted in CDF1 mouse at 0.2 mg/kg assessed as median survival time relative to control;CHEMBL1138436;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL1024045;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 364, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Central Analgesic Activity', 'l3': 'Chemotherapy Induced Pain for Peripheral Neuropathic Pain', 'source': 'Vogel_2008'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against vincristine-resistant mouse P388 cells implanted in CDF1 mouse at 0.1 mg/kg assessed as median survival time relative to control;CHEMBL1138436;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL1026799;[];Agrobacterium tumefaciens;[];B6;;358.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against Agrobacterium tumefaciens B6-induced tumor formation at 10 ug/disk after 12 days by potato disk assay;CHEMBL1151404;Non-molecular target assigned;N;;1;CHEMBL612504;;
CLD0;;;CHEMBL1026800;[];Agrobacterium tumefaciens;[];B6;;358.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against Agrobacterium tumefaciens B6-induced tumor formation at 5 ug/disk after 12 days by potato disk assay;CHEMBL1151404;Non-molecular target assigned;N;;1;CHEMBL612504;;
CLD0;;;CHEMBL1026801;[];Agrobacterium tumefaciens;[];B6;;358.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against Agrobacterium tumefaciens B6-induced tumor formation at 2.5 ug/disk after 12 days by potato disk assay;CHEMBL1151404;Non-molecular target assigned;N;;1;CHEMBL612504;;
CLD0;;;CHEMBL1026802;[];Agrobacterium tumefaciens;[];B6;;358.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against Agrobacterium tumefaciens B6-induced tumor formation at 1.5 ug/disk after 12 days by potato disk assay;CHEMBL1151404;Non-molecular target assigned;N;;1;CHEMBL612504;;
CLD0;;P388;CHEMBL1026803;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells xenografted mouse assessed as increase in life span relative to control;CHEMBL1151404;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL1005198;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of beta tubulin polymerization at 20 uM;CHEMBL1150335;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;Sf9;CHEMBL1006005;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Direct single protein target assigned;9;Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control;CHEMBL1150338;Direct protein target assigned;D;;1;CHEMBL5748;;
CLD0;;MDA-MB-231;CHEMBL958038;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Antiproliferative activity against human MDA-MB-231 cells after 4 days by microplate assay;CHEMBL1150769;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;MCF7;CHEMBL958039;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells after 5 days by microplate assay;CHEMBL1150769;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;U-87MG ATCC;CHEMBL958047;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307575;Target assigned is non-molecular;1;Effect on cell morphology in human U87 MG cells assessed as disruption of microtubule network at 10 nM by confocal fluorescence microscopy;CHEMBL1150769;Non-molecular target assigned;N;;1;CHEMBL614247;;
CLD0;;KB ;CHEMBL961498;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells by sulforhodamine B assay;CHEMBL1150376;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB-VIN;CHEMBL961499;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human KB-VIN cells by sulforhodamine B assay;CHEMBL1150376;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB-VIN;CHEMBL961501;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of ED50 for human KB cells to ED50 for vincristine-resistant human KB-VIN cells;CHEMBL1150376;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;A549;CHEMBL961502;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells by sulforhodamine B assay;CHEMBL1150376;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;MCF7;CHEMBL961503;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells by sulforhodamine B assay;CHEMBL1150376;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;HCT-8;CHEMBL961504;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Cytotoxicity against human HCT8 cells by sulforhodamine B assay;CHEMBL1150376;Non-molecular target assigned;N;;1;CHEMBL613510;;
CLD0;;PC-3;CHEMBL961505;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells by sulforhodamine B assay;CHEMBL1150376;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;;CHEMBL965578;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOA;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3681;;
CLD0;;;CHEMBL965580;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOB;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3050;;
CLD0;;Jurkat;CHEMBL954125;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Target assigned is non-molecular;1;Growth inhibition of human Jurkat cells;CHEMBL1139285;Non-molecular target assigned;N;;1;CHEMBL397;;
CLD0;;Jurkat;CHEMBL954127;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Target assigned is non-molecular;1;Cytotoxicity against human Jurkat cells in presence and relative to TRAIL;CHEMBL1139285;Non-molecular target assigned;N;;1;CHEMBL397;;
CLD0;;COLO 205;CHEMBL1018151;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;Antiproliferative activity against human COLO205 cells after 24 hrs by MTS assay;CHEMBL1139312;Non-molecular target assigned;N;;1;CHEMBL614561;;
CLD0;;KB ;CHEMBL1018152;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells after 3 days by SRB assay;CHEMBL1139312;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;;CHEMBL1018153;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KB 8.5 cells after 3 days by SRB assay;CHEMBL1139312;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB-V1;CHEMBL1018154;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295414;Target assigned is non-molecular;1;Antiproliferative activity against human KBV1 cells after 3 days by SRB assay;CHEMBL1139312;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL1018155;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Default value - Target unknown or has yet to be assigned;0;Ratio of IC50 for human KB 8.5 cells to IC50 for human KB cells;CHEMBL1139312;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;KBV1;CHEMBL1018156;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Ratio of IC50 for human KBV1 cells to IC50 for human KB cells;CHEMBL1139312;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;KB ;CHEMBL1014436;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Growth inhibition of human KB cells after 72 hrs by methylene blue dye assay;CHEMBL1151752;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL1014437;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-VIN10 cells after 72 hrs by methylene blue dye assay;CHEMBL1151752;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL1015234;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-TAX50 cells after 72 hrs by methylene blue dye assay;CHEMBL1151752;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL1015235;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Growth inhibition of human KB-7D cells overexpressing multidrug resistant associated protein after 72 hrs by methylene blue dye assay;CHEMBL1151752;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;NCI-H292;CHEMBL1028627;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308637;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H292 cells after 72 hrs by MTT assay;CHEMBL1158358;Non-molecular target assigned;N;;1;CHEMBL614733;;
CLD0;;HEp-2;CHEMBL1028628;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307694;Target assigned is non-molecular;1;Cytotoxicity against human Hep2 cells after 72 hrs by MTT assay;CHEMBL1158358;Non-molecular target assigned;N;;1;CHEMBL614735;;
CLD0;;HeLa;CHEMBL1032703;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 48 hrs by MTT assay;CHEMBL1158392;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;Vero;CHEMBL1032704;[];Chlorocebus sabaeus;[];;;60711.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307520;Target assigned is non-molecular;1;Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay;CHEMBL1158392;Non-molecular target assigned;N;;1;CHEMBL391;;
CLD0;;Vero;CHEMBL1032705;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307520;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of CC50 for african green monkey Vero cells to CC50 for human HeLa cells;CHEMBL1158392;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;MDR;CHEMBL1060434;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308422;Target assigned is non-molecular;1;Cytotoxicity against multidrug-resistant human KB/VCR cells by SRB assay in presence of MDR reversing agent verapamil;CHEMBL1151957;Non-molecular target assigned;N;;1;CHEMBL614125;;
CLD0;;CCRF-CEM;CHEMBL1055751;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1055752;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM/C2 cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HL60/MX2;CHEMBL1055755;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Cytotoxicity against human HL60/MX2 cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HT-29;CHEMBL1037456;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT-29 cells by MTT assay;CHEMBL1155979;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;A549;CHEMBL1037457;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells by MTT assay;CHEMBL1155979;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;HepG2;CHEMBL1037458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells by MTT assay;CHEMBL1155979;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;MKN-28;CHEMBL1037459;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307602;Target assigned is non-molecular;1;Cytotoxicity against human MKN28 cells by MTT assay;CHEMBL1155979;Non-molecular target assigned;N;;1;CHEMBL614353;;
CLD0;;HL-60;CHEMBL1106834;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 48 hrs by MTT assay;CHEMBL1154247;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;;CHEMBL1108963;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Octanol-water partition coefficient, log P of the compound;CHEMBL1157036;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;MCF7;CHEMBL1114575;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells after 72 hrs by sulforhodamine B assay;CHEMBL1157101;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;K562;CHEMBL1114581;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells after 72 hrs by sulforhodamine B assay;CHEMBL1157101;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;KB ;CHEMBL1114585;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells after 72 hrs by sulforhodamine B assay;CHEMBL1157101;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;K562/A02;CHEMBL1114586;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295416;Target assigned is non-molecular;1;Antiproliferative activity against human K562/A02 cells after 72 hrs by sulforhodamine B assay;CHEMBL1157101;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB/VCR;CHEMBL1114587;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KB/VCR cells after 72 hrs by sulforhodamine B assay;CHEMBL1157101;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Leukemia cell;CHEMBL1109122;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Growth inhibition of human leukemia cell by NCI-CLS assay;CHEMBL1157784;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;NSCLC;CHEMBL1109123;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Growth inhibition of human NSCLC cell by NCI-CLS assay;CHEMBL1157784;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;Cancer cell lines;CHEMBL1109124;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human colon cancer cell by NCI-CLS assay;CHEMBL1157784;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1109125;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human CNS cancer cell by NCI-CLS assay;CHEMBL1157784;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Melanoma cell;CHEMBL1109126;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Growth inhibition of human melanoma cell by NCI-CLS assay;CHEMBL1157784;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1109127;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human ovarian cancer cell by NCI-CLS assay;CHEMBL1157784;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1109128;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human renal cancer cell by NCI-CLS assay;CHEMBL1157784;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1109129;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human prostate cancer cell by NCI-CLS assay;CHEMBL1157784;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1109130;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human breast cancer cell by NCI-CLS assay;CHEMBL1157784;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL1211492;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as accumulation at G2/M phase after 24 hrs using propidium iodide staining by FACS analysis;CHEMBL1208684;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
CLD0;;Leukemia cell;CHEMBL1218940;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Growth inhibition of human leukemia cells after 48 hrs;CHEMBL1212917;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;NSCLC;CHEMBL1218941;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Growth inhibition of human NSCLC cells after 48 hrs;CHEMBL1212917;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;Cancer cell lines;CHEMBL1218942;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human colon cancer cells after 48 hrs;CHEMBL1212917;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1218943;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human CNS cancer cells after 48 hrs;CHEMBL1212917;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Melanoma cell;CHEMBL1218944;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Growth inhibition of human melanoma cells after 48 hrs;CHEMBL1212917;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1218945;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human Ovarian cancer cells after 48 hrs;CHEMBL1212917;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1218946;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human renal cancer cells after 48 hrs;CHEMBL1212917;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1218947;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human prostate cancer cells after 48 hrs;CHEMBL1212917;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL1218948;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Growth inhibition of human breast cancer cells after 48 hrs;CHEMBL1212917;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB/VCR;CHEMBL1247203;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human KB/VCR cells expressing Pgp after 48 hrs by MTT assay;CHEMBL1240517;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL1247204;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 48 hrs by MTT assay;CHEMBL1240517;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB/VCR;CHEMBL1247229;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB/VCR cells expressing Pgp assessed as morphological changes using DAPI staining at 0.2 uM after 48 hrs by fluorescence microscopic analysis;CHEMBL1240517;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;KB/VCR;CHEMBL1247230;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB/VCR cells expressing Pgp assessed as down-regulation of Bcl-2 expression at 0.2 uM after 48 hrs by Western blotting;CHEMBL1240517;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;KB/VCR;CHEMBL1247232;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB/VCR cells expressing Pgp assessed as up-regulation of Bax expression at 0.2 uM after 48 hrs by Western blotting;CHEMBL1240517;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;Vero;CHEMBL1247689;[];Chlorocebus sabaeus;[];;;60711.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307520;Target assigned is non-molecular;1;Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay;CHEMBL1240463;Non-molecular target assigned;N;;1;CHEMBL391;;
CLD0;;HeLa;CHEMBL1247690;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 48 hrs by MTT assay;CHEMBL1240463;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;Vero;CHEMBL1247691;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307520;Target assigned is non-molecular;1;Selectivity index, ratio of IC50 for green monkey Vero cells over IC50 for human HeLa cells;CHEMBL1240463;Non-molecular target assigned;N;;1;CHEMBL391;;
CLD0;;Hep 3B2;CHEMBL1250978;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4106361;Target assigned is non-molecular;1;Anticancer activity against human Hep3B cells after 3 days by SRB assay;CHEMBL1250520;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Hep 3B2;CHEMBL1250979;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4106361;Target assigned is non-molecular;1;Anticancer activity against vincristine-resistant human Hep3B cells after 3 days by SRB assay;CHEMBL1250520;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;LNCaP;CHEMBL1259839;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307965;Target assigned is non-molecular;1;Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay;CHEMBL1255528;Non-molecular target assigned;N;;1;CHEMBL612518;;
CLD0;;PC-3;CHEMBL1259840;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay;CHEMBL1255528;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;;CHEMBL1266173;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antiproliferative activity against mouse neural precursor cells by MTT assay;CHEMBL1255231;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Astrocyte;CHEMBL1266174;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307726;Target assigned is non-molecular;1;Antiproliferative activity against mouse astrocyte cells by MTT assay;CHEMBL1255231;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1266185;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay;CHEMBL1255231;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1267245;[];Plasmodium falciparum;[];3D7;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267246;[];Plasmodium falciparum 7G8;[];;;57266.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267247;[];Plasmodium falciparum D10;[];;;478861.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267248;[];Plasmodium falciparum;[];Dd2;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267249;[];Plasmodium falciparum;[];GB4;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267250;[];Plasmodium falciparum HB3;[];;;137071.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267251;[];Plasmodium falciparum;[];W2;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1614456;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 915 ];CHEMBL1201862;Direct protein target assigned;D;914;7;CHEMBL4261;;
CLD0;confirmatory;;CHEMBL1613803;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 914 ];CHEMBL1201862;Direct protein target assigned;D;915;7;CHEMBL4261;;
CLD0;confirmatory;;CHEMBL1614342;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485313;7;CHEMBL1293277;;
CLD0;confirmatory;;CHEMBL1614414;[];Saccharomyces cerevisiae;[];;;4932.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;485298;7;CHEMBL361;;
CLD0;confirmatory;;CHEMBL1614544;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1487;7;CHEMBL1293235;;
CLD0;confirmatory;;CHEMBL1614550;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;"PUBCHEM_BIOASSAY: Luminescence Cell-Based HTS Dose Confirmation to Identify Inhibitors of of 5&apos;UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]";CHEMBL1201862;Default value - Target has yet to be curated;U;2454;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613869;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)];CHEMBL1201862;Default value - Target has yet to be curated;U;1990;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613871;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response to Identify Inhibitors of Luciferase Translation or Activity in H4-C Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)];CHEMBL1201862;Default value - Target has yet to be curated;U;2458;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613918;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ];CHEMBL1201862;Direct protein target assigned;D;1688;7;CHEMBL5514;;
CLD0;confirmatory;;CHEMBL1614065;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response to Identify Inhibitors of 5&apos;UTR Stem-Loop Driven Prion Protein mRNA Translation in H4-C Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]";CHEMBL1201862;Default value - Target has yet to be curated;U;2452;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614076;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ];CHEMBL1201862;Direct protein target assigned;D;2100;7;CHEMBL2608;;
CLD0;confirmatory;;CHEMBL1614087;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2551;7;CHEMBL1293231;;
CLD0;confirmatory;;CHEMBL1614090;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of 5&apos;UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]";CHEMBL1201862;Default value - Target has yet to be curated;U;1994;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614137;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of of 5&apos;UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]";CHEMBL1201862;Default value - Target has yet to be curated;U;1988;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614146;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21. (Class of assay: confirmatory) ;CHEMBL1201862;Molecular target other than protein assigned;M;2289;7;CHEMBL1615322;;
CLD0;confirmatory;;CHEMBL1614421;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ];CHEMBL1201862;Direct protein target assigned;D;1460;7;CHEMBL1293224;;
CLD0;confirmatory;;CHEMBL1613836;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Activators of miR-21. (Class of assay: confirmatory) ;CHEMBL1201862;Molecular target other than protein assigned;M;2288;7;CHEMBL1615322;;
CLD0;confirmatory;;CHEMBL1613838;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485297;7;CHEMBL1293294;;
CLD0;;;CHEMBL1614670;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614671;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614672;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction unbound in human after iv administration;CHEMBL1614632;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1614673;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Mean residence time in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614674;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Half life in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614675;[];Rattus norvegicus;[];;;10116.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in rat after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614676;[];Rattus norvegicus;[];;;10116.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in rat after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614677;[];Canis lupus familiaris;[];;;9615.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in dog after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614678;[];Canis lupus familiaris;[];;;9615.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in dog after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614679;[];Macaca;[];;;9539.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in monkey after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614680;[];Macaca;[];;;9539.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in monkey after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614681;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in human after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614682;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in human after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1656794;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of tubulin polymerization after 60 mins;CHEMBL1649061;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1656795;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Displacement of [3H]colchicine from tubulin at 30 uM;CHEMBL1649061;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1678152;[];Plasmodium falciparum;[];3D7;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum 3D7 infected in RBCs by firefly luciferase reporter gene assay;CHEMBL1671701;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;A549;CHEMBL1686190;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay;CHEMBL1681672;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;HCT-8;CHEMBL1686191;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Antiproliferative activity against human HCT8 cells after 3 days by sulforhodamine B assay;CHEMBL1681672;Non-molecular target assigned;N;;1;CHEMBL613510;;
CLD0;;MCF7;CHEMBL1686192;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells after 3 days by sulforhodamine B assay;CHEMBL1681672;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;1A9;CHEMBL1686315;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307529;Target assigned is non-molecular;1;Antiproliferative activity against human 1A9 cells after 3 days by sulforhodamine B assay;CHEMBL1681672;Non-molecular target assigned;N;;1;CHEMBL614075;;
CLD0;;PC-3;CHEMBL1686316;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Antiproliferative activity against human PC3 cells after 3 days by sulforhodamine B assay;CHEMBL1681672;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;HepG2;CHEMBL1686317;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 cells after 3 days by sulforhodamine B assay;CHEMBL1681672;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;KB ;CHEMBL1686318;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells after 3 days by sulforhodamine B assay;CHEMBL1681672;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KBVIN;CHEMBL1686319;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KBVIN cells expressing P-glycoprotein after 3 days by sulforhodamine B assay;CHEMBL1681672;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MDCK-II;CHEMBL1694082;[];Canis lupus familiaris;[];;;9615.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Target assigned is non-molecular;1;Growth inhibition of dog MDCK2 cells;CHEMBL1687930;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MDCK-II;CHEMBL1694083;[];Canis lupus familiaris;[];;;9615.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Target assigned is non-molecular;1;Growth inhibition of dog MDCK2-MDR1 cells overexpressing human P-glycoprotein;CHEMBL1687930;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MDCK-II;CHEMBL1694084;[];Canis lupus familiaris;[];;;9615.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Target assigned is non-molecular;1;Growth inhibition of dog MDCK2 cells in presence of P-glycoprotein inhibitor LY335979;CHEMBL1687930;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MDCK-II;CHEMBL1694085;[];Canis lupus familiaris;[];;;9615.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Target assigned is non-molecular;1;Growth inhibition of dog MDCK2-MDR1 cells overexpressing human P-glycoprotein in presence of P-glycoprotein inhibitor LY335979;CHEMBL1687930;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MDCK-II;CHEMBL1694086;[];Canis lupus familiaris;[];;;9615.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Target assigned is non-molecular;1;Ratio of GI50 for dog MDCK2-MDR1 cells overexpressing human P-glycoprotein to GI50 for dog MDCK2 cells;CHEMBL1687930;Non-molecular target assigned;N;;1;CHEMBL4296466;;
CLD0;;LLC-PK1;CHEMBL1694087;[];Sus scrofa;[];;;9823.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Target assigned is non-molecular;1;Growth inhibition of pig LLC-PK1 cells;CHEMBL1687930;Non-molecular target assigned;N;;1;CHEMBL614577;;
CLD0;;L-MDR1;CHEMBL1694088;[];Sus scrofa;[];;;9823.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Growth inhibition of pig L-MDR1 cells overexpressing human P-glycoprotein;CHEMBL1687930;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;LLC-PK1;CHEMBL1694089;[];Sus scrofa;[];;;9823.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Target assigned is non-molecular;1;Growth inhibition of pig LLC-PK1 cells in presence of P-glycoprotein inhibitor LY335979;CHEMBL1687930;Non-molecular target assigned;N;;1;CHEMBL614577;;
CLD0;;L-MDR1;CHEMBL1694090;[];Sus scrofa;[];;;9823.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Growth inhibition of pig L-MDR1 cells overexpressing human P-glycoprotein in presence of P-glycoprotein inhibitor LY335979;CHEMBL1687930;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;LLC-PK1;CHEMBL1694091;[];Sus scrofa;[];;;9823.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Target assigned is non-molecular;1;Ratio of GI50 for pig L-MDR1 cells overexpressing human P-glycoprotein to GI50 for pig LLC-PK1 cells;CHEMBL1687930;Non-molecular target assigned;N;;1;CHEMBL614577;;
CLD0;;HCT-8;CHEMBL1692923;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Antiproliferative activity against human HCT8 cells after 3 days by sulforhodamine B assay;CHEMBL1687889;Non-molecular target assigned;N;;1;CHEMBL613510;;
CLD0;;PC-3;CHEMBL1692924;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Antiproliferative activity against human PC3 cells after 3 days by sulforhodamine B assay;CHEMBL1687889;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;A549;CHEMBL1692925;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay;CHEMBL1687889;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;DU-145;CHEMBL1692926;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;Antiproliferative activity against human DU145 cells after 3 days by sulforhodamine B assay;CHEMBL1687889;Non-molecular target assigned;N;;1;CHEMBL613508;;
CLD0;;MCF7;CHEMBL1692927;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells after 3 days by sulforhodamine B assay;CHEMBL1687889;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;HepG2;CHEMBL1692928;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 cells after 3 days by sulforhodamine B assay;CHEMBL1687889;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;KB ;CHEMBL1692929;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells after 3 days by sulforhodamine B assay;CHEMBL1687889;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KBVIN;CHEMBL1692930;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KBVIN cells after 3 days by sulforhodamine B assay;CHEMBL1687889;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1697722;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset;CHEMBL1697692;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697730;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Human drug-induced liver injury (DILI) modelling dataset from Ekins et al;CHEMBL1697723;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697778;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697779;[];Rodentia;[];;;9989.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697780;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697797;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA HLAED, liver enzyme composite activity;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697798;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, alkaline phosphatase increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697799;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697800;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697801;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, lactate dehydrogenase (LDH) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697802;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, gamma-glutamyl transferase (GGT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;confirmatory;;CHEMBL1738312;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391];CHEMBL1201862;Direct protein target assigned;D;504333;7;CHEMBL1741220;;
CLD0;confirmatory;Jurkat;CHEMBL1738369;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465];CHEMBL1201862;Default value - Target has yet to be curated;U;489035;7;CHEMBL612545;;
CLD0;confirmatory;HEK-293T;CHEMBL1738494;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response cytotoxicity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489041];CHEMBL1201862;Default value - Target has yet to be curated;U;489026;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738552;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465];CHEMBL1201862;Default value - Target has yet to be curated;U;489033;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1737902;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355];CHEMBL1201862;Default value - Target has yet to be curated;U;493014;7;CHEMBL612545;;
CLD0;confirmatory;HEK-293T;CHEMBL1737912;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489026];CHEMBL1201862;Default value - Target has yet to be curated;U;489041;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738184;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648];CHEMBL1201862;Direct protein target assigned;D;504444;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL1738317;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143];CHEMBL1201862;Direct protein target assigned;D;504466;7;CHEMBL1741209;;
CLD0;confirmatory;;CHEMBL1738442;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404];CHEMBL1201862;Direct protein target assigned;D;504332;7;CHEMBL6032;;
CLD0;confirmatory;;CHEMBL1738606;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398];CHEMBL1201862;Direct protein target assigned;D;504327;7;CHEMBL5501;;
CLD0;;;CHEMBL1743273;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Direct single protein target assigned;9;Clinically relevant substrates of human liver microsomal P450 enzymes, isoform CYP3A4;CHEMBL1743201;Direct protein target assigned;D;9;1;CHEMBL340;;
CLD0;;;CHEMBL1768335;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;Inhibition of pig tubulin polymerization at 3 uM;CHEMBL1764957;Direct protein target assigned;D;357995;1;CHEMBL2111354;;
CLD0;confirmatory;;CHEMBL1794345;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504834;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794424;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771];CHEMBL1201862;Homologous protein target assigned;H;588453;7;CHEMBL6035;;
CLD0;confirmatory;;CHEMBL1794580;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504832;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794584;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860];CHEMBL1201862;Homologous protein target assigned;H;588855;7;CHEMBL1293258;;
CLD0;;HCT-116;CHEMBL1799243;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cell cycle arrest in human HCT116 cells assessed as accumulation at sub-G1 phase at 150 nM after 24 hrs by FACS analysis (Rvb = 6.2 %);CHEMBL1795243;Non-molecular target assigned;N;384508;1;CHEMBL394;;
CLD0;;HCT-116;CHEMBL1799244;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cell cycle arrest in human HCT116 cells assessed as accumulation at G0/G1 phase at 150 nM after 24 hrs by FACS analysis (Rvb = 76.5 %);CHEMBL1795243;Non-molecular target assigned;N;384509;1;CHEMBL394;;
CLD0;;HCT-116;CHEMBL1799245;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cell cycle arrest in human HCT116 cells assessed as accumulation at G2/M phase at 150 nM after 24 hrs by FACS analysis (Rvb = 10.9 %);CHEMBL1795243;Non-molecular target assigned;N;384510;1;CHEMBL394;;
CLD0;;HCT-116;CHEMBL1799246;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cell cycle arrest in human HCT116 cells assessed as accumulation at S phase at 150 nM after 24 hrs by FACS analysis (Rvb = 8.5 %);CHEMBL1795243;Non-molecular target assigned;N;384511;1;CHEMBL394;;
CLD0;;HCT-116;CHEMBL1799253;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Induction of apoptosis in human HCT116 cells at 150 nM after 24 hrs using FITC-TUNEL staining by flow cytometry;CHEMBL1795243;Non-molecular target assigned;N;384584;1;CHEMBL394;;
CLD0;;HCT-116;CHEMBL1799255;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cell cycle arrest in human HCT116 cells assessed as increase of phosphorylated histone H3 at Ser10 level at 150 nM after 24 hrs by Western blotting;CHEMBL1795243;Non-molecular target assigned;N;384575;1;CHEMBL394;;
CLD0;;HCT-116;CHEMBL1799257;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cell cycle arrest in human HCT116 cells assessed as increase of phosphorylated histone H3 at Ser10 level at 150 nM after 24 hrs using propidium iodide staining by flow cytometry (Rvb = 1.4 %);CHEMBL1795243;Non-molecular target assigned;N;384578;1;CHEMBL394;;
CLD0;;HCT-116;CHEMBL1799357;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Induction of apoptosis in human HCT116 cells at 150 nM after 48 hrs using FITC-TUNEL staining by flow cytometry (Rvb = 7.3 %);CHEMBL1795243;Non-molecular target assigned;N;384581;1;CHEMBL394;;
CLD0;;HT-1080;CHEMBL1799361;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308396;Multiple direct protein targets may be assigned;5;Inhibition of alpha-tubulin polymerization in human HT1080 cells assessed as disruption of microtubule structures at 100 nM after 4 hrs using Hoechst staining by fluorescence microscopic analysis;CHEMBL1795243;Direct protein target assigned;D;384588;1;CHEMBL2095182;;
CLD0;;KB/VJ300;CHEMBL1804782;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4513114;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity in vincristine-resistant human KB/VJ300 cells in presence of 0.1 ug/ml vincristine;CHEMBL1799972;Default value - Target has yet to be curated;U;386934;1;CHEMBL612558;;
CLD0;;KB ;CHEMBL1804783;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against vincristine-sensitive human KB cells in presence of 0.1 ug/ml vincristine;CHEMBL1799972;Non-molecular target assigned;N;386935;1;CHEMBL398;;
CLD0;;MCF7;CHEMBL1809625;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Resistance factor, ratio of IC50 for drug-resistant MDR1-deficient human NCI/ADR cells expressing Pgp in absence of vinblastin to IC50 for drug-sensitive human MCF7 cells in presence of 50 nM vinblastin;CHEMBL1806466;Non-molecular target assigned;N;389464;1;CHEMBL387;;
CLD0;;MCF7-VP;CHEMBL1809626;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307299;Target assigned is non-molecular;1;Cytotoxic activity against Pgp-deficient human MCF7/VP cells expressing MRP1 after 48 hrs by sulforhodamine B assay;CHEMBL1806466;Non-molecular target assigned;N;389465;1;CHEMBL3879801;;
CLD0;;MCF7;CHEMBL1809627;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Resistance factor, ratio of IC50 for Pgp-deficient human MCF7/VP cells expressing MRP1 in absence of vinblastin to IC50 for drug sensitive human MCF7 cells in presence of 50 nM vinblastin;CHEMBL1806466;Non-molecular target assigned;N;389466;1;CHEMBL387;;
CLD0;;;CHEMBL1809630;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Effect on bovine brain microtubule depolymerization assessed as decrease in absorbance at wavelength 340 nm after 15 mins;CHEMBL1806466;Default value - Target has yet to be curated;U;389469;1;CHEMBL612545;;
CLD0;;MCF7;CHEMBL1811487;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxic activity against drug-sensitive Pgp-, MRP1-deficient human MCF7 cells after 48 hrs by sulforhodamine B assay in presence of 50 nM vinblastin;CHEMBL1806466;Non-molecular target assigned;N;389462;1;CHEMBL387;;
CLD0;;NCI/ADR;CHEMBL1811488;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxic activity against drug-resistant MDR1-deficient human NCI/ADR cells expressing Pgp after 48 hrs by sulforhodamine B assay;CHEMBL1806466;Non-molecular target assigned;N;389463;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL1816742;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is molecular non-protein target;3;Cell cycle arrest in human KB/HeLa cells assessed as accumulation of cells at G2/M phase after 24 hrs by flow cytometry;CHEMBL1811833;Molecular target other than protein assigned;M;387648;1;CHEMBL612546;;
CLD0;;HL-60;CHEMBL1820600;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells;CHEMBL1817624;Non-molecular target assigned;N;394355;1;CHEMBL383;;
CLD0;;K562;CHEMBL1820601;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Ratio of IC50 for homoharringtonine300-resistant human K562 cells to IC50 for human K562 cells;CHEMBL1817624;Non-molecular target assigned;N;394356;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL1820602;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for vinblastine100-resistant human CCRF-CEM cells to IC50 for human CCRF-CEM cells;CHEMBL1817624;Non-molecular target assigned;N;394357;1;CHEMBL382;;
CLD0;;MCF7;CHEMBL1826865;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Drug resistance index, ratio of IC50 for adriyamycin-resistant human MCF7 cells to IC50 for human MCF7 cells;CHEMBL1821706;Non-molecular target assigned;N;398956;1;CHEMBL387;;
CLD0;;KB ;CHEMBL1826866;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Drug resistance index, ratio of IC50 for vincristine-resistant human KB cells to IC50 for human KB cells;CHEMBL1821706;Non-molecular target assigned;N;398955;1;CHEMBL398;;
CLD0;;KB ;CHEMBL1826867;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against vincristine-resistant human KB cells over expressing P-glycoprotein after 72 hrs by SRB assay;CHEMBL1821706;Non-molecular target assigned;N;398954;1;CHEMBL398;;
CLD0;;MCF7;CHEMBL1826868;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against adriyamycin-resistant human MCF7 cells over expressing P-glycoprotein after 72 hrs by SRB assay;CHEMBL1821706;Non-molecular target assigned;N;398953;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL1826870;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay;CHEMBL1821706;Non-molecular target assigned;N;398952;1;CHEMBL387;;
CLD0;;KB ;CHEMBL1827079;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 72 hrs by SRB assay;CHEMBL1821706;Non-molecular target assigned;N;398935;1;CHEMBL398;;
CLD0;;786-0;CHEMBL1828322;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308018;Target assigned is non-molecular;1;Antiproliferative activity against MDR-1 overexpressing human 786-0 cells;CHEMBL1821642;Non-molecular target assigned;N;397155;1;CHEMBL613102;;
CLD0;;786-0;CHEMBL1828332;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308018;Target assigned is non-molecular;1;Antiproliferative activity against MDR-1 overexpressing human 786-0 cells in presence of MDR1 inhibitor verapamil;CHEMBL1821642;Non-molecular target assigned;N;400758;1;CHEMBL613102;;
CLD0;;MDR1-MDCKII;CHEMBL1908285;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;1;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908286;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;2;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908289;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;5;1;CHEMBL4302;;
CLD0;;Sf9;CHEMBL1908291;[];Spodoptera frugiperda;[];(null);Membrane;7108.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM;CHEMBL1908284;Homologous protein target assigned;H;7;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908292;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay;CHEMBL1908284;Homologous protein target assigned;H;8;1;CHEMBL4302;;
CLD0;;;CHEMBL1909163;[];Cavia porcellus;[];;;10141.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4);CHEMBL1909046;Direct protein target assigned;D;67;15;CHEMBL1909043;CHEMBL3638235;
CLD0;;CHO-K1;CHEMBL1909164;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4);CHEMBL1909046;Homologous protein target assigned;H;68;15;CHEMBL1798;;
CLD0;;Reticulocytes;CHEMBL1909165;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid);CHEMBL1909046;Direct protein target assigned;D;69;15;CHEMBL4358;;
CLD0;;HEK293;CHEMBL1909166;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;70;15;CHEMBL4644;;
CLD0;;HEK293;CHEMBL1909167;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;71;15;CHEMBL259;;
CLD0;;HEK293;CHEMBL1909168;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;72;15;CHEMBL4608;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909169;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine);CHEMBL1909046;Homologous protein target assigned;H;73;15;CHEMBL1951;;
CLD0;;CHO-K1;CHEMBL1909170;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;74;15;CHEMBL216;;
CLD0;;CHO-K1;CHEMBL1909171;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;75;15;CHEMBL211;;
CLD0;;CHO-K1;CHEMBL1909172;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;76;15;CHEMBL245;;
CLD0;;CHO-K1;CHEMBL1909173;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;77;15;CHEMBL1821;;
CLD0;;CHO-K1;CHEMBL1909174;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;78;15;CHEMBL2035;;
CLD0;;SK-N-MC;CHEMBL1909175;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307551;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;79;15;CHEMBL4777;;
CLD0;;KAN-TS;CHEMBL1909176;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;80;15;CHEMBL4018;;
CLD0;;IMR-32;CHEMBL1909177;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307656;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine);CHEMBL1909046;Default value - Target has yet to be curated;U;81;15;CHEMBL612545;;
CLD0;;;CHEMBL1909178;[];Rattus norvegicus;[];;;10116.0;In vitro;Cerebellum;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine);CHEMBL1909046;Direct protein target assigned;D;82;15;CHEMBL3048;CHEMBL3638233;
CLD0;;;CHEMBL1909179;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine);CHEMBL1909046;Homologous protein target assigned;H;83;15;CHEMBL3464;;
CLD0;;HEK293;CHEMBL1909180;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole);CHEMBL1909046;Homologous protein target assigned;H;84;15;CHEMBL236;;
CLD0;;HEK293;CHEMBL1909181;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;85;15;CHEMBL237;;
CLD0;;CHO-K1;CHEMBL1909182;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;86;15;CHEMBL233;;
CLD0;;;CHEMBL1909183;[];Mus musculus;[];ICR;Membrane;10090.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu);CHEMBL1909046;Default value - Target has yet to be curated;U;87;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Platelet;CHEMBL1909184;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;88;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909185;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;89;15;CHEMBL612545;;
CLD0;;Platelet;CHEMBL1909186;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP);CHEMBL1909046;Direct protein target assigned;D;90;15;CHEMBL1827;;
CLD0;;Platelet;CHEMBL1909187;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF);CHEMBL1909046;Direct protein target assigned;D;91;15;CHEMBL250;;
CLD0;;NIH3T3;CHEMBL1909188;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF);CHEMBL1909046;Default value - Target has yet to be curated;U;92;15;CHEMBL612545;;
CLD0;;HIT-T15;CHEMBL1909189;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide);CHEMBL1909046;Default value - Target has yet to be curated;U;93;15;CHEMBL612545;;
CLD0;;HEK293;CHEMBL1909190;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);CHEMBL1909046;Homologous protein target assigned;H;94;15;CHEMBL240;;
CLD0;;;CHEMBL1909191;[];Bos taurus;[];;;9913.0;In vitro;Uterus;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020);CHEMBL1909046;Direct protein target assigned;D;95;15;CHEMBL1909044;CHEMBL3638197;
CLD0;;;CHEMBL1909192;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG);CHEMBL1909046;Direct protein target assigned;D;96;15;CHEMBL4074;CHEMBL3638235;
CLD0;;;CHEMBL1909193;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC);CHEMBL1909046;Homologous protein target assigned;H;97;15;CHEMBL4801;;
CLD0;;Neutrophil;CHEMBL1909194;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC);CHEMBL1909046;Direct protein target assigned;D;98;15;CHEMBL4071;;
CLD0;;Neutrophil;CHEMBL1909195;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA);CHEMBL1909046;Direct protein target assigned;D;99;15;CHEMBL248;;
CLD0;;;CHEMBL1909196;[];Homo sapiens;[];;;9606.0;In vitro;Rheumatoid synovial fibroblasts;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Direct protein target assigned;D;100;15;CHEMBL332;;
CLD0;;;CHEMBL1909197;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Homologous protein target assigned;H;101;15;CHEMBL321;;
CLD0;;Sf9;CHEMBL1909198;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone);CHEMBL1909046;Homologous protein target assigned;H;102;15;CHEMBL299;;
CLD0;;;CHEMBL1909199;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;103;15;CHEMBL3385;;
CLD0;;;CHEMBL1909200;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;104;15;CHEMBL4040;;
CLD0;;;CHEMBL1909201;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;105;15;CHEMBL260;;
CLD0;;;CHEMBL1909202;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;106;15;CHEMBL4445;;
CLD0;;Insect cells;CHEMBL1909203;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;107;15;CHEMBL203;;
CLD0;;Insect cells;CHEMBL1909204;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;108;15;CHEMBL1841;;
CLD0;;Insect cells;CHEMBL1909205;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;109;15;CHEMBL1824;;
CLD0;;Insect cells;CHEMBL1909206;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;110;15;CHEMBL258;;
CLD0;;;CHEMBL1909207;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;111;15;CHEMBL3243;;
CLD0;;;CHEMBL1909208;[];Oryctolagus cuniculus;[];New Zealand albino;Membrane;9986.0;In vitro;Urinary bladder;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;112;15;CHEMBL612545;CHEMBL3638205;
CLD0;;CHO-K1;CHEMBL1909209;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT);CHEMBL1909046;Homologous protein target assigned;H;113;15;CHEMBL273;;
CLD0;;;CHEMBL1909210;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Direct protein target assigned;D;114;15;CHEMBL3459;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909211;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin);CHEMBL1909046;Homologous protein target assigned;H;115;15;CHEMBL224;;
CLD0;;HEK293;CHEMBL1909212;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine);CHEMBL1909046;Homologous protein target assigned;H;1;15;CHEMBL220;;
CLD0;;CHO;CHEMBL1909213;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX);CHEMBL1909046;Homologous protein target assigned;H;2;15;CHEMBL226;;
CLD0;;HEK293;CHEMBL1909214;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;3;15;CHEMBL251;;
CLD0;;CHO-K1;CHEMBL1909215;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;4;15;CHEMBL256;;
CLD0;;;CHEMBL1909084;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine);CHEMBL1909046;Default value - Target has yet to be curated;U;5;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909085;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Submaxillary gland;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;6;15;CHEMBL319;CHEMBL3987361;
CLD0;;;CHEMBL1909086;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;7;15;CHEMBL315;CHEMBL3559723;
CLD0;;HEK293;CHEMBL1909087;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Homologous protein target assigned;H;8;15;CHEMBL223;;
CLD0;;Sf9;CHEMBL1909088;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912);CHEMBL1909046;Homologous protein target assigned;H;9;15;CHEMBL1867;;
CLD0;;CHO-K1;CHEMBL1909089;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine);CHEMBL1909046;Homologous protein target assigned;H;10;15;CHEMBL1942;;
CLD0;;Sf9;CHEMBL1909090;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912);CHEMBL1909046;Homologous protein target assigned;H;11;15;CHEMBL1916;;
CLD0;;CHO-K1;CHEMBL1909091;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;12;15;CHEMBL213;;
CLD0;;CHO;CHEMBL1909092;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177);CHEMBL1909046;Homologous protein target assigned;H;13;15;CHEMBL210;;
CLD0;;HEK293;CHEMBL1909093;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;14;15;CHEMBL246;;
CLD0;;MDCK;CHEMBL1909094;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308370;Homologous single protein target assigned;8;DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;15;15;CHEMBL222;;
CLD0;;;CHEMBL1909095;[];Rattus norvegicus;[];;;10116.0;In vitro;Lens of camera-type eye;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde);CHEMBL1909046;Direct protein target assigned;D;16;15;CHEMBL2622;CHEMBL3638191;
CLD0;;CHO-K1;CHEMBL1909096;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A);CHEMBL1909046;Homologous protein target assigned;H;17;15;CHEMBL4607;;
CLD0;;;CHEMBL1909097;[];Sus scrofa;[];;;9823.0;In vitro;Heart;B;Binding;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;18;15;CHEMBL612545;CHEMBL3638187;
CLD0;;;CHEMBL1909098;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Adrenal gland;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat));CHEMBL1909046;Default value - Target has yet to be curated;U;19;15;CHEMBL612545;CHEMBL3638251;
CLD0;;;CHEMBL1909099;[];Bacillus cereus;[];;;1396.0;In vitro;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin);CHEMBL1909046;Default value - Target has yet to be curated;U;20;15;CHEMBL612545;;
CLD0;;Chem-1;CHEMBL1909100;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin);CHEMBL1909046;Homologous protein target assigned;H;21;15;CHEMBL3157;;
CLD0;;T47D;CHEMBL1909101;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307606;Homologous single protein target assigned;8;DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon));CHEMBL1909046;Homologous protein target assigned;H;22;15;CHEMBL1832;;
CLD0;;;CHEMBL1909102;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem);CHEMBL1909046;Default value - Target has yet to be curated;U;23;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909103;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine);CHEMBL1909046;Default value - Target has yet to be curated;U;24;15;CHEMBL612545;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909104;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;116;15;CHEMBL1833;;
CLD0;;CHO-K1;CHEMBL1909105;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine);CHEMBL1909046;Homologous protein target assigned;H;117;15;CHEMBL225;;
CLD0;;HEK293;CHEMBL1909106;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630);CHEMBL1909046;Default value - Target has yet to be curated;U;118;15;CHEMBL612545;;
CLD0;;;CHEMBL1909107;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Striatum;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808);CHEMBL1909046;Direct protein target assigned;D;119;15;CHEMBL5017;CHEMBL3638255;
CLD0;;HeLa;CHEMBL1909108;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308376;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;120;15;CHEMBL3371;;
CLD0;;HEK293;CHEMBL1909109;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine);CHEMBL1909046;Homologous protein target assigned;H;121;15;CHEMBL228;;
CLD0;;Jurkat;CHEMBL1909110;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307526;Homologous single protein target assigned;8;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CHEMBL1909046;Homologous protein target assigned;H;122;15;CHEMBL287;;
CLD0;;;CHEMBL1909111;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil);CHEMBL1909046;Default value - Target has yet to be curated;U;123;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909112;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin);CHEMBL1909046;Default value - Target has yet to be curated;U;124;15;CHEMBL612545;CHEMBL3638188;
CLD0;;CHO;CHEMBL1909113;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P);CHEMBL1909046;Homologous protein target assigned;H;125;15;CHEMBL249;;
CLD0;;CHO;CHEMBL1909114;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968);CHEMBL1909046;Homologous protein target assigned;H;126;15;CHEMBL2327;;
CLD0;;;CHEMBL1909115;[];Escherichia coli;[];;Membrane;562.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone);CHEMBL1909046;Homologous protein target assigned;H;127;15;CHEMBL3072;;
CLD0;;Platelet;CHEMBL1909116;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2);CHEMBL1909046;Direct protein target assigned;D;128;15;CHEMBL1835;;
CLD0;;U-937;CHEMBL1909117;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha);CHEMBL1909046;Default value - Target has yet to be curated;U;129;15;CHEMBL612545;;
CLD0;;HUVEC;CHEMBL1909118;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307501;Homologous single protein target assigned;8;DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF);CHEMBL1909046;Homologous protein target assigned;H;130;15;CHEMBL1868;;
CLD0;;HT-29;CHEMBL1909119;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307768;Homologous single protein target assigned;8;DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP);CHEMBL1909046;Homologous protein target assigned;H;131;15;CHEMBL5144;;
CLD0;;HEK293;CHEMBL1909120;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr);CHEMBL1909046;Homologous protein target assigned;H;132;15;CHEMBL1889;;
CLD0;;;CHEMBL1909121;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888));CHEMBL1909046;Default value - Target has yet to be curated;U;25;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Chem-1;CHEMBL1909122;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A);CHEMBL1909046;Homologous protein target assigned;H;26;15;CHEMBL218;;
CLD0;;Erythrocyte;CHEMBL1909123;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833281;Direct single protein target assigned;9;DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA));CHEMBL1909046;Direct protein target assigned;D;27;15;CHEMBL205;;
CLD0;;CHO-K1;CHEMBL1909124;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1);CHEMBL1909046;Homologous protein target assigned;H;28;15;CHEMBL4015;;
CLD0;;Chem-1;CHEMBL1909125;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC);CHEMBL1909046;Homologous protein target assigned;H;29;15;CHEMBL2414;;
CLD0;;HEK293;CHEMBL1909126;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha);CHEMBL1909046;Homologous protein target assigned;H;30;15;CHEMBL274;;
CLD0;;;CHEMBL1909127;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR1 (IL-8A);CHEMBL1909046;Homologous protein target assigned;H;31;15;CHEMBL4029;;
CLD0;;CHO-K1;CHEMBL1909128;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8);CHEMBL1909046;Homologous protein target assigned;H;32;15;CHEMBL2434;;
CLD0;;1321-N1;CHEMBL1909129;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718);CHEMBL1909046;Homologous protein target assigned;H;33;15;CHEMBL1901;;
CLD0;;Platelet;CHEMBL1909130;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Direct protein target assigned;D;34;15;CHEMBL221;;
CLD0;;Sf21;CHEMBL1909131;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL4106362;Homologous single protein target assigned;8;DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Homologous protein target assigned;H;35;15;CHEMBL230;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909132;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;36;15;CHEMBL3356;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909133;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;37;15;CHEMBL5282;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909134;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;38;15;CHEMBL3622;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909135;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;39;15;CHEMBL3397;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909136;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;40;15;CHEMBL289;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909137;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;41;15;CHEMBL5281;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909138;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin);CHEMBL1909046;Homologous protein target assigned;H;42;15;CHEMBL340;;
CLD0;;CHO;CHEMBL1909139;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390);CHEMBL1909046;Homologous protein target assigned;H;43;15;CHEMBL2056;;
CLD0;;CHO;CHEMBL1909140;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;44;15;CHEMBL217;;
CLD0;;CHO;CHEMBL1909141;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;45;15;CHEMBL234;;
CLD0;;CHO-K1;CHEMBL1909142;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;46;15;CHEMBL219;;
CLD0;;CHO-K1;CHEMBL1909143;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;47;15;CHEMBL238;;
CLD0;;CHO-K1;CHEMBL1909144;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1);CHEMBL1909046;Homologous protein target assigned;H;48;15;CHEMBL252;;
CLD0;;Sf9;CHEMBL1909145;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;49;15;CHEMBL206;;
CLD0;;Sf9;CHEMBL1909146;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;50;15;CHEMBL242;;
CLD0;;;CHEMBL1909147;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol);CHEMBL1909046;Default value - Target has yet to be curated;U;51;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909148;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam);CHEMBL1909046;Default value - Target has yet to be curated;U;52;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909149;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB);CHEMBL1909046;Default value - Target has yet to be curated;U;53;15;CHEMBL612545;CHEMBL3559724;
CLD0;;HeLa S3;CHEMBL1909150;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3886002;Homologous single protein target assigned;8;DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone);CHEMBL1909046;Homologous protein target assigned;H;54;15;CHEMBL2034;;
CLD0;;;CHEMBL1909151;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA);CHEMBL1909046;Default value - Target has yet to be curated;U;55;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909152;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid);CHEMBL1909046;Default value - Target has yet to be curated;U;56;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909153;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653);CHEMBL1909046;Default value - Target has yet to be curated;U;57;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909154;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP);CHEMBL1909046;Default value - Target has yet to be curated;U;58;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909155;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Spinal cord;B;Binding;BAO_0000249;cell membrane format;;Multiple direct protein targets may be assigned;5;DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine);CHEMBL1909046;Direct protein target assigned;D;59;15;CHEMBL3392921;CHEMBL3638246;
CLD0;;CHO-K1;CHEMBL1909156;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine);CHEMBL1909046;Homologous protein target assigned;H;60;15;CHEMBL231;;
CLD0;;CHO-K1;CHEMBL1909157;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine);CHEMBL1909046;Homologous protein target assigned;H;61;15;CHEMBL1941;;
CLD0;;;CHEMBL1909158;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA);CHEMBL1909046;Homologous protein target assigned;H;62;15;CHEMBL402;;
CLD0;;;CHEMBL1909159;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan);CHEMBL1909046;Default value - Target has yet to be curated;U;63;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909160;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin);CHEMBL1909046;Direct protein target assigned;D;64;15;CHEMBL5486;CHEMBL3559723;
CLD0;;NIH3T3;CHEMBL1909161;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta);CHEMBL1909046;Default value - Target has yet to be curated;U;65;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909162;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4);CHEMBL1909046;Default value - Target has yet to be curated;U;66;15;CHEMBL612545;;
CLD0;;;CHEMBL1909307;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";CHEMBL1909294;Non-molecular target assigned;N;1;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909308;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";CHEMBL1909294;Non-molecular target assigned;N;2;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909309;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";CHEMBL1909294;Non-molecular target assigned;N;3;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909310;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";CHEMBL1909294;Non-molecular target assigned;N;4;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909311;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";CHEMBL1909294;Non-molecular target assigned;N;5;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909312;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";CHEMBL1909294;Non-molecular target assigned;N;6;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909313;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";CHEMBL1909294;Non-molecular target assigned;N;7;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909314;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";CHEMBL1909294;Non-molecular target assigned;N;8;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909315;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";CHEMBL1909294;Non-molecular target assigned;N;9;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909316;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";CHEMBL1909294;Non-molecular target assigned;N;10;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909317;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";CHEMBL1909294;Non-molecular target assigned;N;11;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909318;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";CHEMBL1909294;Non-molecular target assigned;N;12;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909319;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";CHEMBL1909294;Non-molecular target assigned;N;13;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909320;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";CHEMBL1909294;Non-molecular target assigned;N;14;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;KB ;CHEMBL1930890;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B and MTT assay;CHEMBL1926616;Non-molecular target assigned;N;420004;1;CHEMBL398;;
CLD0;;KB ;CHEMBL1930891;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against vincristine-selected multi drug-resistant human KB cells after 72 hrs by sulforhodamine B and MTT assay;CHEMBL1926616;Non-molecular target assigned;N;420005;1;CHEMBL398;;
CLD0;;K562;CHEMBL1930892;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B and MTT assay;CHEMBL1926616;Non-molecular target assigned;N;420006;1;CHEMBL385;;
CLD0;;K562;CHEMBL1930893;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against adriamycin-selected multi drug-resistant human K562 cells after 72 hrs by sulforhodamine B and MTT assay;CHEMBL1926616;Non-molecular target assigned;N;420007;1;CHEMBL385;;
CLD0;;KB ;CHEMBL1930894;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Resistance index, ratio of IC50 for vincristine-selected multi drug-resistant human KB cells to IC50 for human KB cells;CHEMBL1926616;Non-molecular target assigned;N;420009;1;CHEMBL398;;
CLD0;;MCF7;CHEMBL1931156;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay;CHEMBL1926673;Non-molecular target assigned;N;420310;1;CHEMBL387;;
CLD0;;MDA-MB-231;CHEMBL1931157;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cytotoxicity against human MDA-MB-231 cells after 48 hrs by SRB assay;CHEMBL1926673;Non-molecular target assigned;N;420311;1;CHEMBL400;;
CLD0;;KB ;CHEMBL1941682;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Growth inhibition of human KB cells after 72 hrs by methylene blue assay;CHEMBL1938387;Non-molecular target assigned;N;427008;1;CHEMBL398;;
CLD0;;KB-VIN10;CHEMBL1941685;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Growth inhibition of human KB-VIN10 cells after 72 hrs by methylene blue assay;CHEMBL1938387;Non-molecular target assigned;N;427011;1;CHEMBL3879801;;
CLD0;;KB-7d;CHEMBL1941686;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Growth inhibition of human KB-7d cells after 72 hrs by methylene blue assay;CHEMBL1938387;Non-molecular target assigned;N;427012;1;CHEMBL3879801;;
CLD0;;KB-S15;CHEMBL1941687;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Growth inhibition of human KB-S15 cells after 72 hrs by methylene blue assay;CHEMBL1938387;Non-molecular target assigned;N;427013;1;CHEMBL3879801;;
CLD0;confirmatory;MDA-N;CHEMBL1963976;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307532;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;87;7;CHEMBL614078;;
CLD0;confirmatory;SN12C;CHEMBL1963981;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307518;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;145;7;CHEMBL614054;;
CLD0;confirmatory;NCI-H23;CHEMBL1963985;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307750;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;1;7;CHEMBL614997;;
CLD0;confirmatory;ACHN;CHEMBL1963989;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307633;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;139;7;CHEMBL614519;;
CLD0;confirmatory;UO-31;CHEMBL1963990;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307612;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;143;7;CHEMBL614388;;
CLD0;confirmatory;HOP-92;CHEMBL1963991;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308091;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;13;7;CHEMBL613889;;
CLD0;confirmatory;HL-60;CHEMBL1963994;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;125;7;CHEMBL383;;
CLD0;confirmatory;DU-145;CHEMBL1964017;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;43;7;CHEMBL613508;;
CLD0;confirmatory;SF-539;CHEMBL1964018;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307721;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;49;7;CHEMBL614860;;
CLD0;confirmatory;SK-MEL-5;CHEMBL1964021;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307744;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;37;7;CHEMBL614922;;
CLD0;confirmatory;Malme-3M;CHEMBL1964025;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307507;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;29;7;CHEMBL614021;;
CLD0;confirmatory;K562;CHEMBL1964030;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;121;7;CHEMBL385;;
CLD0;confirmatory;A498;CHEMBL1964034;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308425;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;129;7;CHEMBL614516;;
CLD0;confirmatory;OVCAR-3;CHEMBL1964037;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;99;7;CHEMBL614213;;
CLD0;confirmatory;MOLT-4;CHEMBL1964040;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;123;7;CHEMBL614177;;
CLD0;confirmatory;HOP-62;CHEMBL1964043;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307671;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;9;7;CHEMBL614643;;
CLD0;confirmatory;NCI/ADR-RES;CHEMBL1964045;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;93;7;CHEMBL613829;;
CLD0;confirmatory;U-251;CHEMBL1964047;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;59;7;CHEMBL615022;;
CLD0;confirmatory;OVCAR-8;CHEMBL1964048;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307975;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;109;7;CHEMBL612555;;
CLD0;confirmatory;OVCAR-5;CHEMBL1964049;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307565;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;107;7;CHEMBL614214;;
CLD0;confirmatory;Schwann;CHEMBL1964055;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624044;7;CHEMBL2007624;;
CLD0;confirmatory;SNB-19;CHEMBL1964059;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307552;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;53;7;CHEMBL614164;;
CLD0;confirmatory;DMS-273;CHEMBL1964062;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308487;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;61;7;CHEMBL614034;;
CLD0;confirmatory;MDA-MB-231;CHEMBL1964063;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;95;7;CHEMBL400;;
CLD0;confirmatory;SR;CHEMBL1964065;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307586;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;115;7;CHEMBL614300;;
CLD0;confirmatory;TK-10;CHEMBL1964066;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308453;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;141;7;CHEMBL614056;;
CLD0;confirmatory;SW-620;CHEMBL1964072;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307944;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;81;7;CHEMBL612262;;
CLD0;confirmatory;M19-MEL;CHEMBL1964074;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307506;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;27;7;CHEMBL614019;;
CLD0;confirmatory;NCI-H522;CHEMBL1964075;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308392;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;15;7;CHEMBL614387;;
CLD0;confirmatory;KM12;CHEMBL1964077;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307689;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;73;7;CHEMBL614709;;
CLD0;confirmatory;Schwann;CHEMBL1964081;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624032;7;CHEMBL2007624;;
CLD0;confirmatory;M14;CHEMBL1964085;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307591;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;25;7;CHEMBL614317;;
CLD0;confirmatory;XF498;CHEMBL1964086;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308037;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;51;7;CHEMBL613533;;
CLD0;confirmatory;NCI-H322M;CHEMBL1964087;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307710;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;5;7;CHEMBL614803;;
CLD0;confirmatory;RPMI-8226;CHEMBL1964088;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307732;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;113;7;CHEMBL614882;;
CLD0;confirmatory;OVCAR-4;CHEMBL1964091;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307517;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;105;7;CHEMBL614051;;
CLD0;confirmatory;LOX IMVI ;CHEMBL1964092;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307535;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;23;7;CHEMBL614096;;
CLD0;confirmatory;P388;CHEMBL1964095;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;111;7;CHEMBL389;;
CLD0;confirmatory;BT-549;CHEMBL1964099;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308490;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;89;7;CHEMBL614072;;
CLD0;confirmatory;SK-MEL-2;CHEMBL1963844;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307743;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;35;7;CHEMBL614917;;
CLD0;confirmatory;KM-20L2;CHEMBL1963848;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307782;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;75;7;CHEMBL614791;;
CLD0;confirmatory;A549;CHEMBL1963854;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;19;7;CHEMBL392;;
CLD0;confirmatory;HCC 2998;CHEMBL1963860;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308074;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;77;7;CHEMBL613855;;
CLD0;confirmatory;SNB-75;CHEMBL1963866;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307616;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;55;7;CHEMBL614451;;
CLD0;confirmatory;HCT-15;CHEMBL1963868;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307945;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;71;7;CHEMBL612263;;
CLD0;confirmatory;HCT-116;CHEMBL1963874;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;79;7;CHEMBL394;;
CLD0;confirmatory;SF-268;CHEMBL1963876;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;45;7;CHEMBL613977;;
CLD0;confirmatory;EKVX ;CHEMBL1963880;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307626;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;21;7;CHEMBL614487;;
CLD0;confirmatory;MCF7;CHEMBL1963882;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;83;7;CHEMBL387;;
CLD0;confirmatory;PC-3;CHEMBL1963885;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;41;7;CHEMBL390;;
CLD0;confirmatory;DMS-114;CHEMBL1963887;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307670;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;63;7;CHEMBL614642;;
CLD0;confirmatory;LXFL 529;CHEMBL1963889;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307537;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;17;7;CHEMBL614110;;
CLD0;confirmatory;SK-OV-3;CHEMBL1963895;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;103;7;CHEMBL614925;;
CLD0;confirmatory;T47D;CHEMBL1963900;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307606;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;91;7;CHEMBL614361;;
CLD0;confirmatory;NCI-H460;CHEMBL1963901;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;7;7;CHEMBL396;;
CLD0;confirmatory;UACC-62;CHEMBL1963903;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307660;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;31;7;CHEMBL614610;;
CLD0;confirmatory;CAKI-1;CHEMBL1963911;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307522;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;131;7;CHEMBL614067;;
CLD0;confirmatory;P388/ADR;CHEMBL1963918;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388/ADR Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;117;7;CHEMBL614218;;
CLD0;confirmatory;MDA-MB-435;CHEMBL1963921;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;85;7;CHEMBL614697;;
CLD0;confirmatory;SF-295;CHEMBL1963922;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307738;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;47;7;CHEMBL614908;;
CLD0;confirmatory;IGROV-1;CHEMBL1963929;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;101;7;CHEMBL613984;;
CLD0;confirmatory;RXF 631;CHEMBL1963935;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307735;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;135;7;CHEMBL614888;;
CLD0;confirmatory;Hs-578T;CHEMBL1963945;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307672;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;97;7;CHEMBL614645;;
CLD0;confirmatory;786-0;CHEMBL1963953;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308018;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;137;7;CHEMBL613102;;
CLD0;confirmatory;SNB-78;CHEMBL1963954;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307969;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;57;7;CHEMBL612543;;
CLD0;confirmatory;UACC-257;CHEMBL1963960;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308008;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;33;7;CHEMBL612796;;
CLD0;confirmatory;CCRF-CEM;CHEMBL1963961;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;119;7;CHEMBL382;;
CLD0;confirmatory;DLD-1;CHEMBL1963963;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307580;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;69;7;CHEMBL614285;;
CLD0;confirmatory;NCI-H226;CHEMBL1964004;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307697;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;3;7;CHEMBL614740;;
CLD0;confirmatory;HT-29;CHEMBL1964006;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;65;7;CHEMBL384;;
CLD0;confirmatory;SK-MEL-28;CHEMBL1964007;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;39;7;CHEMBL614919;;
CLD0;confirmatory;RXF 393;CHEMBL1964009;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307734;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;133;7;CHEMBL614886;;
CLD0;confirmatory;COLO 205;CHEMBL1964012;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;67;7;CHEMBL614561;;
CLD0;confirmatory;HOP-18;CHEMBL1964014;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307783;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;11;7;CHEMBL614809;;
CLD0;confirmatory;SN12K1;CHEMBL1964015;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307784;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;127;7;CHEMBL1909241;;
CLD0;;KB ;CHEMBL2024772;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells at 4 uM after 48 hrs by SRB assay;CHEMBL2021899;Non-molecular target assigned;N;445008;1;CHEMBL398;;
CLD0;;KB ;CHEMBL2024773;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Ratio of GI50 for human vincristine-resistance KB cells to GI50 for wild type human KB cells;CHEMBL2021899;Non-molecular target assigned;N;445009;1;CHEMBL398;;
CLD0;;C6;CHEMBL2032728;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Antiproliferative activity against rat C6 cells at 0.1 to 10 uM after 48 hrs by neutral red incorporation assay;CHEMBL2029220;Non-molecular target assigned;N;448524;1;CHEMBL614657;;
CLD0;;Astrocyte;CHEMBL2032733;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307726;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against mouse astrocytes assessed as decrease in cell viability at 1 to 10 uM after 48 hrs by neutral red incorporation assay;CHEMBL2029220;Default value - Target has yet to be curated;U;448594;1;CHEMBL612558;;
CLD0;;Astrocyte;CHEMBL2032734;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307726;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against mouse astrocytes assessed as decrease in cell viability at 1 to 10 uM after 48 hrs by propidium iodide incorporation assay;CHEMBL2029220;Default value - Target has yet to be curated;U;448595;1;CHEMBL612558;;
CLD0;;Astrocyte;CHEMBL2032735;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307726;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against mouse astrocytes assessed as decrease in cell viability at 0.1 uM after 48 hrs by neutral red incorporation assay;CHEMBL2029220;Default value - Target has yet to be curated;U;448596;1;CHEMBL612558;;
CLD0;;Astrocyte;CHEMBL2032736;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307726;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against mouse astrocytes assessed as decrease in cell viability at 0.1 uM after 48 hrs by propidium iodide incorporation assay;CHEMBL2029220;Default value - Target has yet to be curated;U;448597;1;CHEMBL612558;;
CLD0;;Astrocyte;CHEMBL2032737;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307726;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against mouse astrocytes assessed as decrease in cell viability at 0.1 uM after 48 hrs by Hoechst 33342 staining;CHEMBL2029220;Default value - Target has yet to be curated;U;448598;1;CHEMBL612558;;
CLD0;;SNU-398;CHEMBL2032750;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307619;Target assigned is non-molecular;1;Antiproliferative activity against human SNU398 cells;CHEMBL2029236;Non-molecular target assigned;N;447730;1;CHEMBL614454;;
CLD0;;PLC-PRF-5;CHEMBL2032751;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308140;Target assigned is non-molecular;1;Antiproliferative activity against human PLC/PRF/5 cells;CHEMBL2029236;Non-molecular target assigned;N;447731;1;CHEMBL3879801;;
CLD0;;SMMC-7721;CHEMBL2032752;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Antiproliferative activity against human SMMC7721 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447732;1;CHEMBL613831;;
CLD0;;MHCC97H;CHEMBL2032753;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;CHEMBL4295459;Target assigned is non-molecular;1;Antiproliferative activity against human MHCC97H after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447733;1;CHEMBL3879801;;
CLD0;;Bel-7402;CHEMBL2032754;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307770;Target assigned is non-molecular;1;Antiproliferative activity against human Bel7402 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447734;1;CHEMBL614279;;
CLD0;;Hep 3B2;CHEMBL2032755;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;CHEMBL4106361;Target assigned is non-molecular;1;Antiproliferative activity against human Hep3B after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447735;1;CHEMBL3879801;;
CLD0;;HepG2;CHEMBL2032756;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447736;1;CHEMBL395;;
CLD0;;Huh-7 ;CHEMBL2032757;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307515;Target assigned is non-molecular;1;Antiproliferative activity against human HuH7 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447737;1;CHEMBL614039;;
CLD0;;;CHEMBL2032758;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antiproliferative activity against human JHH2 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447738;1;CHEMBL3879801;;
CLD0;;;CHEMBL2032759;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antiproliferative activity against human JHH4 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447739;1;CHEMBL3879801;;
CLD0;;;CHEMBL2032760;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antiproliferative activity against human JHH7 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447740;1;CHEMBL3879801;;
CLD0;;PLC-PRF-5;CHEMBL2032761;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;CHEMBL3308140;Target assigned is non-molecular;1;Antiproliferative activity against human PLC/PRF/5 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447741;1;CHEMBL3879801;;
CLD0;;SNU-182;CHEMBL2032762;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295423;Target assigned is non-molecular;1;Antiproliferative activity against human SNU182 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447742;1;CHEMBL3879801;;
CLD0;;SNU-387;CHEMBL2032763;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308817;Target assigned is non-molecular;1;Antiproliferative activity against human SNU387 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447743;1;CHEMBL1075583;;
CLD0;;SNU-398;CHEMBL2032764;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307619;Target assigned is non-molecular;1;Antiproliferative activity against human SNU398 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447744;1;CHEMBL614454;;
CLD0;;SNU-423;CHEMBL2032765;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308367;Target assigned is non-molecular;1;Antiproliferative activity against human SNU423 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447745;1;CHEMBL1075584;;
CLD0;;SNU-449;CHEMBL2032766;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308480;Target assigned is non-molecular;1;Antiproliferative activity against human SNU449 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447746;1;CHEMBL1075585;;
CLD0;;SNU-475;CHEMBL2032767;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308787;Target assigned is non-molecular;1;Antiproliferative activity against human SNU475 after 72 hrs by CellTiter Glo assay;CHEMBL2029236;Non-molecular target assigned;N;447747;1;CHEMBL1075586;;
CLD0;;SNU-398;CHEMBL2032784;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307619;Target assigned is non-molecular;1;Cell cycle arrest in human SNU398 cells assessed as accumulation at G1 phase after 24 hrs by FACS analysis (Rvb = 55.8%);CHEMBL2029236;Non-molecular target assigned;N;447923;1;CHEMBL614454;;
CLD0;;SNU-398;CHEMBL2032785;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307619;Target assigned is non-molecular;1;Cell cycle arrest in human SNU398 cells assessed as accumulation at G2 phase after 24 hrs by FACS analysis (Rvb = 38.2%);CHEMBL2029236;Non-molecular target assigned;N;447924;1;CHEMBL614454;;
CLD0;;SNU-398;CHEMBL2032786;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307619;Target assigned is non-molecular;1;Cell cycle arrest in human SNU398 cells assessed as accumulation at sub-G1 phase after 24 hrs by FACS analysis (Rvb = 1.2%);CHEMBL2029236;Non-molecular target assigned;N;447925;1;CHEMBL614454;;
CLD0;;PLC-PRF-5;CHEMBL2032787;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308140;Target assigned is molecular non-protein target;3;Cell cycle arrest in human PLC/PRF/5 cells assessed as accumulation at G1 phase after 24 hrs by FACS analysis (Rvb = 66.8%);CHEMBL2029236;Molecular target other than protein assigned;M;447926;1;CHEMBL612546;;
CLD0;;PLC-PRF-5;CHEMBL2032788;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308140;Target assigned is molecular non-protein target;3;Cell cycle arrest in human PLC/PRF/5 cells assessed as accumulation at G2 phase after 24 hrs by FACS analysis (Rvb = 26.1%);CHEMBL2029236;Molecular target other than protein assigned;M;447927;1;CHEMBL612546;;
CLD0;;PLC-PRF-5;CHEMBL2032789;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308140;Target assigned is molecular non-protein target;3;Cell cycle arrest in human PLC/PRF/5 cells assessed as accumulation at sub-G1 phase after 24 hrs by FACS analysis (Rvb = 1.4%);CHEMBL2029236;Molecular target other than protein assigned;M;447928;1;CHEMBL612546;;
CLD0;;Leukemia cell;CHEMBL2066355;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Cytotoxicity against human leukemia cells after 48 hrs;CHEMBL2062525;Non-molecular target assigned;N;462702;1;CHEMBL3879801;;
CLD0;;NSCLC;CHEMBL2066356;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Cytotoxicity against human NSCLC cells after 48 hrs;CHEMBL2062525;Non-molecular target assigned;N;462703;1;CHEMBL612554;;
CLD0;;;CHEMBL2066357;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human COLON cells after 48 hrs;CHEMBL2062525;Non-molecular target assigned;N;462704;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL2066358;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human CNS cancer cells after 48 hrs;CHEMBL2062525;Non-molecular target assigned;N;462705;1;CHEMBL3879801;;
CLD0;;Melanoma cell;CHEMBL2066608;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Cytotoxicity against human melanoma cells after 48 hrs;CHEMBL2062525;Non-molecular target assigned;N;462706;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL2066609;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human ovarian cancer cells after 48 hrs;CHEMBL2062525;Non-molecular target assigned;N;462707;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL2066610;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human renal cancer cells after 48 hrs;CHEMBL2062525;Non-molecular target assigned;N;462708;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL2066611;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human prostate cancer cells after 48 hrs;CHEMBL2062525;Non-molecular target assigned;N;462709;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL2066612;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human breast cancer cells after 48 hrs;CHEMBL2062525;Non-molecular target assigned;N;462710;1;CHEMBL3879801;;
CLD0;;;CHEMBL2077373;[];Mus musculus;[];mdr1a(-/-);;10090.0;In vivo;Brain;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;TP_TRANSPORTER: increase in brain concentration in mdr1a(-/-) mouse;CHEMBL2074408;Direct protein target assigned;D;2431;18;CHEMBL2573;CHEMBL3638188;
CLD0;;MDCK-II;CHEMBL2077557;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of EGCG in MRP2-expressing MDCKII cells;CHEMBL2074563;Homologous protein target assigned;H;285;18;CHEMBL5748;;
CLD0;;HeLa;CHEMBL2077586;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3308376;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.05 uM) in membrane vesicle from MRP1-expressing HeLa cells;CHEMBL2074383;Homologous protein target assigned;H;318;18;CHEMBL3004;;
CLD0;;;CHEMBL2075060;[];Rattus norvegicus;[];Wistar;Plasma membrane vesicle;10116.0;In vitro;Liver;F;Functional;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;TP_TRANSPORTER: inhibition of LTC4 uptake (LTC4: 0.01 uM, Vincristine: 100 uM) in liver plasma membrane vesicles of Wistar rat;CHEMBL2074429;Direct protein target assigned;D;1597;18;CHEMBL2073676;CHEMBL3559723;
CLD0;;KB-VIN10;CHEMBL2076285;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in KB-VIN10 cells;CHEMBL2074333;Homologous protein target assigned;H;335;18;CHEMBL4302;;
CLD0;;KB-TAX50;CHEMBL2076286;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in KB-TAX50 cells;CHEMBL2074333;Homologous protein target assigned;H;336;18;CHEMBL4302;;
CLD0;;HEK293;CHEMBL2076524;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 1 uM, Vincristine: 30 uM) in membrane vesicles from MRP7-expressing HEK293 cells;CHEMBL2074568;Homologous protein target assigned;H;1687;18;CHEMBL2073687;;
CLD0;;HEK293;CHEMBL2077476;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;TP_TRANSPORTER: efflux in Mrp1-expressing HEK293 cells;CHEMBL2073844;Homologous protein target assigned;H;485;18;CHEMBL2532;;
CLD0;;NIH3T3;CHEMBL2075689;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307716;Homologous single protein target assigned;8;TP_TRANSPORTER: increase in Calcein-AM intracellular accumulation (Calcein-AM: 0.5 uM, Vincristine: 200 uM) in MDR1-expressing NIH-3T3 cells;CHEMBL2074246;Homologous protein target assigned;H;2924;18;CHEMBL4302;;
CLD0;;HEK293;CHEMBL2076177;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of MTX uptake (MTX: 1 uM, Vincristine: 300 uM) in membrane vesicle from MRP3-expessing HEK 293 cell;CHEMBL2073963;Homologous protein target assigned;H;1245;18;CHEMBL2073669;;
CLD0;;LLC-PK1;CHEMBL2077634;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: intracellular accumulation in MRP2-expressing LLC PK1 cells;CHEMBL2073997;Homologous protein target assigned;H;1318;18;CHEMBL5748;;
CLD0;;GLC-4/ADR;CHEMBL2075733;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3833703;Homologous single protein target assigned;8;TP_TRANSPORTER: uptake in membrane vesicles from GLC4/ADR cells;CHEMBL2074451;Homologous protein target assigned;H;2223;18;CHEMBL3004;;
CLD0;;"KB-3-1; C-A120";CHEMBL2075740;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: intracellular accumulation in KB-3-1 and C-A120 cells;CHEMBL2074493;Homologous protein target assigned;H;2230;18;CHEMBL3004;;
CLD0;;MDCK-II;CHEMBL2076208;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;9;18;CHEMBL4302;;
CLD0;;Sf9;CHEMBL2076219;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;TP_TRANSPORTER: ATP hydrolysis in MDR1-expressing Sf9 cells;CHEMBL1908284;Homologous protein target assigned;H;20;18;CHEMBL4302;;
CLD0;;HEK293;CHEMBL2076257;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in MRP1-expressing HEK293 cells;CHEMBL2074511;Homologous protein target assigned;H;60;18;CHEMBL2532;;
CLD0;;MDCK;CHEMBL2076066;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308370;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Digoxin transepithelial transport (basal to apical) in MDR1-expressing MDCK cells;CHEMBL2074370;Homologous protein target assigned;H;92;18;CHEMBL4302;;
CLD0;;Caco-2;CHEMBL2078149;[];;[];;Membrane;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3307519;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Verapamil binding in membranes from Vinblastine-induced Caco-2 cells;CHEMBL2074241;Homologous protein target assigned;H;120;18;CHEMBL4302;;
CLD0;;LLC-PK1;CHEMBL2078487;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: intracellular accumulation in Bsep-expressing LLC-PK1 cells;CHEMBL2074223;Homologous protein target assigned;H;135;18;CHEMBL2073695;;
CLD0;;MEF3.8;CHEMBL2078493;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in BCRP-expressing MEF3.8 cells;CHEMBL2074346;Homologous protein target assigned;H;141;18;CHEMBL2073705;;
CLD0;;MDCK;CHEMBL2078561;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308370;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Vinblastine transepithelial transport (basal to apical) in MRP2-expressing MDCK cells;CHEMBL2073914;Homologous protein target assigned;H;166;18;CHEMBL5748;;
CLD0;;PEAKSTABLE;CHEMBL2078574;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in MRP1-expressing PEAKSTABEL cells;CHEMBL2074335;Homologous protein target assigned;H;180;18;CHEMBL3004;;
CLD0;;LLC-PK1;CHEMBL2078578;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: intracellular accumulation in MDR1-expressing LLC-PK1 cells;CHEMBL2074223;Homologous protein target assigned;H;185;18;CHEMBL4302;;
CLD0;;MCF7;CHEMBL2078581;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in MDR1-expressing MCF7 cells;CHEMBL2074080;Homologous protein target assigned;H;188;18;CHEMBL4302;;
CLD0;;;CHEMBL2089575;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of MAP rich tubulin polymerization in bovine brain at 1 uM after 5 mins by spectrophotometric analysis;CHEMBL2086284;Default value - Target has yet to be curated;U;469038;1;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114843;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624296;7;CHEMBL1293278;;
CLD0;confirmatory;SW480;CHEMBL2114780;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307758;Direct single protein target assigned;9;PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624297;7;CHEMBL1293278;;
CLD0;confirmatory;;CHEMBL2114784;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651635;7;CHEMBL1795085;;
CLD0;confirmatory;;CHEMBL2114821;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling: Hit Validation in Primary Screen. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;651558;7;CHEMBL612545;;
CLD0;;HL-60;CHEMBL2150100;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay;CHEMBL2146381;Non-molecular target assigned;N;473954;1;CHEMBL383;;
CLD0;;K562;CHEMBL2150101;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay;CHEMBL2146381;Non-molecular target assigned;N;474020;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL2150102;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay;CHEMBL2146381;Non-molecular target assigned;N;474023;1;CHEMBL382;;
CLD0;;HL-60;CHEMBL2150103;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474028;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL2150104;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for human HL60/ADR cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474029;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL2150105;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474030;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL2150106;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for doxorubicin-resistant human HL60 cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474031;1;CHEMBL383;;
CLD0;;K562;CHEMBL2150107;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Ratio of IC50 for doxorubicin-resistant human K562 cells to IC50 for human K562 cells;CHEMBL2146381;Non-molecular target assigned;N;474032;1;CHEMBL385;;
CLD0;;K562;CHEMBL2150108;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Ratio of IC50 for human K562/HHT300 cells to IC50 for human K562 cells;CHEMBL2146381;Non-molecular target assigned;N;474033;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL2150109;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for human CCRF-CEM/C2 cells IC50 for human CCRF-CEM cells;CHEMBL2146381;Non-molecular target assigned;N;474034;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL2150110;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for human CCRF-CEM/VM-1-5 cells IC50 for human CCRF-CEM cells;CHEMBL2146381;Non-molecular target assigned;N;474035;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL2150111;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for human CCRF-CEM/VLB100 cells IC50 for human CCRF-CEM cells;CHEMBL2146381;Non-molecular target assigned;N;474036;1;CHEMBL382;;
CLD0;;;CHEMBL2166270;[];Electrophorus electricus;[];;;8005.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of electric eel AChE at 2 mg/ml by Ellman's method;CHEMBL2163249;Direct protein target assigned;D;480081;1;CHEMBL4078;;
CLD0;;;CHEMBL2166271;[];Equus caballus;[];;;9796.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of horse BChE at 2 mg/ml by Ellman's method;CHEMBL2163249;Direct protein target assigned;D;480080;1;CHEMBL5763;;
CLD0;;;CHEMBL2169417;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for human liver OATP1B1 to IC50 for OATP1B3;CHEMBL2163248;Default value - Target has yet to be curated;U;479735;1;CHEMBL612558;CHEMBL3559723;
CLD0;;HEK293;CHEMBL2169429;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466159;1;CHEMBL1697668;;
CLD0;;HEK293;CHEMBL2169430;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466160;1;CHEMBL1743121;;
CLD0;;HEK293;CHEMBL2169431;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466161;1;CHEMBL1743124;;
CLD0;;HEK293;CHEMBL2169432;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466162;1;CHEMBL1697668;;
CLD0;;HEK293;CHEMBL2169433;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake incubated for 5 mins by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466163;1;CHEMBL1743121;;
CLD0;;HCT-116;CHEMBL2182531;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells;CHEMBL2177037;Non-molecular target assigned;N;487559;1;CHEMBL394;;
CLD0;;L1210;CHEMBL2182532;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity against mouse L1210 cells;CHEMBL2177037;Non-molecular target assigned;N;487558;1;CHEMBL386;;
CLD0;;NFF;CHEMBL2216646;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307561;Target assigned is non-molecular;1;Cytotoxicity against human NFF cells after 72 hrs by alamar blue assay;CHEMBL2203019;Non-molecular target assigned;N;498974;1;CHEMBL614198;;
CLD0;;PC-3;CHEMBL2216647;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay;CHEMBL2203019;Non-molecular target assigned;N;498972;1;CHEMBL390;;
CLD0;;HEK293;CHEMBL2216648;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human HEK cells after 72 hrs by alamar blue assay;CHEMBL2203019;Default value - Target has yet to be curated;U;498973;1;CHEMBL612558;;
CLD0;;LNCaP;CHEMBL2216649;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307965;Target assigned is non-molecular;1;Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay;CHEMBL2203019;Non-molecular target assigned;N;498971;1;CHEMBL612518;;
CLD0;;HeLa;CHEMBL2216650;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 72 hrs by alamar blue assay;CHEMBL2203019;Non-molecular target assigned;N;498970;1;CHEMBL399;;
CLD0;;A549;CHEMBL2216651;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells after 72 hrs by alamar blue assay;CHEMBL2203019;Non-molecular target assigned;N;498969;1;CHEMBL392;;
CLD0;;HL-60;CHEMBL2321354;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cell cycle arrest in human HL60 cells assessed as accumulation at G2 phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524217;1;CHEMBL383;;
CLD0;;HT-29;CHEMBL2321355;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cell cycle arrest in human HT-29 cells assessed as accumulation at G2 phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524216;1;CHEMBL384;;
CLD0;;CAL-33;CHEMBL2317178;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308715;Target assigned is non-molecular;1;Cell cycle arrest in human CAL33 cells assessed as accumulation at G2 phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524215;1;CHEMBL1075409;;
CLD0;;HL-60;CHEMBL2317179;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cell cycle arrest in human HL60 cells assessed as accumulation at S phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524214;1;CHEMBL383;;
CLD0;;HT-29;CHEMBL2317180;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cell cycle arrest in human HT-29 cells assessed as accumulation at S phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524211;1;CHEMBL384;;
CLD0;;CAL-33;CHEMBL2317042;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308715;Target assigned is non-molecular;1;Cell cycle arrest in human CAL33 cells assessed as accumulation at S phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524209;1;CHEMBL1075409;;
CLD0;;HL-60;CHEMBL2317043;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cell cycle arrest in human HL60 cells assessed as accumulation at G1 phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524205;1;CHEMBL383;;
CLD0;;HT-29;CHEMBL2317044;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cell cycle arrest in human HT-29 cells assessed as accumulation at G1 phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524204;1;CHEMBL384;;
CLD0;;CAL-33;CHEMBL2317045;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308715;Target assigned is non-molecular;1;Cell cycle arrest in human CAL33 cells assessed as accumulation at G1 phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524203;1;CHEMBL1075409;;
CLD0;;HL-60;CHEMBL2317046;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cell cycle arrest in human HL60 cells assessed as accumulation at sub-G1 phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524201;1;CHEMBL383;;
CLD0;;HT-29;CHEMBL2317047;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cell cycle arrest in human HT-29 cells assessed as accumulation at sub-G1 phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524200;1;CHEMBL384;;
CLD0;;CAL-33;CHEMBL2317048;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308715;Target assigned is non-molecular;1;Cell cycle arrest in human CAL33 cells assessed as accumulation at sub-G1 phase at 0.5 uM after 24 hrs flow cytometry;CHEMBL2311499;Non-molecular target assigned;N;524194;1;CHEMBL1075409;;
CLD0;;KB-VIN10;CHEMBL2343798;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Resistance factor, ratio of IC50 for human KB-VIN10 cells to IC50 for human KB cells;CHEMBL2331340;Default value - Target has yet to be curated;U;556413;1;CHEMBL612545;;
CLD0;;MES-SA/Dx5;CHEMBL2343799;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308373;Target assigned is non-molecular;1;Cytotoxicity against human MES-SA/Dx5 cells after 72 hrs by Presto Blue assay;CHEMBL2331340;Non-molecular target assigned;N;556412;1;CHEMBL3879801;;
CLD0;;KB-VIN10;CHEMBL2343800;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human KB-VIN10 cells after 72 hrs by SRB assay;CHEMBL2331340;Non-molecular target assigned;N;556410;1;CHEMBL3879801;;
CLD0;;MES-SA ;CHEMBL2343801;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;Cytotoxicity against human MES-SA cells after 72 hrs by Presto Blue assay;CHEMBL2331340;Non-molecular target assigned;N;556411;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL2343803;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 72 hrs by SRB assay;CHEMBL2331340;Non-molecular target assigned;N;556409;1;CHEMBL398;;
CLD0;;NFF;CHEMBL2343634;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307561;Target assigned is non-molecular;1;Cytotoxicity against human NFF cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay;CHEMBL2331272;Non-molecular target assigned;N;558223;1;CHEMBL614198;;
CLD0;;PC-3;CHEMBL2343637;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay;CHEMBL2331272;Non-molecular target assigned;N;558221;1;CHEMBL390;;
CLD0;;HeLa;CHEMBL2343639;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay;CHEMBL2331272;Non-molecular target assigned;N;558219;1;CHEMBL399;;
CLD0;confirmatory;;CHEMBL2354211;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;686971;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2354221;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686978;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354222;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;"PubChem BioAssay. Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput dose response assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay. (Class of assay: confirmatory) ";CHEMBL1201862;Default value - Target has yet to be curated;U;687018;7;CHEMBL2362975;;
CLD0;confirmatory;;CHEMBL2354254;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686979;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354292;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;"PubChem BioAssay. Luminescence-based cell-based high throughput dose response assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1. (Class of assay: confirmatory) ";CHEMBL1201862;Homologous protein target assigned;H;687017;7;CHEMBL1795094;;
CLD0;confirmatory;;CHEMBL2354311;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686970;7;CHEMBL2007625;;
CLD0;;Cancer cell lines;CHEMBL2389644;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human prostate cancer cells after 48 hrs;CHEMBL2385029;Non-molecular target assigned;N;573121;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL2389645;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human breast cancer cells after 48 hrs;CHEMBL2385029;Non-molecular target assigned;N;573122;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL2389646;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human renal cancer cells after 48 hrs;CHEMBL2385029;Non-molecular target assigned;N;573120;1;CHEMBL3879801;;
CLD0;;Melanoma cell;CHEMBL2389647;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Cytotoxicity against human melanoma cells after 48 hrs;CHEMBL2385029;Non-molecular target assigned;N;573118;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL2389648;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human ovarian cancer cells after 48 hrs;CHEMBL2385029;Non-molecular target assigned;N;573119;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL2388147;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human colon cancer cells after 48 hrs;CHEMBL2385029;Non-molecular target assigned;N;573116;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL2388148;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human CNS cancer cells after 48 hrs;CHEMBL2385029;Non-molecular target assigned;N;573117;1;CHEMBL3879801;;
CLD0;;Leukemia cell;CHEMBL2388149;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Cytotoxicity against human leukemia cells after 48 hrs;CHEMBL2385029;Non-molecular target assigned;N;573114;1;CHEMBL3879801;;
CLD0;;NSCLC;CHEMBL2388150;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Cytotoxicity against human NSCLC cells after 48 hrs;CHEMBL2385029;Non-molecular target assigned;N;573115;1;CHEMBL3879801;;
CLD0;;;CHEMBL2400152;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;Competitive binding affinity to pig brain tubulin vinblastine binding site at 0.1 to 100 uM after 1 hr by mass spectrophotometric analysis in presence of vinblastine;CHEMBL2396655;Direct protein target assigned;D;578006;1;CHEMBL2111354;;
CLD0;;Endothelial cell;CHEMBL2410475;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against temperature-sensitive rat lymphatic endothelial cells after 48 hrs by MTS assay;CHEMBL2406939;Non-molecular target assigned;N;585232;1;CHEMBL3879801;;
CLD0;;HeLa;CHEMBL2410476;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay;CHEMBL2406939;Non-molecular target assigned;N;585230;1;CHEMBL399;;
CLD0;;NCI-H522;CHEMBL2422400;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308392;Multiple direct protein targets may be assigned;5;Inhibition of tubulin polymerization in human NCI-H522 cells assessed as beta-tubulin accumulation in cytoskeletal fraction at 100 nM after 24 hrs by Western blot analysis;CHEMBL2417372;Direct protein target assigned;D;592085;1;CHEMBL2095182;;
CLD0;;NCI-H522;CHEMBL2422401;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308392;Multiple direct protein targets may be assigned;5;Inhibition of tubulin polymerization in human NCI-H522 cells assessed as alpha-tubulin accumulation in cytoskeletal fraction at 100 nM after 24 hrs by Western blot analysis;CHEMBL2417372;Direct protein target assigned;D;592084;1;CHEMBL2095182;;
CLD0;;;CHEMBL2422404;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;Inhibition of porcine brain tubulin polymerization at 1 uM measured every 30 seconds for 30 mins;CHEMBL2417372;Direct protein target assigned;D;592079;1;CHEMBL2111354;;
CLD0;;H22;CHEMBL2427015;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];KM;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307751;Target assigned is non-molecular;1;Toxicity in KM mouse allografted with mouse H22 cells assessed as body weight at 0.5 mg/kg, ip administered on day 1 and 4 measured on day 8 (Rvb = 30 +/- 3.24 g);CHEMBL2424644;Non-molecular target assigned;N;595460;1;CHEMBL375;;
CLD0;;H22;CHEMBL2427174;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];KM;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307751;Target assigned is non-molecular;1;Toxicity in KM mouse allografted with mouse H22 cells assessed as body weight at 0.25 mg/kg, ip administered on day 1 and 4 measured on day 8 (Rvb = 30 +/- 3.24 g);CHEMBL2424644;Non-molecular target assigned;N;595459;1;CHEMBL375;;
CLD0;;H22;CHEMBL2427179;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antitumor activity against mouse H22 cells allografted in KM mouse assessed as tumor growth inhibition at 0.5 mg/kg, ip administered on day 1 and 4 measured on day 8 relative to control;CHEMBL2424644;Non-molecular target assigned;N;595452;1;CHEMBL614998;;
CLD0;;H22;CHEMBL2427180;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antitumor activity against mouse H22 cells allografted in KM mouse assessed as tumor growth inhibition at 0.25 mg/kg, ip administered on day 1 and 4 measured on day 8 relative to control;CHEMBL2424644;Non-molecular target assigned;N;595451;1;CHEMBL614998;;
CLD0;;MX1;CHEMBL2428394;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308046;Target assigned is non-molecular;1;Cytotoxicity against taxol-resistant human MX1 cells assessed as growth inhibition after 72 hrs by MTT assay;CHEMBL2424644;Non-molecular target assigned;N;595434;1;CHEMBL613704;;
CLD0;;MX1;CHEMBL2428395;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308046;Target assigned is non-molecular;1;Cytotoxicity against human MX1 cells assessed as growth inhibition after 72 hrs by MTT assay;CHEMBL2424644;Non-molecular target assigned;N;595433;1;CHEMBL613704;;
CLD0;;KB ;CHEMBL2428396;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against vincristine-resistant human KB cells assessed as growth inhibition after 72 hrs by MTT assay;CHEMBL2424644;Non-molecular target assigned;N;595432;1;CHEMBL398;;
CLD0;;KB ;CHEMBL2428397;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by MTT assay;CHEMBL2424644;Non-molecular target assigned;N;595431;1;CHEMBL398;;
CLD0;;BXPC-3;CHEMBL2428521;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307637;Target assigned is non-molecular;1;Cytotoxicity against human BxPC3 cells assessed as growth inhibition after 72 hrs by MTT assay;CHEMBL2424644;Non-molecular target assigned;N;595426;1;CHEMBL614530;;
CLD0;;HT-29;CHEMBL2428522;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay;CHEMBL2424644;Non-molecular target assigned;N;595424;1;CHEMBL384;;
CLD0;;HepG2;CHEMBL2428523;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay;CHEMBL2424644;Non-molecular target assigned;N;595425;1;CHEMBL395;;
CLD0;;A549;CHEMBL2428524;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay;CHEMBL2424644;Non-molecular target assigned;N;595423;1;CHEMBL392;;
CLD0;;MCF7;CHEMBL2428525;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay;CHEMBL2424644;Non-molecular target assigned;N;595422;1;CHEMBL387;;
CLD0;;;CHEMBL2439156;[];Trypanosoma brucei brucei;[];427;;5702.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitrypanosomal activity against bloodstream form of Trypanosoma brucei brucei 427 after 3 days by Alamar Blue assay;CHEMBL2434842;Non-molecular target assigned;N;599478;1;CHEMBL612851;;
CLD0;;KB-7d;CHEMBL2446772;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human KB-7d cells overexpressing MRP assessed as growth inhibition after 72 hrs by methylene blue staining-based assay;CHEMBL2440102;Non-molecular target assigned;N;601840;1;CHEMBL3879801;;
CLD0;;KB-S15;CHEMBL2446773;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human KB-S15 cells overexpressing P-gp170/MDR assessed as growth inhibition after 72 hrs by methylene blue staining-based assay;CHEMBL2440102;Non-molecular target assigned;N;601839;1;CHEMBL3879801;;
CLD0;;KB-VIN10;CHEMBL2446774;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human KB-VIN10 cells overexpressing P-gp170/MDR assessed as growth inhibition after 72 hrs by methylene blue staining-based assay;CHEMBL2440102;Non-molecular target assigned;N;601838;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL2447314;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by methylene blue staining-based assay;CHEMBL2440102;Non-molecular target assigned;N;601829;1;CHEMBL398;;
CLD0;;NCI-H157;CHEMBL3090245;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H157 cells at 100 uM after 24 hrs by sulforhodamine B assay;CHEMBL3085736;Non-molecular target assigned;N;607377;1;CHEMBL614783;;
CLD0;;;CHEMBL3108431;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Multiple direct protein targets may be assigned;5;Inhibition of tubulin polymerization (unknown origin) at 20 uM by spectrophotometric analysis;CHEMBL3102857;Direct protein target assigned;D;614868;1;CHEMBL2095182;;
CLD0;;HeLa;CHEMBL3108432;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Antiproliferative activity against human HeLa cells after 72 hrs by SRB assay;CHEMBL3102857;Non-molecular target assigned;N;614779;1;CHEMBL399;;
CLD0;;CCRF-CEM VCR/R;CHEMBL3124373;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human CCRF-CEM VCR/R cells assessed as cell viability at 2.5 uM after 72 hrs by CellTitre-Blue assay relative to control;CHEMBL3120073;Default value - Target has yet to be curated;U;625111;1;CHEMBL612545;;
CLD0;;CCRF-CEM VCR/R;CHEMBL3124374;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human CCRF-CEM VCR/R cells at 1 uM after 48 hrs by propidium iodide staining-based flow cytometry;CHEMBL3120073;Default value - Target has yet to be curated;U;625109;1;CHEMBL612545;;
CLD0;;CCRF-CEM;CHEMBL3124375;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Induction of apoptosis in human CCRF-CEM cells at 1 to 100 nM after 48 hrs by propidium iodide staining-based flow cytometry;CHEMBL3120073;Non-molecular target assigned;N;625108;1;CHEMBL382;;
CLD0;;MDA-MB-231;CHEMBL3124558;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cytotoxicity against human MDA-MB-231 cells after 72 hrs by CellTitre-Blue assay;CHEMBL3120073;Non-molecular target assigned;N;625086;1;CHEMBL400;;
CLD0;;;CHEMBL3128355;[];Canis lupus familiaris;[];;;9615.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Competitive inhibition of dog brain tubulin using BODIPY FL-vinblastine as substrate at 10 uM incubated for 30 mins prior to substrate addition measured after 30 mins by fluorescence assay;CHEMBL3124791;Default value - Target has yet to be curated;U;627002;1;CHEMBL612545;;
CLD0;;;CHEMBL3137722;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;1;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137723;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;2;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137724;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;3;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137725;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source];CHEMBL3137667;Non-molecular target assigned;N;4;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137726;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;5;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137727;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;6;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137728;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;7;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137729;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;8;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137730;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;9;1;CHEMBL612545;;
CLD0;;;CHEMBL3137731;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source];CHEMBL3137667;Non-molecular target assigned;N;10;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137732;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;11;1;CHEMBL612545;;
CLD0;;;CHEMBL3137733;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;12;1;CHEMBL612545;;
CLD0;;;CHEMBL3137734;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;13;1;CHEMBL612545;;
CLD0;;;CHEMBL3137735;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source];CHEMBL3137667;Non-molecular target assigned;N;14;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137736;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Animal toxicity known. [column 'TOXIC' in source];CHEMBL3137667;Non-molecular target assigned;N;15;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137737;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Presence of at least one case with successful reintroduction. [column 'REINT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;16;1;CHEMBL612545;;
CLD0;;;CHEMBL3137738;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Comments (NB not yet translated). [column 'COMMENTAIRES' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;17;1;CHEMBL612545;;
CLD0;;;CHEMBL3137739;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source];CHEMBL3137667;Non-molecular target assigned;N;18;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137740;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Proposed mechanism(s) of liver damage. [column 'MEC' in source];CHEMBL3137667;Non-molecular target assigned;N;19;1;CHEMBL3879801;CHEMBL3559723;
CLD0;confirmatory;;CHEMBL3215017;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720579;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215270;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720580;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214913;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720532;7;CHEMBL612545;;
CLD0;;P1534;CHEMBL3231474;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.10 mg/kg, ip administered daily for 8 to 10 days;CHEMBL3227917;Non-molecular target assigned;N;656259;1;CHEMBL3879801;;
CLD0;;P1534;CHEMBL3231475;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.2'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.20 mg/kg, ip administered daily for 8 to 10 days;CHEMBL3227917;Non-molecular target assigned;N;656260;1;CHEMBL3879801;;
CLD0;;P1534;CHEMBL3231476;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.25 mg/kg, ip administered daily for 8 to 10 days;CHEMBL3227917;Non-molecular target assigned;N;656261;1;CHEMBL3879801;;
CLD0;;;CHEMBL3231575;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in iv dosed mouse assessed as lethality;CHEMBL3227917;Non-molecular target assigned;N;656289;1;CHEMBL375;;
CLD0;;P388/S;CHEMBL3231903;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.67', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.67'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307337;Target assigned is non-molecular;1;Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.67 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656298;1;CHEMBL614220;;
CLD0;;P388/S;CHEMBL3231904;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307337;Target assigned is non-molecular;1;Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.00 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656300;1;CHEMBL614220;;
CLD0;;P388/S;CHEMBL3231905;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307337;Target assigned is non-molecular;1;Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656302;1;CHEMBL614220;;
CLD0;;P388/S;CHEMBL3231906;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.36', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.36'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307337;Target assigned is non-molecular;1;Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.36 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656304;1;CHEMBL614220;;
CLD0;;P388/VCR;CHEMBL3231909;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307268;Target assigned is non-molecular;1;Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.00 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656310;1;CHEMBL613520;;
CLD0;;P388/VCR;CHEMBL3231910;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307268;Target assigned is non-molecular;1;Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656311;1;CHEMBL613520;;
CLD0;;P388/VCR;CHEMBL3231911;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.36', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.36'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307268;Target assigned is non-molecular;1;Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.36 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656312;1;CHEMBL613520;;
CLD0;;P388/VCR;CHEMBL3231912;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.2'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307268;Target assigned is non-molecular;1;Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 1.20 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656313;1;CHEMBL613520;;
CLD0;;P388/VCR;CHEMBL3231913;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.9', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.9'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307268;Target assigned is non-molecular;1;Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 0.90 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656314;1;CHEMBL613520;;
CLD0;;P388/VCR;CHEMBL3231914;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307268;Target assigned is non-molecular;1;Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656315;1;CHEMBL613520;;
CLD0;;P388/VCR;CHEMBL3231917;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.67', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.67'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CD2F1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307268;Target assigned is non-molecular;1;Toxicity in CD2F1 mouse allografted with mouse P388/VCR cells at 1.67 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656318;1;CHEMBL375;;
CLD0;;;CHEMBL3231922;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against mouse P388/VCR/I/63 cells allografted in Dublin-CDF1 mouse assessed as day of host death at 1.5 mg/kg, ip administered on days 1, 5 and 9 (Rvb = 10 days);CHEMBL3227917;Non-molecular target assigned;N;656325;1;CHEMBL3879801;;
CLD0;;;CHEMBL3231994;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against mouse P388/VCR/I/63 cells allografted in Dublin-CDF1 mouse assessed as increase in host lifespan at 1.5 mg/kg, ip administered on days 1, 5 and 9;CHEMBL3227917;Non-molecular target assigned;N;656330;1;CHEMBL3879801;;
CLD0;;CHO;CHEMBL3231997;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Mitotic arrest in CHO cells assessed as increase in cell accumulation at 0.02 ug/ml;CHEMBL3227917;Non-molecular target assigned;N;656342;1;CHEMBL613853;;
CLD0;;CHO;CHEMBL3231998;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Mitotic arrest in CHO cells assessed as increase in cell accumulation at 0.002 ug/ml;CHEMBL3227917;Non-molecular target assigned;N;656343;1;CHEMBL613853;;
CLD0;;;CHEMBL3231999;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;Displacement of [3H]VLB from tubulin in pig brain by competitive assay;CHEMBL3227917;Direct protein target assigned;D;656344;1;CHEMBL2111354;;
CLD0;;CHO;CHEMBL3232002;[];Cricetulus griseus;[];;;10029.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Cytotoxicity against CHO cells at 0.02 ug/ml;CHEMBL3227917;Non-molecular target assigned;N;656366;1;CHEMBL613853;;
CLD0;;BHK-21;CHEMBL3239866;[];Mesocricetus auratus;[];;;10036.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Anticancer activity against Syrian golden hamster BHK21 cells at 100 uM after 48 hrs by SRB assay;CHEMBL3232838;Non-molecular target assigned;N;662197;1;CHEMBL3879801;;
CLD0;;BHK-21;CHEMBL3239867;[];Mesocricetus auratus;[];;;10036.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Anticancer activity against Syrian golden hamster BHK21 cells at 10 uM after 48 hrs by SRB assay;CHEMBL3232838;Non-molecular target assigned;N;662198;1;CHEMBL3879801;;
CLD0;;BHK-21;CHEMBL3239868;[];Mesocricetus auratus;[];;;10036.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Anticancer activity against Syrian golden hamster BHK21 cells at 1 uM after 48 hrs by SRB assay;CHEMBL3232838;Non-molecular target assigned;N;662199;1;CHEMBL3879801;;
CLD0;;BHK-21;CHEMBL3239869;[];Mesocricetus auratus;[];;;10036.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Anticancer activity against Syrian golden hamster BHK21 cells at 0.1 uM after 48 hrs by SRB assay;CHEMBL3232838;Non-molecular target assigned;N;662200;1;CHEMBL3879801;;
CLD0;;NCI-H157;CHEMBL3239870;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Anticancer activity against human NCI-H157 cells at 100 uM after 48 hrs by SRB assay;CHEMBL3232838;Non-molecular target assigned;N;662201;1;CHEMBL614783;;
CLD0;;NCI-H157;CHEMBL3239871;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Anticancer activity against human NCI-H157 cells at 10 uM after 48 hrs by SRB assay;CHEMBL3232838;Non-molecular target assigned;N;662202;1;CHEMBL614783;;
CLD0;;NCI-H157;CHEMBL3239872;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Anticancer activity against human NCI-H157 cells at 1 uM after 48 hrs by SRB assay;CHEMBL3232838;Non-molecular target assigned;N;662203;1;CHEMBL614783;;
CLD0;;NCI-H157;CHEMBL3239873;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Anticancer activity against human NCI-H157 cells at 0.1 uM after 48 hrs by SRB assay;CHEMBL3232838;Non-molecular target assigned;N;662204;1;CHEMBL614783;;
CLD0;;Leukemia cell;CHEMBL3239650;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307719;Target assigned is non-molecular;1;Cytotoxicity against human leukemia cells after 48 hrs;CHEMBL3232816;Non-molecular target assigned;N;663480;1;CHEMBL3879801;;
CLD0;;NSCLC;CHEMBL3239651;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Cytotoxicity against human NSCLC cells after 48 hrs;CHEMBL3232816;Non-molecular target assigned;N;663482;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL3239652;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human colon cancer cells after 48 hrs;CHEMBL3232816;Non-molecular target assigned;N;663484;1;CHEMBL3879801;;
CLD0;;Melanoma cell;CHEMBL3239653;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307541;Target assigned is non-molecular;1;Cytotoxicity against human melanoma cells after 48 hrs;CHEMBL3232816;Non-molecular target assigned;N;663485;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL3239654;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human ovarian cancer cells after 48 hrs;CHEMBL3232816;Non-molecular target assigned;N;663488;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL3239655;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human renal cancer cells after 48 hrs;CHEMBL3232816;Non-molecular target assigned;N;663490;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL3239656;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human prostate cancer cells after 48 hrs;CHEMBL3232816;Non-molecular target assigned;N;663491;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL3239657;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human breast cancer cells after 48 hrs;CHEMBL3232816;Non-molecular target assigned;N;663492;1;CHEMBL3879801;;
CLD0;;Cancer cell lines;CHEMBL3239658;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Target assigned is non-molecular;1;Cytotoxicity against human CNS cancer cells after 48 hrs;CHEMBL3232816;Non-molecular target assigned;N;663494;1;CHEMBL3879801;;
CLD0;;NCI-H157;CHEMBL3241350;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Antiproliferative activity against human NCI-H157 cells at 100 uM after 48 hrs by SRB assay;CHEMBL3232752;Non-molecular target assigned;N;662214;1;CHEMBL614783;;
CLD0;;KB ;CHEMBL3243452;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 72 hrs by methylene blue assay;CHEMBL3232864;Non-molecular target assigned;N;661720;1;CHEMBL398;;
CLD0;;KB-VIN10;CHEMBL3243455;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human vincristine/paclitaxel-resistant KB-VIN10 cells overexpressing P-gp170 after 72 hrs by methylene blue assay;CHEMBL3232864;Non-molecular target assigned;N;661764;1;CHEMBL3879801;;
CLD0;;KB-S15;CHEMBL3243456;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human vincristine/paclitaxel-resistant KB-S15 cells overexpressing P-gp170 after 72 hrs by methylene blue assay;CHEMBL3232864;Non-molecular target assigned;N;661765;1;CHEMBL3879801;;
CLD0;;KB-7d;CHEMBL3243457;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human VP16-resistant KB-7d cells overexpressing MRP after 72 hrs by methylene blue assay;CHEMBL3232864;Non-molecular target assigned;N;661767;1;CHEMBL3879801;;
CLD0;;sarcoma;CHEMBL3283007;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against mouse Ridgeway osteogenic sarcoma cells allografted in mouse at 0.1 to 0.2 mg/kg/day, ip;CHEMBL3272325;Non-molecular target assigned;N;666842;1;CHEMBL3879801;;
CLD0;;;CHEMBL3283011;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against mouse Gardner lymphosarcoma cell allografted in mouse at 0.1 to 0.2 mg/kg/day, ip;CHEMBL3272325;Non-molecular target assigned;N;666854;1;CHEMBL3879801;;
CLD0;;;CHEMBL3283015;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Acute toxicity in ip dosed mouse;CHEMBL3272325;Non-molecular target assigned;N;666860;1;CHEMBL375;;
CLD0;;P388;CHEMBL3283286;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 1.8 mg/kg/day after 1 day;CHEMBL3272325;Non-molecular target assigned;N;666917;1;CHEMBL389;;
CLD0;;P1534J ;CHEMBL3283287;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307483;Target assigned is non-molecular;1;Antitumor activity against mouse P1534(J) cells allografted in mouse assessed as tumor growth inhibition at 0.25 mg/kg/day, ip administered from day 1 to day 9 relative to unreated control;CHEMBL3272325;Non-molecular target assigned;N;666873;1;CHEMBL3879801;;
CLD0;;;CHEMBL3283291;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in ip dosed mouse allografted with mouse P1534(J) cells administered from day 1 to day 9;CHEMBL3272325;Non-molecular target assigned;N;666887;1;CHEMBL375;;
CLD0;;P388;CHEMBL3283295;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 1.2 mg/kg/day after 1 day;CHEMBL3272325;Non-molecular target assigned;N;666921;1;CHEMBL389;;
CLD0;;B16;CHEMBL3281980;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.60 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days);CHEMBL3272325;Non-molecular target assigned;N;666996;1;CHEMBL381;;
CLD0;;B16;CHEMBL3281982;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days);CHEMBL3272325;Non-molecular target assigned;N;666995;1;CHEMBL381;;
CLD0;;B16;CHEMBL3281983;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1.67 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days);CHEMBL3272325;Non-molecular target assigned;N;666994;1;CHEMBL381;;
CLD0;;P388;CHEMBL3281984;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 0.33 mg/kg/day, ip administered from day 1 to day 9 relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;666933;1;CHEMBL389;;
CLD0;;P388;CHEMBL3281986;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 0.22 mg/kg/day, ip administered from day 1 to day 9 relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;666935;1;CHEMBL389;;
CLD0;;P388;CHEMBL3282224;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 4 mg/kg/day, ip after 1 day;CHEMBL3272325;Non-molecular target assigned;N;666947;1;CHEMBL389;;
CLD0;;P388;CHEMBL3282225;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 2.7 mg/kg/day, ip after 1 day;CHEMBL3272325;Non-molecular target assigned;N;666948;1;CHEMBL389;;
CLD0;;P388;CHEMBL3282226;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 1.8 mg/kg/day, ip after 1 day;CHEMBL3272325;Non-molecular target assigned;N;666949;1;CHEMBL389;;
CLD0;;P388;CHEMBL3282227;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 1.2 mg/kg/day, ip after 1 day;CHEMBL3272325;Non-molecular target assigned;N;666950;1;CHEMBL389;;
CLD0;;P388;CHEMBL3282231;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in ip dosed mouse allografted with mouse p388 cells administered from day 1 to day 9;CHEMBL3272325;Non-molecular target assigned;N;666973;1;CHEMBL375;;
CLD0;;P388;CHEMBL3282232;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in ip dosed mouse allografted with mouse p388 cells after 1 day;CHEMBL3272325;Non-molecular target assigned;N;666974;1;CHEMBL375;;
CLD0;;B16;CHEMBL3282233;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.36 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days);CHEMBL3272325;Non-molecular target assigned;N;666997;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282234;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.216 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days);CHEMBL3272325;Non-molecular target assigned;N;666998;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282240;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1.67 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;667004;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282241;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;667005;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282242;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.60 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;667006;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282243;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.36 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;667007;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282244;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.216 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;667008;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282250;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1.67 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days);CHEMBL3272325;Non-molecular target assigned;N;667016;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282251;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days);CHEMBL3272325;Non-molecular target assigned;N;667017;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282252;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.60 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days);CHEMBL3272325;Non-molecular target assigned;N;667018;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282253;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.36 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days);CHEMBL3272325;Non-molecular target assigned;N;667019;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282471;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.216 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days);CHEMBL3272325;Non-molecular target assigned;N;667020;1;CHEMBL381;;
CLD0;;B16;CHEMBL3282477;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1.67 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;667026;1;CHEMBL381;;
CLD0;;B16;CHEMBL3285360;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;667027;1;CHEMBL381;;
CLD0;;B16;CHEMBL3285361;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.60 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;667028;1;CHEMBL381;;
CLD0;;B16;CHEMBL3285362;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.36 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;667029;1;CHEMBL381;;
CLD0;;B16;CHEMBL3285363;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.216 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control;CHEMBL3272325;Non-molecular target assigned;N;667030;1;CHEMBL381;;
CLD0;;;CHEMBL3285620;[];Rattus norvegicus;[];;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Acute toxicity in rat;CHEMBL3272325;Non-molecular target assigned;N;667075;1;CHEMBL376;;
CLD0;;;CHEMBL3285621;[];Gallus gallus;[];;;9031.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Neurotoxicity in iv dosed chicken assessed as neuromuscular disturbance by measuring loss of balance;CHEMBL3272325;Non-molecular target assigned;N;667087;1;CHEMBL613109;;
CLD0;;;CHEMBL3285622;[];Macaca mulatta;[];;;9544.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Neurotoxicity in iv dosed monkey assessed as leukopenia;CHEMBL3272325;Non-molecular target assigned;N;667088;1;CHEMBL614875;;
CLD0;;;CHEMBL3285623;[];Macaca mulatta;[];;;9544.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Neurotoxicity in iv dosed monkey assessed as peripheral neuropathy;CHEMBL3272325;Non-molecular target assigned;N;667089;1;CHEMBL614875;;
CLD0;;P388;CHEMBL3285630;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 0.22 mg/kg/day administered from day 1 to day 9;CHEMBL3272325;Non-molecular target assigned;N;669673;1;CHEMBL389;;
CLD0;;KB ;CHEMBL3390169;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against vincristine-sensitive human KB cells;CHEMBL3352798;Non-molecular target assigned;N;717313;1;CHEMBL398;;
CLD0;;KB/VJ300;CHEMBL3390170;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513114;Target assigned is non-molecular;1;Cytotoxicity against vincristine-resistant human KB/VJ300 cells;CHEMBL3352798;Non-molecular target assigned;N;717314;1;CHEMBL3879801;;
CLD0;;NCI-H157;CHEMBL3384910;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H157 cells by sulforhodamine B assay;CHEMBL3352388;Non-molecular target assigned;N;710811;1;CHEMBL614783;;
CLD0;;Vero;CHEMBL3384911;[];Chlorocebus sabaeus;[];;;60711.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307520;Target assigned is non-molecular;1;Cytotoxicity against African green monkey Vero cells by sulforhodamine B assay;CHEMBL3352388;Non-molecular target assigned;N;710812;1;CHEMBL391;;
CLD0;;PC-3;CHEMBL3377410;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is molecular non-protein target;3;Cell cycle arrest in human PC3 cells assessed as accumulation at G2/M phase at 500 nM after 24 hrs by propidium iodide staining-based flow cytometry;CHEMBL3351435;Molecular target other than protein assigned;M;697317;1;CHEMBL612546;;
CLD0;;RD;CHEMBL3377411;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307547;Target assigned is non-molecular;1;Cell cycle arrest in human RD cells assessed as accumulation at G2/M phase at 500 nM after 24 hrs by propidium iodide staining-based flow cytometry;CHEMBL3351435;Non-molecular target assigned;N;697318;1;CHEMBL614144;;
CLD0;;PC-3;CHEMBL3377413;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is molecular non-protein target;3;Cell cycle arrest in human PC3 cells assessed as rounded cells at 500 nM after 24 hrs by propidium iodide staining-based flow cytometry;CHEMBL3351435;Molecular target other than protein assigned;M;697320;1;CHEMBL612546;;
CLD0;;RD;CHEMBL3377414;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307547;Target assigned is non-molecular;1;Cell cycle arrest in human RD cells assessed as rounded cells at 500 nM after 24 hrs by propidium iodide staining-based flow cytometry;CHEMBL3351435;Non-molecular target assigned;N;697321;1;CHEMBL614144;;
CLD0;;PC-3;CHEMBL3377416;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is molecular non-protein target;3;Cell cycle arrest in human PC3 cells at 500 to 2000 nM incubated for 24 hrs followed by compound washout measured after 24 hrs;CHEMBL3351435;Molecular target other than protein assigned;M;697323;1;CHEMBL612546;;
CLD0;;RD;CHEMBL3377417;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307547;Target assigned is non-molecular;1;Cell cycle arrest in human RD cells at 1000 to 2000 nM incubated for 24 hrs followed by compound washout measured after 24 hrs;CHEMBL3351435;Non-molecular target assigned;N;697324;1;CHEMBL614144;;
CLD0;;RD;CHEMBL3377418;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307547;Target assigned is non-molecular;1;Cell cycle arrest in human RD cells at 500 nM incubated for 24 hrs followed by compound washout measured after 24 hrs;CHEMBL3351435;Non-molecular target assigned;N;697325;1;CHEMBL614144;;
CLD0;;HepG2;CHEMBL3377419;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cell cycle arrest in human HepG2 cells at 500 to 2000 nM incubated for 24 hrs followed by compound washout measured after 24 hrs;CHEMBL3351435;Non-molecular target assigned;N;697326;1;CHEMBL395;;
CLD0;;;CHEMBL3363566;[];Agrobacterium tumefaciens;[];;;358.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against Agrobacterium tumefaciens -induced tumor at 1000 ug/ml after 21 days by potato disc bioassay technique;CHEMBL3352265;Non-molecular target assigned;N;701489;1;CHEMBL612504;;
CLD0;;;CHEMBL3363567;[];Agrobacterium tumefaciens;[];;;358.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against Agrobacterium tumefaciens -induced tumor at 100 ug/ml after 21 days by potato disc bioassay technique;CHEMBL3352265;Non-molecular target assigned;N;701490;1;CHEMBL612504;;
CLD0;;;CHEMBL3363568;[];Agrobacterium tumefaciens;[];;;358.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against Agrobacterium tumefaciens -induced tumor at 10 ug/ml after 21 days by potato disc bioassay technique;CHEMBL3352265;Non-molecular target assigned;N;701491;1;CHEMBL612504;;
CLD0;;KB ;CHEMBL3370643;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells;CHEMBL3351617;Non-molecular target assigned;N;703191;1;CHEMBL398;;
CLD0;;KB-VIN10;CHEMBL3370646;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KB-VIN10 cells;CHEMBL3351617;Non-molecular target assigned;N;703195;1;CHEMBL3879801;;
CLD0;;KB-S15;CHEMBL3370647;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KB-S15 cells;CHEMBL3351617;Non-molecular target assigned;N;703197;1;CHEMBL3879801;;
CLD0;;KB-7d;CHEMBL3370648;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KB-7d cells;CHEMBL3351617;Non-molecular target assigned;N;703198;1;CHEMBL3879801;;
CLD0;;CCRF-CEM;CHEMBL3368795;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM cells assessed as growth inhibition after 72 hrs by Alamar Blue assay;CHEMBL3351946;Non-molecular target assigned;N;659240;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL3369011;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against vinblastine-resistant human CCRF-CEM cells assessed as growth inhibition after 72 hrs by Alamar Blue assay;CHEMBL3351946;Non-molecular target assigned;N;659241;1;CHEMBL382;;
CLD0;;PC-3;CHEMBL3369012;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay;CHEMBL3351946;Non-molecular target assigned;N;659242;1;CHEMBL3879801;;
CLD0;;NCI-H460;CHEMBL3369015;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Cytotoxicity against human H460 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay;CHEMBL3351946;Non-molecular target assigned;N;659257;1;CHEMBL3879801;;
CLD0;;NCI-H1299;CHEMBL3369016;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is non-molecular;1;Cytotoxicity against human H1299 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay;CHEMBL3351946;Non-molecular target assigned;N;659258;1;CHEMBL3879801;;
CLD0;;HCT-116;CHEMBL3369017;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay;CHEMBL3351946;Non-molecular target assigned;N;659259;1;CHEMBL3879801;;
CLD0;;CCRF-CEM;CHEMBL3369018;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Resistance factor, ratio of IC50 for vinblastine-resistant human CCRF-CEM cells to IC50 for human CCRF-CEM cells;CHEMBL3351946;Non-molecular target assigned;N;659260;1;CHEMBL382;;
CLD0;;A2780;CHEMBL3396161;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Antiproliferative activity against human A2780 cells after 48 hrs by SRB method;CHEMBL3393048;Non-molecular target assigned;N;724029;1;CHEMBL614004;;
CLD0;;A2780;CHEMBL3396162;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Antiproliferative activity against taxol-resistant human A2780 cells after 48 hrs by SRB method;CHEMBL3393048;Non-molecular target assigned;N;724030;1;CHEMBL614004;;
CLD0;;HCT-8;CHEMBL3396163;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Antiproliferative activity against human HCT8 cells after 48 hrs by SRB method;CHEMBL3393048;Non-molecular target assigned;N;724031;1;CHEMBL3879801;;
CLD0;;HCT-8;CHEMBL3396164;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Antiproliferative activity against vincristine-resistant human HCT8 cells after 48 hrs by SRB method;CHEMBL3393048;Non-molecular target assigned;N;724032;1;CHEMBL3879801;;
CLD0;;A549;CHEMBL3396165;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against cis-platinum-resistant human A549 cells after 48 hrs by SRB method;CHEMBL3393048;Non-molecular target assigned;N;724033;1;CHEMBL392;;
CLD0;;MCF7;CHEMBL3396166;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against doxorubicin-resistant human MCF7 cells after 48 hrs by SRB method;CHEMBL3393048;Non-molecular target assigned;N;724034;1;CHEMBL387;;
CLD0;;A549;CHEMBL3396260;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Drug resistance index, ratio of IC50 for cis-platinum-resistant human A549 cells to IC50 for human A549 cells;CHEMBL3393048;Non-molecular target assigned;N;724037;1;CHEMBL392;;
CLD0;;MCF7;CHEMBL3396261;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Drug resistance index, ratio of IC50 for doxorubicin-resistant human MCF7 cells to IC50 for human MCF7 cells;CHEMBL3393048;Non-molecular target assigned;N;724038;1;CHEMBL387;;
CLD0;;;CHEMBL3396290;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Multiple direct protein targets may be assigned;5;Displacement of (E)-3-(4-(Dimethylamino)phenyl)-1-(4'-fluoro[1,1'-biphenyl]-2-yl)prop-2-en-1-one from tubulin (unknown origin) by fluorescence assay;CHEMBL3393048;Direct protein target assigned;D;724735;1;CHEMBL2095182;;
CLD0;;KB/VCR;CHEMBL3396776;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human KB/VCR cells after 72 hrs by SRB method;CHEMBL3393024;Non-molecular target assigned;N;725714;1;CHEMBL3879801;;
CLD0;;;CHEMBL3411290;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human OATP1B1-mediated [3H]estrone 3-sulfate at 100 uM after 5 mins relative to control;CHEMBL3407465;Direct protein target assigned;D;732530;1;CHEMBL1697668;;
CLD0;;;CHEMBL3411292;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human OATP1B3-mediated [3H]CCK-8 at 100 uM after 5 mins relative to control;CHEMBL3407465;Direct protein target assigned;D;732532;1;CHEMBL1743121;;
CLD0;;;CHEMBL3411294;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human OATP1B3-mediated [3H]CCK-8 after 5 mins by Dixon plot method;CHEMBL3407465;Direct protein target assigned;D;732534;1;CHEMBL1743121;;
CLD0;;;CHEMBL3534590;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Bile;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Drug excretion in iv dosed Sprague-Dawley rat assessed as compound excreted into bile;CHEMBL3526096;Default value - Target has yet to be curated;U;643059;1;CHEMBL612558;CHEMBL3638228;
CLD0;;;CHEMBL3534613;[];Homo sapiens;[];;;9606.0;;Bile;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Drug excretion in iv dosed human assessed as compound excreted into bile after 72 hrs by T-tube method;CHEMBL3526096;Default value - Target has yet to be curated;U;643114;1;CHEMBL612558;CHEMBL3638228;
CLD0;;Caco-2;CHEMBL3529272;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis;CHEMBL3526001;Default value - Target has yet to be curated;U;651650;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529273;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis;CHEMBL3526001;Default value - Target has yet to be curated;U;651651;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529274;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis;CHEMBL3526001;Default value - Target has yet to be curated;U;651652;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529276;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651654;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529277;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651655;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529278;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651656;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529279;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651657;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529280;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651658;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529281;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651659;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529284;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651662;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529285;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651663;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529286;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651664;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529291;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651773;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529292;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651774;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529293;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651775;1;CHEMBL612558;;
CLD0;;;CHEMBL3529538;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Bile;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Total biliary clearance in iv dosed Sprague-Dawley rat;CHEMBL3526096;Non-molecular target assigned;N;641775;1;CHEMBL376;CHEMBL3638228;
CLD0;;;CHEMBL3529541;[];Homo sapiens;[];;;9606.0;;Bile;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Total biliary clearance in iv dosed human after 72 hrs by T-tube method;CHEMBL3526096;Non-molecular target assigned;N;641597;1;CHEMBL372;CHEMBL3638228;
CLD0;;;CHEMBL3529737;[];Homo sapiens;[];;;9606.0;;Bile;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Unbound biliary clearance in iv dosed human after 72 hrs by T-tube method;CHEMBL3526096;Non-molecular target assigned;N;641743;1;CHEMBL372;CHEMBL3638228;
CLD0;;;CHEMBL3529770;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Bile;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Unbound biliary clearance in iv dosed Sprague-Dawley rat;CHEMBL3526096;Non-molecular target assigned;N;642927;1;CHEMBL376;CHEMBL3638228;
CLD0;;;CHEMBL3527758;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction absorbed in human;CHEMBL3526001;Non-molecular target assigned;N;651649;1;CHEMBL372;;
CLD0;confirmatory;;CHEMBL3561973;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117303;7;CHEMBL612545;;
CLD0;confirmatory;C2C12;CHEMBL3561978;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308003;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117325;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561981;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117309;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561990;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117310;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3561991;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117349;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562011;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 3, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117313;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562024;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117324;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562026;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Decreased HeLa cell count-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117347;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562033;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117308;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562035;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 3 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117306;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562043;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117337;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562049;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 3, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117307;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562064;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117314;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562075;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 3 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117299;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562085;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117318;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562088;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117315;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562092;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 3, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117317;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562096;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 3 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117300;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562112;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117311;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562119;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117298;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562120;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117351;7;CHEMBL612545;;
CLD0;confirmatory;C2C12;CHEMBL3562121;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308003;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117327;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562133;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117302;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562135;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117301;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562136;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117304;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562139;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117350;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562144;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117316;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562146;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117305;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562152;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117312;7;CHEMBL612545;;
CLD0;;KB-VIN10;CHEMBL3595573;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KB-VIN10 cells expressing P-gp170/MDR after 72 hrs by methylene blue assay;CHEMBL3593220;Non-molecular target assigned;N;755451;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL3595574;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells after 72 hrs by methylene blue assay;CHEMBL3593220;Non-molecular target assigned;N;755448;1;CHEMBL398;;
CLD0;;KB-S15;CHEMBL3595576;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KB-S15 cells expressing P-gp170/MDR after 72 hrs by methylene blue assay;CHEMBL3593220;Non-molecular target assigned;N;755452;1;CHEMBL3879801;;
CLD0;;KB-7d;CHEMBL3595577;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KB-7d cells expressing MRP after 72 hrs by methylene blue assay;CHEMBL3593220;Non-molecular target assigned;N;755454;1;CHEMBL3879801;;
CLD0;;;CHEMBL3602455;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;Inhibition of porcine tubulin polymerization at 10 uM measured every min for 30 mins by spectrophotometric analysis;CHEMBL3600297;Direct protein target assigned;D;760288;1;CHEMBL2111354;;
CLD0;;A549;CHEMBL3602457;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Induction of microtubule destabilization in human A549 cells at 1 uM after 24 hrs by DAPI staining-based immunofluorescence confocal microscopic analysis;CHEMBL3600297;Default value - Target has yet to be curated;U;760290;1;CHEMBL612545;;
CLD0;;HepG2;CHEMBL3603695;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay;CHEMBL3600380;Non-molecular target assigned;N;759220;1;CHEMBL395;;
CLD0;;MDA-MB-231;CHEMBL3603696;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay;CHEMBL3600380;Non-molecular target assigned;N;759221;1;CHEMBL400;;
CLD0;;MDA-MB-435;CHEMBL3603697;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay;CHEMBL3600380;Non-molecular target assigned;N;759222;1;CHEMBL614697;;
CLD0;;HeLa;CHEMBL3603698;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 72 hrs by MTT assay;CHEMBL3600380;Non-molecular target assigned;N;759223;1;CHEMBL399;;
CLD0;;PC-3;CHEMBL3603699;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells after 72 hrs by MTT assay;CHEMBL3600380;Non-molecular target assigned;N;759224;1;CHEMBL390;;
CLD0;;KB ;CHEMBL3636021;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells assessed as inhibition of cell proliferation after 72 hrs by SRB assay;CHEMBL3632476;Non-molecular target assigned;N;777227;1;CHEMBL3879801;;
CLD0;;KB/VCR;CHEMBL3636022;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human KB/VCR cells assessed as inhibition of cell proliferation after 72 hrs by SRB assay;CHEMBL3632476;Non-molecular target assigned;N;777229;1;CHEMBL3879801;;
CLD0;;A549;CHEMBL3636023;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by SRB assay;CHEMBL3632476;Non-molecular target assigned;N;777231;1;CHEMBL392;;
CLD0;;KB ;CHEMBL3739135;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 72 hrs by SRB assay;CHEMBL3734715;Non-molecular target assigned;N;782968;1;CHEMBL398;;
CLD0;;Lu1;CHEMBL3739136;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308512;Target assigned is non-molecular;1;Cytotoxicity against human Lu1 cells after 72 hrs by SRB assay;CHEMBL3734715;Non-molecular target assigned;N;782972;1;CHEMBL613290;;
CLD0;;HepG2;CHEMBL3739137;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay;CHEMBL3734715;Non-molecular target assigned;N;782974;1;CHEMBL395;;
CLD0;;MCF7;CHEMBL3739138;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay;CHEMBL3734715;Non-molecular target assigned;N;782981;1;CHEMBL387;;
CLD0;;;CHEMBL3750043;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;Inhibition of bovine MAP rich tubulin polymerization at 1 uM measured every 2 mins for 30 mins by UV-visible spectrophotometric analysis;CHEMBL3745707;Direct protein target assigned;D;792789;1;CHEMBL2094134;;
CLD0;;;CHEMBL3748554;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;Displacement of [3H]-colchicine from biotinylated porcine tubulin after 2 hrs by competitive binding assay;CHEMBL3745658;Direct protein target assigned;D;785579;1;CHEMBL2111354;;
CLD0;;;CHEMBL3748558;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;Potency index, ratio of vincristine IC50 to docetaxel IC50 for displacement of [3H]-paclitaxel from biotinylated porcine tubulin;CHEMBL3745658;Direct protein target assigned;D;785600;1;CHEMBL2111354;;
CLD0;;;CHEMBL3748559;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;Displacement of [3H]-paclitaxel from biotinylated porcine tubulin after 25 mins by competitive binding assay;CHEMBL3745658;Direct protein target assigned;D;785599;1;CHEMBL2111354;;
CLD0;;;CHEMBL3748560;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;Displacement of [3H]-vinblastine from biotinylated porcine tubulin after 15 mins by competitive binding assay;CHEMBL3745658;Direct protein target assigned;D;785598;1;CHEMBL2111354;;
CLD0;;HeLa;CHEMBL3784809;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 3 days by SRB assay;CHEMBL3779888;Non-molecular target assigned;N;814425;1;CHEMBL399;;
CLD0;;KB ;CHEMBL3782351;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human vincristine-sensitive KB cells assessed as cell viability after 72 hrs by MTT assay;CHEMBL3779857;Non-molecular target assigned;N;816276;1;CHEMBL398;;
CLD0;;KB/VJ300;CHEMBL3782352;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513114;Target assigned is non-molecular;1;Cytotoxicity against human KB/VJ300 cells assessed as cell viability after 72 hrs by MTT assay;CHEMBL3779857;Non-molecular target assigned;N;816277;1;CHEMBL3879801;;
CLD0;;A549;CHEMBL3822007;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells assessed as cell viability after 48 hrs by MTT assay;CHEMBL3817728;Non-molecular target assigned;N;839268;1;CHEMBL392;;
CLD0;;MCF7;CHEMBL3822010;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as cell viability after 48 hrs by MTT assay;CHEMBL3817728;Non-molecular target assigned;N;839271;1;CHEMBL387;;
CLD0;;A2780;CHEMBL3822011;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Cytotoxicity against human A2780 cells assessed as cell viability after 48 hrs by MTT assay;CHEMBL3817728;Non-molecular target assigned;N;839272;1;CHEMBL614004;;
CLD0;;HCT-8;CHEMBL3822012;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Cytotoxicity against human HCT8 cells assessed as cell viability after 48 hrs by MTT assay;CHEMBL3817728;Non-molecular target assigned;N;839273;1;CHEMBL3879801;;
CLD0;;A2780/TAX;CHEMBL3822021;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human A2780/TAX cells assessed as growth inhibition after 48 hrs by MTT assay;CHEMBL3817728;Non-molecular target assigned;N;839300;1;CHEMBL3879801;;
CLD0;;A2780;CHEMBL3822022;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Resistance index, ratio of IC50 for human A2780/TAX cells to IC50 for human A2780 cells;CHEMBL3817728;Non-molecular target assigned;N;839301;1;CHEMBL614004;;
CLD0;;HCT8/VCT;CHEMBL3822023;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human HCT8/VCT cells assessed as growth inhibition after 48 hrs by MTT assay;CHEMBL3817728;Non-molecular target assigned;N;839302;1;CHEMBL3879801;;
CLD0;;HCT-8;CHEMBL3822024;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Resistance index, ratio of IC50 for human HCT8/VCT cells to IC50 for human HCT8 cells;CHEMBL3817728;Non-molecular target assigned;N;839303;1;CHEMBL613510;;
CLD0;;A549;CHEMBL3822025;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549/CDDP cells assessed as growth inhibition after 48 hrs by MTT assay;CHEMBL3817728;Non-molecular target assigned;N;839304;1;CHEMBL3879801;;
CLD0;;A549;CHEMBL3822026;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Resistance index, ratio of IC50 for human A549/CDDP cells to IC50 for human A549 cells;CHEMBL3817728;Non-molecular target assigned;N;839305;1;CHEMBL392;;
CLD0;;MCF7/DX;CHEMBL3822027;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human MCF7/DX cells assessed as growth inhibition after 48 hrs by MTT assay;CHEMBL3817728;Non-molecular target assigned;N;839306;1;CHEMBL3879801;;
CLD0;;MCF7;CHEMBL3822028;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Resistance index, ratio of IC50 for human MCF7/DX cells to IC50 for human MCF7 cells;CHEMBL3817728;Non-molecular target assigned;N;839307;1;CHEMBL387;;
CLD0;;NCI-H157;CHEMBL3821856;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Antiproliferative activity against human NCI-H157 cells assessed as cell growth inhibition after 48 hrs by SRB assay;CHEMBL3817741;Non-molecular target assigned;N;837978;1;CHEMBL614783;;
CLD0;;Vero;CHEMBL3821857;[];Chlorocebus sabaeus;[];;;60711.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307520;Target assigned is non-molecular;1;Antiproliferative activity against African green monkey Vero cells assessed as reduction in cell viability at 100 uM after 48 hrs by SRB assay;CHEMBL3817741;Non-molecular target assigned;N;837979;1;CHEMBL391;;
CLD0;;NCI-H157;CHEMBL3830510;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Growth inhibition of human NCI-H157 cells at 100 uM after 48 hrs by SRB assay;CHEMBL3826920;Non-molecular target assigned;N;843965;1;CHEMBL614783;;
862515;;MCF7;CHEMBL3856791;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay;CHEMBL3856194;Non-molecular target assigned;N;;1;CHEMBL3879801;;
862522;;Vero;CHEMBL3856792;[];Chlorocebus sabaeus;[];;;60711.0;;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307520;Target assigned is non-molecular;1;Cytotoxicity against African green monkey Vero cells assessed as cell growth inhibition after 48 hrs by MTT assay;CHEMBL3856194;Non-molecular target assigned;N;;1;CHEMBL3879801;;
862524;;MCF7;CHEMBL3856793;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Selectivity index, ratio of IC50 for African green monkey Vero cells to IC50 for human MCF7 cells;CHEMBL3856194;Non-molecular target assigned;N;;1;CHEMBL387;;
862536;;MCF7;CHEMBL3856800;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is molecular non-protein target;3;Cell cycle arrest in human MCF7 cells assessed as accumulation at sub-G0 phase at 0.5 uM after 18 to 24 hrs by propidium iodide staining based flow cytometry (Rvb = 1.4 %);CHEMBL3856194;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
862537;;MCF7;CHEMBL3856801;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is molecular non-protein target;3;Cell cycle arrest in human MCF7 cells assessed as accumulation at G0/G1 phase at 0.5 uM after 18 to 24 hrs by propidium iodide staining based flow cytometry (Rvb = 67 %);CHEMBL3856194;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
862538;;MCF7;CHEMBL3856802;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is molecular non-protein target;3;Cell cycle arrest in human MCF7 cells assessed as accumulation at S phase at 0.5 uM after 18 to 24 hrs by propidium iodide staining based flow cytometry (Rvb = 8.5 %);CHEMBL3856194;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
862539;;MCF7;CHEMBL3856803;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is molecular non-protein target;3;Cell cycle arrest in human MCF7 cells assessed as accumulation at G2/M phase at 0.5 uM after 18 to 24 hrs by propidium iodide staining based flow cytometry (Rvb = 18.8 %);CHEMBL3856194;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
862550;;MCF7;CHEMBL3856804;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Induction of apoptosis in human MCF7 cells assessed as viable cells after 24 to 48 hrs by Annexin V/7-AAD staining based flow cytometry (Rvb = 72.30 %);CHEMBL3856194;Non-molecular target assigned;N;;1;CHEMBL387;;
862551;;MCF7;CHEMBL3856805;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Induction of apoptosis in human MCF7 cells assessed as early apoptotic cells after 24 to 48 hrs by Annexin V/7-AAD staining based flow cytometry (Rvb = 4.90 %);CHEMBL3856194;Non-molecular target assigned;N;;1;CHEMBL387;;
862553;;MCF7;CHEMBL3856806;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Induction of apoptosis in human MCF7 cells assessed as late apoptotic cells after 24 to 48 hrs by Annexin V/7-AAD staining based flow cytometry (Rvb = 16.05 %);CHEMBL3856194;Non-molecular target assigned;N;;1;CHEMBL387;;
862554;;MCF7;CHEMBL3856807;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Induction of apoptosis in human MCF7 cells assessed as necrotic cells after 24 to 48 hrs by Annexin V/7-AAD staining based flow cytometry (Rvb = 6.75 %);CHEMBL3856194;Non-molecular target assigned;N;;1;CHEMBL387;;
862526;;MCF7;CHEMBL3857838;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as inhibition of cell survival rate after 48 hrs by MTT assay;CHEMBL3856213;Non-molecular target assigned;N;;1;CHEMBL3879801;;
866036;;HCC1428;CHEMBL3860264;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human HCC1428 cells assessed as decrease in cell viability at 1 uM after 60 hrs by xCELLigence system;CHEMBL3860030;Non-molecular target assigned;N;;1;CHEMBL3879801;;
866038;;HCC1428;CHEMBL3860266;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is molecular non-protein target;3;Cell cycle arrest in human HCC1428 cells assessed as accumulation at G1 phase at 1 uM after 24 hrs by propidium iodide staining-based flow cytometric method (Rvb = 69.83%);CHEMBL3860030;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
866039;;HCC1428;CHEMBL3860267;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is molecular non-protein target;3;Cell cycle arrest in human HCC1428 cells assessed as accumulation at S phase at 1 uM after 24 hrs by propidium iodide staining-based flow cytometric method (Rvb = 21.01%);CHEMBL3860030;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
866040;;HCC1428;CHEMBL3860268;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is molecular non-protein target;3;Cell cycle arrest in human HCC1428 cells assessed as accumulation at G2/M phase at 1 uM after 24 hrs by propidium iodide staining-based flow cytometric method (Rvb = 9.17%);CHEMBL3860030;Molecular target other than protein assigned;M;;1;CHEMBL612546;;
866048;;;CHEMBL3860276;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of microtubule depolymerization in human HCC1428 cells at 1 uM after 24 hrs by DAPI staining-based confocal microscopic method;CHEMBL3860030;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
866049;;;CHEMBL3860277;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of bovine brain tubulin polymerization at 5 uM measured every minute for 1 hr by spectrophotometric method;CHEMBL3860030;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
868441;;A549;CHEMBL3862060;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells assessed as decrease in cell viability after 24 hrs by MTT assay;CHEMBL3861942;Non-molecular target assigned;N;;1;CHEMBL3879801;;
868442;;HeLa;CHEMBL3862061;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 24 hrs by MTT assay;CHEMBL3861942;Non-molecular target assigned;N;;1;CHEMBL3879801;;
871617;;K562;CHEMBL3866635;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells after 72 hrs by MTT assay;CHEMBL3865815;Non-molecular target assigned;N;;1;CHEMBL3879801;;
871618;;K562/A02;CHEMBL3866636;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295416;Target assigned is non-molecular;1;Antiproliferative activity against human K562/A02 cells after 72 hrs by MTT assay;CHEMBL3865815;Non-molecular target assigned;N;;1;CHEMBL3879801;;
871619;;KB ;CHEMBL3866637;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells after 72 hrs by MTT assay;CHEMBL3865815;Non-molecular target assigned;N;;1;CHEMBL3879801;;
871620;;KB/VCR;CHEMBL3866638;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human KB/VCR cells after 72 hrs by MTT assay;CHEMBL3865815;Non-molecular target assigned;N;;1;CHEMBL3879801;;
871621;;MCF7;CHEMBL3866639;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay;CHEMBL3865815;Non-molecular target assigned;N;;1;CHEMBL3879801;;
871632;;A549;CHEMBL3866645;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Inhibition of alpha tubulin polymerization in human A549 cells at 50 nM by Hoechst 33258 staining based fluorescent microscopic analysis;CHEMBL3865815;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
876713;;SiHa;CHEMBL3871121;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307968;Target assigned is non-molecular;1;Cytotoxicity against human SiHa cells by MTT assay;CHEMBL3870355;Non-molecular target assigned;N;;1;CHEMBL3879801;;
876714;;B16-F10;CHEMBL3871122;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307762;Target assigned is non-molecular;1;Cytotoxicity against mouse B16F10 cells by MTT assay;CHEMBL3870355;Non-molecular target assigned;N;;1;CHEMBL3879801;;
876715;;Chang;CHEMBL3871123;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human Chang cells by MTT assay;CHEMBL3870355;Non-molecular target assigned;N;;1;CHEMBL3879801;;
1;;;CHEMBL3885882;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daily Repeat', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daily Repeat', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 50 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
901004;;BT-549;CHEMBL3995433;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308490;Target assigned is non-molecular;1;Antiproliferative activity against human BT549 cells after 48 hrs by MTT assay;CHEMBL3994605;Non-molecular target assigned;N;;1;CHEMBL614072;;
901002;;A549;CHEMBL3995434;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells after 48 hrs by MTT assay;CHEMBL3994605;Non-molecular target assigned;N;;1;CHEMBL392;;
901003;;MDA-MB-231;CHEMBL3995435;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay;CHEMBL3994605;Non-molecular target assigned;N;;1;CHEMBL400;;
901005;;4T1;CHEMBL3995436;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307995;Target assigned is non-molecular;1;Antiproliferative activity against mouse 4T1 cells after 48 hrs by MTT assay;CHEMBL3994605;Non-molecular target assigned;N;;1;CHEMBL612589;;
901006;;PC-3;CHEMBL3995437;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay;CHEMBL3994605;Non-molecular target assigned;N;;1;CHEMBL390;;
901007;;DU-145;CHEMBL3995438;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay;CHEMBL3994605;Non-molecular target assigned;N;;1;CHEMBL613508;;
901008;;HGC-27;CHEMBL3995439;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308741;Target assigned is non-molecular;1;Antiproliferative activity against human HGC27 cells after 48 hrs by MTT assay;CHEMBL3994605;Non-molecular target assigned;N;;1;CHEMBL1075463;;
901009;;HeLa;CHEMBL3995440;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay;CHEMBL3994605;Non-molecular target assigned;N;;1;CHEMBL399;;
902841;;CCRF-CEM;CHEMBL3998527;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay;CHEMBL3997781;Non-molecular target assigned;N;;1;CHEMBL382;;
902850;;CCRF-CEM/VBL;CHEMBL3998528;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human CCRF-CEM/VBL cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay;CHEMBL3997781;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
902852;;HCT-116;CHEMBL3998529;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay;CHEMBL3997781;Non-molecular target assigned;N;;1;CHEMBL394;;
902853;;PC-3;CHEMBL3998530;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay;CHEMBL3997781;Non-molecular target assigned;N;;1;CHEMBL390;;
902854;;NCI-H460;CHEMBL3998531;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H460 cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay;CHEMBL3997781;Non-molecular target assigned;N;;1;CHEMBL396;;
902855;;NCI-H526;CHEMBL3998532;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308881;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H526 cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay;CHEMBL3997781;Non-molecular target assigned;N;;1;CHEMBL2366102;;
902856;;NCI-H211;CHEMBL3998533;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4523547;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H211 cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay;CHEMBL3997781;Non-molecular target assigned;N;;1;CHEMBL4523578;;
902857;;;CHEMBL3998534;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance factor, ratio of IC50 for human CCRF-CEM/VBL cells to IC50 for human CCRF-CEM cells;CHEMBL3997781;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
909498;;;CHEMBL4009488;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of bovine brain tubulin polymerization at 5 uM measured every 1 min for 1 hr by spectrophotometric method;CHEMBL4007433;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
909494;;;CHEMBL4009489;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of alpha-tubulin polymerization in human HCC1428 cells at 1 uM after 24 hrs by confocal microscopic method;CHEMBL4007433;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
909482;;HCC1428;CHEMBL4009496;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human HCC1428 cells at 1 uM up to 60 hrs by RTCA;CHEMBL4007433;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
909483;;HCC1428;CHEMBL4009497;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cell cycle arrest in human HCC1428 cells assessed as accumulation at G1 phase at 1 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 62.61%);CHEMBL4007433;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
909484;;HCC1428;CHEMBL4009498;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cell cycle arrest in human HCC1428 cells assessed as accumulation at S phase at 1 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 24.46%);CHEMBL4007433;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
909485;;HCC1428;CHEMBL4009499;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cell cycle arrest in human HCC1428 cells assessed as accumulation at G2/M phase at 1 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 12.93%);CHEMBL4007433;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
906943;;;CHEMBL4028921;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL6020;;
906944;;;CHEMBL4028922;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL5748;;
906945;;;CHEMBL4028923;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL5918;;
906946;;;CHEMBL4028924;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL1743128;;
911630;;;CHEMBL4029349;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
911633;;;CHEMBL4029350;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
942189;;;CHEMBL4034795;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of tubulin (unknown origin) polymerization by fluorescence assay;CHEMBL4033650;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
942834;;KB ;CHEMBL4037381;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells after 72 hrs by sulforhodamine B assay;CHEMBL4033782;Non-molecular target assigned;N;;1;CHEMBL398;;
942892;;KB/VCR;CHEMBL4037382;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human KB/VCR cells after 72 hrs by sulforhodamine B assay;CHEMBL4033782;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
890244;;KB/S;CHEMBL4042129;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human KB/S cells assessed as reduction in cell viability after 72 hrs by MTT assay;CHEMBL4041503;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
890245;;KB/VJ300;CHEMBL4042130;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513114;Target assigned is non-molecular;1;Cytotoxicity against human KB/VJ300 cells assessed as reduction in cell viability after 72 hrs by MTT assay;CHEMBL4041503;Non-molecular target assigned;N;;1;CHEMBL4513128;;
954375;;;CHEMBL4045304;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of bovine brain tubulin polymerization;CHEMBL4043145;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
955415;;HeLa;CHEMBL4049313;[];Ebolavirus;[];;;186536.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;Inhibition of Ebolavirus glycoprotein/matrix protein VP40 entry in human HeLa cells after 4.5 hrs beta-lactamase reporter assay;CHEMBL4043309;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
912003;;KB ;CHEMBL4050895;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells after 72 hrs by SRB assay;CHEMBL4049418;Non-molecular target assigned;N;;1;CHEMBL398;;
912062;;KB/VCR;CHEMBL4050954;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human KB/VCR cells after 72 hrs by SRB assay;CHEMBL4049418;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
912063;;;CHEMBL4050955;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance factor, ratio of IC50 for human KB/VCR cells to IC50 for human KB cells;CHEMBL4049418;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
982805;;K562/VCR;CHEMBL4122014;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295433;Target assigned is non-molecular;1;Antiproliferative activity against human K562/VCR cells after 72 hrs by CCK8 assay;CHEMBL4118137;Non-molecular target assigned;N;;1;CHEMBL4296450;;
982806;;K562;CHEMBL4122015;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay;CHEMBL4118137;Non-molecular target assigned;N;;1;CHEMBL385;;
982807;;;CHEMBL4122016;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance factor, ratio of IC50 for human K562/VCR cells to IC50 for human K562 cells;CHEMBL4118137;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1000037;;NCI-H157;CHEMBL4142106;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H157 cells at 100 uM after 48 hrs by sulforhodamine B assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL614783;;
1000038;;NCI-H157;CHEMBL4142107;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H157 cells at 10 uM after 48 hrs by sulforhodamine B assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL614783;;
1000039;;NCI-H157;CHEMBL4142108;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H157 cells at 1 uM after 48 hrs by sulforhodamine B assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL614783;;
1000040;;NCI-H157;CHEMBL4142109;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H157 cells at 0.1 uM after 48 hrs by sulforhodamine B assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL614783;;
1000043;;BHK-21;CHEMBL4142110;[];Mesocricetus auratus;[];;;10036.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Cytotoxicity against golden hamster BHK21 cells at 100 uM after 48 hrs by sulforhodamine B assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL614527;;
1000044;;BHK-21;CHEMBL4142111;[];Mesocricetus auratus;[];;;10036.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Cytotoxicity against golden hamsterBHK21 cells at 10 uM after 48 hrs by sulforhodamine B assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL614527;;
1000045;;BHK-21;CHEMBL4142112;[];Mesocricetus auratus;[];;;10036.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Cytotoxicity against golden hamster BHK21 cells at 1 uM after 48 hrs by sulforhodamine B assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL614527;;
1000046;;BHK-21;CHEMBL4142113;[];Mesocricetus auratus;[];;;10036.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Cytotoxicity against golden hamster BHK21 cells at 0.1 uM after 48 hrs by sulforhodamine B assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL614527;;
1000208;;NCI-H157;CHEMBL4142156;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H157 cells after 48 hrs by sulforhodamine B assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL614783;;
1000209;;BHK-21;CHEMBL4142157;[];Mesocricetus auratus;[];;;10036.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Cytotoxicity against golden hamster BHK21 cells after 48 hrs by sulforhodamine B assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL614527;;
1000211;;HepG2;CHEMBL4142158;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells by MTT assay;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL395;;
1000212;;;CHEMBL4142159;[];Agrobacterium tumefaciens;[];;;358.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against Agrobacterium tumefaciens-induced tumor after 21 days by potato disc bioassay technique;CHEMBL4138175;Non-molecular target assigned;N;;1;CHEMBL612504;;
999924;;HL-60;CHEMBL4142204;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 48 hrs by MTT assay;CHEMBL4138179;Non-molecular target assigned;N;;1;CHEMBL383;;
999925;;PC-3;CHEMBL4142205;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay;CHEMBL4138179;Non-molecular target assigned;N;;1;CHEMBL390;;
1012528;;;CHEMBL4149475;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Growth inhibition of human KB/S cells after 72 hrs by MTT assay;CHEMBL4145571;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1012530;;KB/VJ300;CHEMBL4149476;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;CHEMBL4513114;Target assigned is non-molecular;1;Growth inhibition of human KB/VJ300 cells after 72 hrs by MTT assay;CHEMBL4145571;Non-molecular target assigned;N;;1;CHEMBL4513128;;
1011647;;KB ;CHEMBL4149991;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells after 48 hrs by MTT assay;CHEMBL4145601;Non-molecular target assigned;N;;1;CHEMBL398;;
1011653;;;CHEMBL4149997;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human KBV cells after 48 hrs by MTT assay;CHEMBL4145601;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1011657;;;CHEMBL4150000;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance ratio of IC50 for human KBV cells to IC50 for human KB cells;CHEMBL4145601;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1034688;;SMMC-7721;CHEMBL4155616;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Cytotoxicity against human SMMC7721 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034691;;L02;CHEMBL4155617;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Cytotoxicity against human LO2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034697;;SMMC-7721;CHEMBL4155622;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Growth inhibition of human SMMC7721 cells at 0.01 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034698;;SMMC-7721;CHEMBL4155623;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Growth inhibition of human SMMC7721 cells at 0.1 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034700;;SMMC-7721;CHEMBL4155624;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Growth inhibition of human SMMC7721 cells at 0.5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034701;;SMMC-7721;CHEMBL4155625;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Growth inhibition of human SMMC7721 cells at 2.5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034703;;SMMC-7721;CHEMBL4155626;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Growth inhibition of human SMMC7721 cells at 5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034706;;L02;CHEMBL4155627;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Growth inhibition of human LO2 cells at 0.01 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034707;;L02;CHEMBL4155628;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Growth inhibition of human LO2 cells at 0.1 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034708;;L02;CHEMBL4155629;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Growth inhibition of human LO2 cells at 0.5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034709;;L02;CHEMBL4155630;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Growth inhibition of human LO2 cells at 2.5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034710;;L02;CHEMBL4155631;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Growth inhibition of human LO2 cells at 5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
967915;;MOLT-4;CHEMBL4184789;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;Cytotoxicity against human MOLT4 cells assessed as reduction in cell viability;CHEMBL4184103;Non-molecular target assigned;N;;1;CHEMBL614177;;
1020395;;;CHEMBL4196284;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Multiple direct protein targets may be assigned;5;Inhibition of tubulin (unknown origin) polymerization assessed as tubulin assembly rate by fluorescence assay;CHEMBL4196002;Direct protein target assigned;D;;1;CHEMBL2095182;;
1022591;;MCF7;CHEMBL4201254;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cell cycle arrest in human MCF7 cells assessed as increase in accumulation at G2/M phase at 100 nM after 18 hrs by Hoechst 33342 staining based FACS analysis relative to control;CHEMBL4196179;Non-molecular target assigned;N;;1;CHEMBL387;;
1022599;;PANC-1;CHEMBL4201256;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307545;Target assigned is non-molecular;1;Cell cycle arrest in human PANC1 cells assessed as increase in accumulation at G2/M phase at 100 nM after 18 hrs by Hoechst 33342 staining based FACS analysis relative to control;CHEMBL4196179;Non-molecular target assigned;N;;1;CHEMBL614139;;
1022603;;PANC-1;CHEMBL4201258;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307545;Target assigned is non-molecular;1;Cell cycle arrest in human PANC1 cells assessed as accumulation at G1 phase at 100 nM after 18 hrs by Hoechst 33342 staining based FACS analysis (Rvb = 70.7%);CHEMBL4196179;Non-molecular target assigned;N;;1;CHEMBL614139;;
1022604;;PANC-1;CHEMBL4201259;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307545;Target assigned is non-molecular;1;Cell cycle arrest in human PANC1 cells assessed as accumulation at S phase at 100 nM after 18 hrs by Hoechst 33342 staining based FACS analysis (Rvb = 11.1%);CHEMBL4196179;Non-molecular target assigned;N;;1;CHEMBL614139;;
1022606;;PANC-1;CHEMBL4201260;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307545;Target assigned is non-molecular;1;Cell cycle arrest in human PANC1 cells assessed as accumulation at G2/M phase at 100 nM after 18 hrs by Hoechst 33342 staining based FACS analysis (Rvb = 13.7%);CHEMBL4196179;Non-molecular target assigned;N;;1;CHEMBL614139;;
1027204;;;CHEMBL4231285;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of porcine brain tubulin polymerization assessed as tubulin polymerization level by measuring arbitary units at 3 uM by fluorescence analysis;CHEMBL4229351;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1009022;;HeLa;CHEMBL4252841;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 48 hrs by MTT assay;CHEMBL4251576;Non-molecular target assigned;N;;1;CHEMBL399;;
1009023;;HGC-27;CHEMBL4252842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308741;Target assigned is non-molecular;1;Cytotoxicity against human HGC27 cells assessed as inhibition of cell viability after 48 hrs by MTT assay;CHEMBL4251576;Non-molecular target assigned;N;;1;CHEMBL1075463;;
1009024;;NCI-H460;CHEMBL4252843;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H460 cells assessed as inhibition of cell viability after 48 hrs by MTT assay;CHEMBL4251576;Non-molecular target assigned;N;;1;CHEMBL396;;
1009025;;DU-145;CHEMBL4252844;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;Cytotoxicity against human DU145 cells assessed as inhibition of cell viability after 48 hrs by MTT assay;CHEMBL4251576;Non-molecular target assigned;N;;1;CHEMBL613508;;
1009026;;PC-3;CHEMBL4252845;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay;CHEMBL4251576;Non-molecular target assigned;N;;1;CHEMBL390;;
1009028;;4T1;CHEMBL4252846;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307995;Target assigned is non-molecular;1;Cytotoxicity against mouse 4T1 cells assessed as inhibition of cell viability after 48 hrs by MTT assay;CHEMBL4251576;Non-molecular target assigned;N;;1;CHEMBL612589;;
1009030;;RWPE-1;CHEMBL4252847;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295468;Target assigned is non-molecular;1;Cytotoxicity against human RWPE1 cells assessed as inhibition of cell viability after 48 hrs by MTT assay;CHEMBL4251576;Non-molecular target assigned;N;;1;CHEMBL4296492;;
1056640;;HEL;CHEMBL4259352;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;Antiproliferative activity against HEL cells after 48 hrs by MTT assay;CHEMBL4257520;Non-molecular target assigned;N;;1;CHEMBL613888;;
1056641;;K562;CHEMBL4259353;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells after 48 hrs by MTT assay;CHEMBL4257520;Non-molecular target assigned;N;;1;CHEMBL385;;
1056642;;PC-3;CHEMBL4259354;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay;CHEMBL4257520;Non-molecular target assigned;N;;1;CHEMBL390;;
1056643;;;CHEMBL4259355;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human WM9 cells after 48 hrs by MTT assay;CHEMBL4257520;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1056644;;MDA-MB-231;CHEMBL4259356;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay;CHEMBL4257520;Non-molecular target assigned;N;;1;CHEMBL400;;
1039670;;KB ;CHEMBL4271209;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity in human KB cells assessed as reduction in cell viability;CHEMBL4270497;Non-molecular target assigned;N;;1;CHEMBL398;;
1041142;;;CHEMBL4273763;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Multiple direct protein targets may be assigned;5;Inhibition of tubulin (unknown origin) polymerization assessed as polymerized tubulin level at 5 to 25 uM by fluorescence assay;CHEMBL4270577;Direct protein target assigned;D;;1;CHEMBL2095182;;
GN_003;;;CHEMBL4296186;[];Klebsiella pneumoniae;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 700603;;573.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL350;;
GN_042;;;CHEMBL4296187;[];Pseudomonas aeruginosa;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 27853;;287.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL348;;
FG_001;;;CHEMBL4296189;[];Candida albicans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD530)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD530)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 90028;;5476.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL366;;
FG_002R;;;CHEMBL4296190;[];Cryptococcus neoformans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Resazurin; Absorption (OD600-OD570)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Resazurin; Absorption (OD600-OD570)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 208821;;5207.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL365;;
GP_020F;;;CHEMBL4296192;[];Staphylococcus aureus subsp. aureus;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Resazurin; Fluorescence (ex560/em590)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Resazurin; Fluorescence (ex560/em590)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 43300;;46170.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media using NBS plates, by Resazurin F(560/590)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL2366800;;
GN_034F;;;CHEMBL4296193;[];Acinetobacter baumannii;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Resazurin; Fluorescence (ex560/em590)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Resazurin; Fluorescence (ex560/em590)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 19606;;470.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by Resazurin F(560/590)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL614425;;
GN_001F;;;CHEMBL4296783;[];Escherichia coli;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Resazurin; Fluorescence (ex560/em590)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Resazurin; Fluorescence (ex560/em590)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 25922;;562.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by Resazurin F(560/590)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL354;;
1_HEI;;HRCE;CHEMBL4303810;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4303839;Target assigned is non-molecular;1;Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits);CHEMBL4303122;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1128105;;MDA-MB-231;CHEMBL4305678;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability at 100 uM relative to control;CHEMBL4304757;Non-molecular target assigned;N;;1;CHEMBL400;;
1067477;;A2780/Taxol;CHEMBL4310851;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4483130;Target assigned is non-molecular;1;Potentiation of paclitaxel-induced cytotoxicity against human A2780/TAX cells assessed as paclitaxel IC50 at 10 uM after 48 hrs by MTT assay (Rvb = 3970 nM);CHEMBL4308879;Non-molecular target assigned;N;;1;CHEMBL4483224;;
1067478;;;CHEMBL4310852;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Potentiation of cisplatin-induced cytotoxicity against human A2780/CDDP cells assessed as cisplatin IC50 at 10 uM after 48 hrs by MTT assay (Rvb = 43.11 nM);CHEMBL4308879;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1067480;;A2780/Taxol;CHEMBL4310854;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4483130;Target assigned is non-molecular;1;Reversal ratio of IC50 for paclitaxel-induced cytotoxicity against human A2780/TAX cells in absence of compound to IC50 paclitaxel-induced cytotoxicity against human A2780/TAX cells in presence of compound;CHEMBL4308879;Non-molecular target assigned;N;;1;CHEMBL4483224;;
1067481;;;CHEMBL4310855;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Reversal ratio of IC50 for cisplatin-induced cytotoxicity against human A2780/CDDP cells in absence of compound to IC50 for cisplatin-induced cytotoxicity against human A2780/CDDP cells in presence of compound;CHEMBL4308879;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1067489;;KB ;CHEMBL4310859;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 48 hrs by MTT assay;CHEMBL4308879;Non-molecular target assigned;N;;1;CHEMBL398;;
1067490;;;CHEMBL4310860;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance ratio of IC50 for human KBV cells to IC50 for human KB cells;CHEMBL4308879;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1193369;;;CHEMBL4343140;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of bovine brain microtubule polymerization incubated for 60 mins by spectrophotometric method;CHEMBL4342416;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1114650;;SMMC-7721;CHEMBL4346910;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Cytotoxicity against human SMMC7721 cells incubated for 72 hrs by MTT assay;CHEMBL4346655;Non-molecular target assigned;N;;1;CHEMBL613831;;
1114651;;L02;CHEMBL4346911;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Cytotoxicity against human L02 cells incubated for 72 hrs by MTT assay;CHEMBL4346655;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1146086;;KB ;CHEMBL4362658;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells assessed as reduction in cell viability after 72 hrs by MTS assay;CHEMBL4359883;Non-molecular target assigned;N;;1;CHEMBL398;;
1146094;;CCRF-CEM;CHEMBL4362666;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Antiproliferative activity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by MTS assay;CHEMBL4359883;Non-molecular target assigned;N;;1;CHEMBL382;;
1146199;;;CHEMBL4362719;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;Inhibition of porcine tubulin at 5 uM in presence of GTP measured every minute for 1 hr by microplate reader analysis;CHEMBL4359883;Direct protein target assigned;D;;1;CHEMBL2111354;;
1146585;;;CHEMBL4362735;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Multiple direct protein targets may be assigned;5;Binding affinity to tubulin (unknown origin) assessed as reduction in Beta-colfragment production at 100 uM after 30 mins by coomassie brilliant blue staining based trypsin proteolysis assay;CHEMBL4359883;Direct protein target assigned;D;;1;CHEMBL2095182;;
1146586;;;CHEMBL4362736;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Multiple direct protein targets may be assigned;5;Binding affinity to tubulin (unknown origin) assessed as reduction in alpha-N fragment production at 100 uM after 30 mins by coomassie brilliant blue staining based trypsin proteolysis assay;CHEMBL4359883;Direct protein target assigned;D;;1;CHEMBL2095182;;
1146587;;;CHEMBL4362737;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Multiple direct protein targets may be assigned;5;Binding affinity to tubulin (unknown origin) assessed as reduction in alpha-C fragment production at 100 uM after 30 mins by coomassie brilliant blue staining based trypsin proteolysis assay;CHEMBL4359883;Direct protein target assigned;D;;1;CHEMBL2095182;;
1146590;;;CHEMBL4362739;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human KBtax cells assessed as reduction in cell viability after 72 hrs by MTS assay;CHEMBL4359883;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1146591;;;CHEMBL4362740;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for human KBtax cells to IC50 for human KB cells;CHEMBL4359883;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1146592;;;CHEMBL4362741;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human KB/VCR cells assessed as reduction in cell viability after 72 hrs by MTS assay;CHEMBL4359883;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1146593;;;CHEMBL4362742;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for human KB/VCR cells to IC50 for human KB cells;CHEMBL4359883;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1146595;;;CHEMBL4362743;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human CCRF-CEM/VBL cells assessed as reduction in cell viability after 72 hrs by MTS assay;CHEMBL4359883;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1146596;;;CHEMBL4362744;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for human CCRF-CEM/VBL cells to IC50 for human CCRF-CEM cells;CHEMBL4359883;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1165455;;NCI-H157;CHEMBL4375930;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307706;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H157 cells assessed as reduction in cell viability after 48 hrs by SRB assay;CHEMBL4373717;Non-molecular target assigned;N;;1;CHEMBL614783;;
1165454;;BHK-21;CHEMBL4375932;[];Mesocricetus auratus;[];;;10036.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Cytotoxicity against BHK21 cells assessed as reduction in cell viability after 48 hrs by SRB assay;CHEMBL4373717;Non-molecular target assigned;N;;1;CHEMBL614527;;
1077010;;K562;CHEMBL4412023;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells after 72 hrs by MTT assay;CHEMBL4411275;Non-molecular target assigned;N;;1;CHEMBL385;;
1077013;;HCT-8;CHEMBL4412026;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay;CHEMBL4411275;Non-molecular target assigned;N;;1;CHEMBL613510;;
1077030;;A549;CHEMBL4412030;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells after 72 hrs by MTT assay;CHEMBL4411275;Non-molecular target assigned;N;;1;CHEMBL392;;
1077031;;Bel-7402;CHEMBL4412031;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307770;Target assigned is non-molecular;1;Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay;CHEMBL4411275;Non-molecular target assigned;N;;1;CHEMBL614279;;
1077032;;;CHEMBL4412032;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human taxol-resistant HCT8/T cells after 72 hrs by MTT assay;CHEMBL4411275;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1077033;;;CHEMBL4412033;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Drug resistance index, ratio of IC50 for taxol-resistant human HCT8/T cells to IC50 for human HCT8 cells;CHEMBL4411275;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1077034;;A549/TR;CHEMBL4412034;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4483127;Target assigned is non-molecular;1;Antiproliferative activity against human taxol-resistant A549/TR cells after 72 hrs by MTT assay;CHEMBL4411275;Non-molecular target assigned;N;;1;CHEMBL4483226;;
1077035;;;CHEMBL4412035;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Drug resistance index, ratio of IC50 for taxol-resistant human A549/TR cells to IC50 for human A549 cells;CHEMBL4411275;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1077036;;K562/VCR;CHEMBL4412036;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295433;Target assigned is non-molecular;1;Antiproliferative activity against human VCR-resistant K562/VCR cells after 72 hrs by MTT assay;CHEMBL4411275;Non-molecular target assigned;N;;1;CHEMBL4296450;;
1077037;;;CHEMBL4412037;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Drug resistance index, ratio of IC50 for VCR-resistant human K562/VCR cells to IC50 for human K562 cells;CHEMBL4411275;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1077059;;;CHEMBL4412039;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human ADR-resistant Bel7402/ADR cells after 72 hrs by MTT assay;CHEMBL4411275;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1077060;;;CHEMBL4412040;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Drug resistance index, ratio of IC50 for ADR-resistant human Bel7402/ADR cells to IC50 for human Bel7402 cells;CHEMBL4411275;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1174398;;;CHEMBL4416667;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human KB/S cells assessed as reduction in cell growth after 72 hrs by MTT assay;CHEMBL4414629;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1174399;;KB/VJ300;CHEMBL4416668;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513114;Target assigned is non-molecular;1;Antiproliferative activity against human KB/VJ300 cells assessed as reduction in cell growth after 72 hrs by MTT assay;CHEMBL4414629;Non-molecular target assigned;N;;1;CHEMBL4513128;;
849343;;;CHEMBL4431645;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Growth inhibition of human KB/S cells after 72 hrs by MTT assay;CHEMBL4431302;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
849344;;KB/VJ300;CHEMBL4431646;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513114;Target assigned is non-molecular;1;Growth inhibition of human KB/VJ300 cells after 72 hrs by MTT assay;CHEMBL4431302;Non-molecular target assigned;N;;1;CHEMBL4513128;;
850357;;B16;CHEMBL4431655;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308454;Target assigned is non-molecular;1;Cytotoxicity against mouse B16 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay;CHEMBL4431303;Non-molecular target assigned;N;;1;CHEMBL381;;
850358;;HaCaT;CHEMBL4431656;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308509;Target assigned is non-molecular;1;Cytotoxicity against human HaCaT cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay;CHEMBL4431303;Non-molecular target assigned;N;;1;CHEMBL614392;;
1085430;;;CHEMBL4482060;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human KB/S cells after 72 hrs by MTT assay;CHEMBL4480449;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1085431;;KB/VJ300;CHEMBL4482061;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513114;Target assigned is non-molecular;1;Cytotoxicity against human KB/VJ300 cells after 72 hrs by MTT assay;CHEMBL4480449;Non-molecular target assigned;N;;1;CHEMBL4513128;;
1222742;;HL-60;CHEMBL4624687;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antiproliferative activity against human HL60 cells incubated for 2 days by MTT assay;CHEMBL4622912;Non-molecular target assigned;N;;1;CHEMBL383;;
1234945;;A2780;CHEMBL4667298;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Antiproliferative activity against human A2780 cells incubated for 72 hrs by ATPlite reagent based assay;CHEMBL4665649;Non-molecular target assigned;N;;1;CHEMBL614004;;
1234946;;A2780;CHEMBL4667299;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Antiproliferative activity against D4-9-31 resistance human A2780 cells incubated for 72 hrs by ATPlite reagent based assay;CHEMBL4665649;Non-molecular target assigned;N;;1;CHEMBL614004;;
1230744;;MOLM-13;CHEMBL4669271;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Inhibition of tubulin polymerization in human MOLM-13 cells assessed as disruption of microtubule network at 200 nM after 18 hrs by FITC-staining based flow cytometry analysis;CHEMBL4665719;Direct protein target assigned;D;;1;CHEMBL2095182;;
1234395;;PBL;CHEMBL4671791;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307569;Target assigned is non-molecular;1;Cytotoxicity against human PBL assessed as reduction in cell viability in presence of mitogenic stimulus phytohaemagglutinin incubated for 72 hrs by MTT assay;CHEMBL4665839;Non-molecular target assigned;N;;1;CHEMBL614233;;
1234394;;PBL;CHEMBL4671792;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307569;Target assigned is non-molecular;1;Cytotoxicity against human PBL assessed as reduction in cell viability incubated for 72 hrs by MTT assay;CHEMBL4665839;Non-molecular target assigned;N;;1;CHEMBL614233;;
1269181;;KB ;CHEMBL4686044;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells incubated for 48 hrs by SRB assay;CHEMBL4680226;Non-molecular target assigned;N;;1;CHEMBL398;;
1269182;;KB-VIN;CHEMBL4686045;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human KB-VIN cells incubated for 48 hrs by SRB assay;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269237;;KB-VIN;CHEMBL4686066;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cell cycle arrest in human KB-VIN cells assessed as increase in accumulation at sub-G1 phase at 0.01 to 0.1 uM measured after 24 hrs by propidium iodide staining based flow cytometry;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269273;;KB-VIN;CHEMBL4686067;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved PARP expression at 0.1 uM measured after 24 hrs by Western blot analysis;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269274;;KB-VIN;CHEMBL4686068;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-3 expression at 0.1 uM measured after 24 hrs by Western blot analysis;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269303;;KB-VIN;CHEMBL4686072;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-8 expression at 0.1 uM measured after 24 hrs by Western blot analysis;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269304;;KB-VIN;CHEMBL4686073;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-9 expression at 0.1 uM measured after 24 hrs by Western blot analysis;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269306;;KB-VIN;CHEMBL4686074;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB-VIN cells assessed as increase in activated gammaH2AX expression at 0.1 uM measured after 24 hrs by Western blot analysis;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269360;;KB-VIN;CHEMBL4686093;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cell cycle arrest in human KB-VIN cells assessed as increase in accumulation at sub-G1 phase at 0.1 uM measured after 48 hrs by propidium iodide staining based flow cytometry;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269361;;KB-VIN;CHEMBL4686094;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved PARP expression at 0.1 uM measured after 48 hrs by Western blot analysis;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269362;;KB-VIN;CHEMBL4686095;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-3 expression at 0.1 uM measured after 48 hrs by Western blot analysis;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269363;;KB-VIN;CHEMBL4686096;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-8 expression at 0.1 uM measured after 48 hrs by Western blot analysis;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269364;;KB-VIN;CHEMBL4686097;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-9 expression at 0.1 uM measured after 48 hrs by Western blot analysis;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269365;;KB-VIN;CHEMBL4686098;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human KB-VIN cells assessed as increase in activated gammaH2AX expression at 0.1 uM measured after 48 hrs by Western blot analysis;CHEMBL4680226;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1269381;;KB-VIN;CHEMBL4686103;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Induction of microtubule disruption in human KB-VIN cells at 1 uM measured after 24 hrs by DAPI staining based deconvolution fluorescence microscopic analysis;CHEMBL4680226;Direct protein target assigned;D;;1;CHEMBL2095182;;
1269382;;KB7D;CHEMBL4686104;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Induction of microtubule disruption in human KB7D cells at 1 uM measured after 24 hrs by DAPI staining based deconvolution fluorescence microscopic analysis;CHEMBL4680226;Direct protein target assigned;D;;1;CHEMBL2095182;;
1269407;;KB-VIN;CHEMBL4686107;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Induction of microtubule disruption in human KB-VIN cells assessed as polymerized fraction at 0.01 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 23.1 to 25.5%);CHEMBL4680226;Direct protein target assigned;D;;1;CHEMBL2095182;;
1269408;;KB-VIN;CHEMBL4686108;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Induction of microtubule disruption in human KB-VIN cells assessed as polymerized fraction at 0.1 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 23.1 to 25.5%);CHEMBL4680226;Direct protein target assigned;D;;1;CHEMBL2095182;;
1269410;;KB-VIN;CHEMBL4686109;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Induction of microtubule disruption in human KB-VIN cells assessed as polymerized fraction at 1 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 23.1 to 25.5%);CHEMBL4680226;Direct protein target assigned;D;;1;CHEMBL2095182;;
1269411;;KB7D;CHEMBL4686110;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Induction of microtubule disruption in human KB7D cells assessed as polymerized fraction at 0.01 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 26.4 to 29%);CHEMBL4680226;Direct protein target assigned;D;;1;CHEMBL2095182;;
1269412;;KB7D;CHEMBL4686111;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Induction of microtubule disruption in human KB7D cells assessed as polymerized fraction at 0.1 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 26.4 to 29%);CHEMBL4680226;Direct protein target assigned;D;;1;CHEMBL2095182;;
1269413;;KB7D;CHEMBL4686112;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Induction of microtubule disruption in human KB7D cells assessed as polymerized fraction at 1 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 26.4 to 29%);CHEMBL4680226;Direct protein target assigned;D;;1;CHEMBL2095182;;
1273348;;MCF7;CHEMBL4689432;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay;CHEMBL4680354;Non-molecular target assigned;N;;1;CHEMBL387;;
1273349;;HT-29;CHEMBL4689433;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay;CHEMBL4680354;Non-molecular target assigned;N;;1;CHEMBL384;;
1273355;;MCF7;CHEMBL4689436;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human cells MCF-7 assessed as reduction in cell viability incubated for 24 hrs by MTT assay;CHEMBL4680354;Non-molecular target assigned;N;;1;CHEMBL387;;
1241306;;518T2;CHEMBL4705354;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to beta-tubulin in mouse 518T2 cells at 0.1 to 50 uM measured after 1.5 hrs using Alexa Fluor 532 dye by copper-mediated click reaction based SDS PAGE analysis;CHEMBL4699638;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1245537;;HepG2;CHEMBL4705782;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Inhibition of N,N'-Ethylenebis(iodoacetamide) binding to beta-tubulin in human HepG2 cells assessed as reduction in EBI/beta-tubulin adduct formation at 5 uM preincubated for 2 hrs followed by EBI addition and measured after 1.5 hrs by Western blot analysis;CHEMBL4699650;Direct protein target assigned;D;;1;CHEMBL3832942;;
1299413;;SMMC-7721;CHEMBL4738989;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Cytotoxicity against human SMMC-7721 cells assessed as cell viability after 24 hrs by MTT assay;CHEMBL4732241;Non-molecular target assigned;N;;1;CHEMBL613831;;
1299414;;L02;CHEMBL4738990;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Cytotoxicity against human L02 cells assessed as cell viability after 24 hrs by MTT assay;CHEMBL4732241;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1304878;;NCI/ADR-RES;CHEMBL4817009;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7/ADR cells incubated for 48 hrs by CCK-8 assay;CHEMBL4813991;Non-molecular target assigned;N;;1;CHEMBL613829;;
1305121;;NCI/ADR-RES;CHEMBL4817019;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of P-glycoprotein in human MCF7/ADR cells assessed as reversal fold by measuring reduction in vincristine IC50 at 5 uM incubated for 48 hrs by CCK-8 assay;CHEMBL4813991;Direct protein target assigned;D;;1;CHEMBL4302;;
1311161;;K562;CHEMBL4819385;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 method;CHEMBL4818987;Non-molecular target assigned;N;;1;CHEMBL385;;
1311162;;K562/VCR;CHEMBL4819386;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295433;Target assigned is non-molecular;1;Antiproliferative activity against human K562/VCR cells incubated for 72 hrs by CCK8 method;CHEMBL4818987;Non-molecular target assigned;N;;1;CHEMBL4296450;;
1311396;;KBV;CHEMBL4819423;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human KBV cells by MTT assay;CHEMBL4818987;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1313276;;MCF-T;CHEMBL4820215;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308561;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human MCF-T cells assessed as cell survival measured after 72 hrs by MTT assay;CHEMBL4819015;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1331388;;KB ;CHEMBL4837727;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human vincristine-sensitive KB cells assessed as cell growth inhibition measured after 72 hrs by MTT assay;CHEMBL4837192;Non-molecular target assigned;N;;1;CHEMBL398;;
1331389;;KB ;CHEMBL4837728;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human vincristine-resistant KB cells assessed as cell growth inhibition measured after 72 hrs by MTT assay;CHEMBL4837192;Non-molecular target assigned;N;;1;CHEMBL398;;
1335580;;A2780S;CHEMBL4845253;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Inhibition of EBI binding to beta tubulin in human A2780S cells at 5 to 25 uM preincubated for 2 hrs followed by addition of EBI and measured after 2 hrs by western blot assay;CHEMBL4842387;Direct protein target assigned;D;;1;CHEMBL3832942;;
1397840;;HCT-8;CHEMBL5143969;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Antiproliferative activity against human HCT-8 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay;CHEMBL5143510;Non-molecular target assigned;N;;1;CHEMBL613510;;
1397884;;HCT-8/VCR;CHEMBL5143979;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against vincristine resistant human HCT-8/VCR cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay;CHEMBL5143510;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1397891;;;CHEMBL5143982;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Resistance index, ratio of IC50 for antiproliferative activity against vincristine resistant human HCT-8/VCR cells to IC50 for antiproliferative activity against human HCT-8 cells;CHEMBL5143510;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1387435;;KB ;CHEMBL5155644;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB cells measured after 72 hrs by SRB assay;CHEMBL5154650;Non-molecular target assigned;N;;1;CHEMBL398;;
1387436;;KB/VCR;CHEMBL5155645;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human KB/VCR cells measured after 72 hrs by SRB assay;CHEMBL5154650;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1387437;;KB ;CHEMBL5155646;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Default value - Target unknown or has yet to be assigned;0;Resistant index, ratio IC50 for KB/VCR cells over IC50 for KB cells;CHEMBL5154650;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1387438;;KB-V1;CHEMBL5155647;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295414;Target assigned is non-molecular;1;Antiproliferative activity against human KB-V1 cells measured after 72 hrs by SRB assay;CHEMBL5154650;Non-molecular target assigned;N;;1;CHEMBL4296451;;
1387439;;KB ;CHEMBL5155648;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Default value - Target unknown or has yet to be assigned;0;Resistant index, ratio IC50 for KB-V1 cells over IC50 for KB cells;CHEMBL5154650;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1387440;;K562;CHEMBL5155649;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells measured after 72 hrs by SRB assay;CHEMBL5154650;Non-molecular target assigned;N;;1;CHEMBL385;;
1387441;;K562/Adr;CHEMBL5155650;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3833721;Target assigned is non-molecular;1;Antiproliferative activity against human K562/Adr cells measured after 72 hrs by SRB assay;CHEMBL5154650;Non-molecular target assigned;N;;1;CHEMBL4296449;;
1387442;;K562/Adr;CHEMBL5155651;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3833721;Default value - Target unknown or has yet to be assigned;0;Resistant index, ratio IC50 for K562/Adr cells over IC50 for K562 cells;CHEMBL5154650;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1373412;;HCT-8;CHEMBL5161604;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Default value - Target unknown or has yet to be assigned;0;Resistance index, ratio of IC50 for antiproliferative activity against human vincristine-resistant HCT-8/VCR cells to IC50 for antiproliferative activity against HCT-8 cells;CHEMBL5154799;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1373188;;A549;CHEMBL5161609;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells assessed as cell viability incubated for 48 hrs by MTT assay;CHEMBL5154799;Non-molecular target assigned;N;;1;CHEMBL392;;
1373191;;A2780;CHEMBL5161611;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Antiproliferative activity against human A2780 cells assessed as cell viability incubated for 48 hrs by MTT assay;CHEMBL5154799;Non-molecular target assigned;N;;1;CHEMBL614004;;
1373193;;HCT-8;CHEMBL5161612;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Antiproliferative activity against human HCT-8 cells assessed as cell viability incubated for 48 hrs by MTT assay;CHEMBL5154799;Non-molecular target assigned;N;;1;CHEMBL613510;;
1373393;;A549;CHEMBL5161632;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human adriamycin-resistant A549/ADR cells assessed as cell viability incubated for 48 hrs by MTT assay;CHEMBL5154799;Non-molecular target assigned;N;;1;CHEMBL392;;
1373408;;A549;CHEMBL5161633;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Resistance index, ratio of IC50 for antiproliferative activity against human adriamycin-resistant A549/ADR cells to IC50 for antiproliferative activity against human A549 cells;CHEMBL5154799;Non-molecular target assigned;N;;1;CHEMBL392;;
1373409;;HCT-8;CHEMBL5161634;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308035;Target assigned is non-molecular;1;Antiproliferative activity against human vincristine-resistant HCT-8/VCR cells assessed as cell viability incubated for 48 hrs by MTT assay;CHEMBL5154799;Non-molecular target assigned;N;;1;CHEMBL613510;;
1373414;;A2780;CHEMBL5161635;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Antiproliferative activity against human paclitaxel-resistant A2780/TAX cells assessed as cell viability incubated for 48 hrs by MTT assay;CHEMBL5154799;Non-molecular target assigned;N;;1;CHEMBL614004;;
1373418;;A2780;CHEMBL5161636;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Default value - Target unknown or has yet to be assigned;0;Resistance index, ratio of IC50 for antiproliferative activity against human paclitaxel-resistant A2780/TAX cells to IC50 for antiproliferative activity against human A2780 cells;CHEMBL5154799;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1392219;;HeLa;CHEMBL5162749;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Binding affinity to beta-tubulin colchicine binding site in human HeLa cells assessed as decrease of adduct formation by measuring gray value measured at 25 uM incubated for 2 hrs followed by addition of EBI measured after 1.5 hrs by EBI competition based Western blotting analysis;CHEMBL5154820;Direct protein target assigned;D;;1;CHEMBL3832942;;
1385742;;HeLa;CHEMBL5162765;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Binding affinity to beta-tubulin colchicine binding site in human HeLa cells assessed as inhibition of EBI-beta-tubulin adduct formation measured at 5 to 25 uM incubated for 2 hrs followed by addition of EBI measured after 1.5 hrs by EBI competition based Western blotting analysis;CHEMBL5154820;Direct protein target assigned;D;;1;CHEMBL2095182;;
1392218;;HeLa;CHEMBL5162904;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Multiple direct protein targets may be assigned;5;Binding affinity to beta-tubulin colchicine binding site in human HeLa cells assessed as decrease of adduct formation by measuring gray value measured at 5 uM incubated for 2 hrs followed by addition of EBI measured after 1.5 hrs by EBI competition based Western blotting analysis;CHEMBL5154820;Direct protein target assigned;D;;1;CHEMBL3832942;;
